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Abstract  
Organoboron compounds are of great importance to organic, medicinal, and materials chemistry, 
representing key intermediates for the introduction of a wide variety of functional groups. This is best 
exemplified by the Suzuki-Miyaura cross-coupling reaction. In recent years, the direct C-H borylation of 
arenes has become an attractive method for the synthesis of aryl boronate esters. However, this 
transformation is more challenging for heteroarenes bearing an azinyl nitrogen atom, where the 
presence of the nitrogen lone pair can inhibit the reaction. This is particularly evident at the proximal C-
H bond, where C-H activation often does not occur. Whilst many heteroarenes have been investigated, 
aminopyrazoles remain underexplored. This nucleus features in an array of bioactive molecules, such 
as herbicides, anti-cancer, and anti-parastic drugs. This thesis presents simple methods for the 
selective C-H functionalisation of 3- and 5-aminopyrazoles. 
 
 
 
 
 
 
 
 
 
 
 
 
Contents 
2 
 
Contents  
Abstract ................................................................................................................................................... 1 
Contents .................................................................................................................................................. 2 
Abbreviations .......................................................................................................................................... 5 
Declaration and Statement of Copyright ................................................................................................. 8 
Acknowledgements ................................................................................................................................. 9 
1 Introduction ........................................................................................................................................ 11 
1.1 Thesis Overview .......................................................................................................................... 11 
1.2 Introduction to Organoboron Compounds ................................................................................... 12 
1.3 Synthesis of Aromatic Organoboron Compounds ....................................................................... 15 
1.4 Introduction to Ir Catalysed C-H Borylation ................................................................................. 17 
1.5 Mechanism .................................................................................................................................. 17 
1.6 Scope and Reactivity ................................................................................................................... 18 
1.7 Regiochemistry ............................................................................................................................ 19 
1.7.1 Intrinsic Selectivity ................................................................................................................ 19 
1.7.2 Directed Borylation ............................................................................................................... 23 
1.7.3 Borylation of Heteroarenes ................................................................................................... 32 
1.8 Summary ..................................................................................................................................... 65 
1.9 References .................................................................................................................................. 65 
2 Previous Work and Aims .................................................................................................................... 74 
2.1 Previous Work ............................................................................................................................. 74 
Contents 
3 
 
2.2 Aims ............................................................................................................................................. 75 
2.3 References .................................................................................................................................. 78 
3 Results and Discussion ...................................................................................................................... 78 
3.1 Intrinsic Selectivities .................................................................................................................... 79 
3.1.1 3(5)-Aminopyrazole .............................................................................................................. 79 
3.1.2 N-Methyl-3-Aminopyrazole ................................................................................................... 81 
3.1.3 N-Methyl-5-Aminopyrazole ................................................................................................... 84 
3.2 Orthogonal Selectivities ............................................................................................................... 86 
3.2.1 N-H Borylation ....................................................................................................................... 86 
3.2.2 Urea-Directed Borylation ...................................................................................................... 87 
3.2.3 Protecting Group Switch ..................................................................................................... 109 
3.3 Conclusions and Future Work ................................................................................................... 145 
3.3.1 3-Aminopyrazoles ............................................................................................................... 145 
3.3.2 5-Aminopyrazoles ............................................................................................................... 148 
3.4 References ................................................................................................................................ 150 
4 Experimental .................................................................................................................................... 152 
4.1 Chemical Synthesis ................................................................................................................... 152 
4.1.1 General Notes ..................................................................................................................... 152 
4.2 Synthetic Procedures ................................................................................................................ 154 
4.2.1 C-H Borylation and Suzuki-Miyaura Cross-Coupling of Aminopyrazole Derivatives .......... 154 
4.2.2 Synthesis of Pyrazole Derivatives ...................................................................................... 173 
Contents 
4 
 
4.2.3 Synthesis of Heterocyclic Ureas ......................................................................................... 205 
4.2.4 Borylation of Aminopyridyl Derivatives ............................................................................... 214 
4.2.5 Protecting Group Switch of Aminopyrazole Derivatives ..................................................... 216 
4.3 X-ray Crystallography Data ....................................................................................................... 219 
4.4 References ................................................................................................................................ 222 
5 Appendix .......................................................................................................................................... 223 
5.1 NMR Spectra ............................................................................................................................. 224 
5.2 X-Ray Crystallography Data ...................................................................................................... 326 
5.3 Additional Metal Complexes and Ligands ................................................................................. 341 
5.3.1 Structures of Metal Complexes ........................................................................................... 341 
5.3.2 Strucutures of Ligands ........................................................................................................ 342 
 
 
 
 
 
 
 
 
 
 
Abbreviations 
5 
 
Abbreviations  
(Bpin)2bpy 4,4'-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,2'-bipyridine 
ASAP Atmospheric Solids Analysis Probe  
ATR Attenuated total reflection  
B2pin2 Bis(pinacolato)diboron 
Boc tert-Butyloxycarbonyl  
bpy 2,2’-Bipyridine 
cod 1,5-Cyclooctadiene 
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conc. Concentrated  
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DG Directing group 
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DMAP 4-Dimethylaminopyridine  
dmbpy 3,8-Dimethyl-2,2’-bipyridine 
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DoM Directed ortho Metalation 
dppe 1,2-Bis(diphenylphosphino)ethane 
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dppp 1,3-Bis(diphenylphosphino)propane 
dtbpy 4,4’-Di-tert-butyl-2,2’dipyridyl 
dvtms 1,3-Divinyl-1,1,3,3-tetramethyldisiloxane 
EI Electron Ionisation 
Eg Ethylene Glycol 
eq Equivalents 
ES Electrospray  
GCMS Gas Chromatography–Mass Spectrometry 
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HIM Hartwig Ishiyama Miyaura 
HMBC Heteronuclear multiple-bond correlation spectroscopy  
HRMS High-Resolution Mass Spectrometry  
HSQC Heteronuclear Single Quantum Coherence Spectroscopy 
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LiHMDS Lithium Bis(trimethylsilyl)amide  
L-DBTA Dibenzoyl-L-tartaric acid 
m-Xyl 1,3-Xylene 
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Neop Neopentyl 
NOESY Nuclear Overhauser Effect Spectroscopy  
Phen 1,10-Phenanthroline 
PMP p-Methoxyphenyl 
PMPNCO p-Methoxyphenylisocyanate 
rt Room Temperature/Ambient Temperature  
SEAr Electrophilic Aromatic Substitution 
SEM 2-(Trimethylsilyl)ethoxy]methyl 
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SMAP Silica-supported Silicon-constrained Monodentate Trialkylphosphine 
TBAB Tetra-n-butylammonium bromide 
TFA Trifluoroacetic Acid  
THF Tetrahydfofuran  
THP Tetrahydropyranyl 
tmphen 3,4,7,8-Tetramethyl-1,10-phenanthroline 
TLC Thin Layer Chromatography  
TQD Tandem Quadrupole Detector  
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1 Introduction  
1.1 Thesis Overview 
 
This thesis discusses new methodology for the regioselective Ir-catalysed C-H borylation of 
heteroarenes. The focus of this study is the pharmaceutically important aminopyrazole scaffold, with 
the primary goal to synthesise four arylated aminopyrazole isomers 2, 3, 5, and 6 using Ir C-H borylation 
and Suzuki Miyaura cross-coupling (Figure 1).  
The thesis contains four chapters. Chapter 1 provides an introduction to organoboron compounds and 
aromatic Ir C-H borylation, with a primary focus on the regiochemistry in heteroaromatic Ir C-H 
borylation. Chapters 2 and 3 present and discuss the research undertaken. Chapter 4 provides the 
detailed experimental methods and analytical data to support compound characterisation. 
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1.2 Introduction to Organoboron Compounds 
 
In 1860, the synthesis of triethyl borane 8 and diethyl ethylborate 9 was reported by Frankland and 
Duppa (Scheme 1a).[1] These were the first recorded compounds to contain a C-B bond, and molecules 
featuring this linkage are now known as organoboron compounds. Nearly one hundred years later, 
Brown developed hydroboration of alkenes using diborane 10 for the synthesis of trialkylboranes such 
as 11, and discovered that they could be oxidised to alcohols with alkaline peroxide (Scheme 1b).[2] A 
further twenty years later, Suzuki and Miyaura described that organoboron compounds could be cross-
coupled with organohalides to form sp2-sp2 C-C bonds with catalytic quantities of Pd (Scheme 2a).[3,4]  
As of 2014, this is the second most practiced reaction in medicinal and natural product synthesis. [5] 
Whilst C-B bonds do not appear in nature, their use is emerging slowly in chemical biology and drug 
discovery.[6,7] For example, Shinkai and co-workers have exploited the Lewis acidity of phenylboronic 
acid groups in porphyrin-based sugar-sensing agents, such as 13.[8] Furthermore, the anti-cancer drug 
Velcade and the antifungal drug Tavaborole both feature a C-B bond (Figure 2).   
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In the past two decades, further useful transformations of the C-B bond have been developed, which 
has secured the status of organoboron compounds as important intermediates in synthesis. These 
include (but are not limited to) amination/etherification/thiolation (Scheme 2b), fluorination (Scheme 2c), 
homologation/alkylation (Scheme 2d), cyanation (Scheme 2e), and carboxylation (Scheme 2f).[9–13] The 
utility of these new transformations is illustrated by their widespread usage in drug discovery and 
process development. For example, trifluoromethylation and bromination of (hetero)aryl boronates have 
been used for the synthesis of spiro-oxetane drug scaffold 27 and a nicotine hapten precursor 29, 
respectively (Scheme 2g, h).[14,15]   
A variety of organoboron derivatives, such as boranes, boronic acids, boronic (boronate) esters, borinic 
acids, borinic esters, boroxines, and trifluoroborates, among others, can be employed for these 
transformations (Figure 3). Of these derivatives, boronate esters are among the most synthetically 
useful, owing to their ease of handling, good reactivity, and solubility. Furthermore, these compounds 
carry advantages over their organometallic analogues, such as organostannane, organozinc, and 
organocopper reagents, including greater air stability, lower toxicity, and commercial availability. [16,17] 
Reflecting the abundance of densely functionalised aromatic scaffolds in organic molecules, the 
development of new methodologies for the formation of aromatic boronate esters is of interest in 
synthesis. This forms the focus of the following sections in this review. Space precludes a discussion 
of the borylation of other C-H bonds, such as those within aliphatic, vinylic, allylic, and benzylic systems. 
However, a number of reviews within this area are available.[18–23] 
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1.3 Synthesis of Aromatic Organoboron Compounds 
 
Traditionally, the synthesis of aromatic organoboron compounds is accomplished by metalation of a C-
H or C-X bond (X = Cl, Br, I) by a representative organometallic reagent, followed by an electrophilic 
quench with a borate (Scheme 3a, b).[24,25] Whilst this strategy carries advantages, such as low reagent 
cost and operational simplicity, there are limitations. For instance, in C-H metalation a 
directing/activating group such as the tertiary amine in 30 can be required to provide C-H acidity and 
selectivity in the deprotonation step. This is less problematic in metal halogen exchange, which is 
typically faster than C-H deprotonation. However, pre-functionalisation is required to generate the 
haloarene precursor. Furthermore, the hard bases required offer poor functional group tolerance (FGT). 
In this context, transition metal catalysts are attractive because they can offer superior scope, milder 
reaction conditions, and improved atom economy. For example, in 1995 Miyaura and co-workers 
described the Pd catalyzed borylation of aryl halides such as aryl ketone 34 using 
bis(pinacolato)diboron 35 to form the corresponding aryl boronate ester 36 (Scheme 3c).[26] Whilst this 
approach is amenable to late stage functionalisation, it remains limited by the requirement for a pre-
functionalised aromatic halide. A simple approach to borylation involves the direct transformation of C-
H to C-B. To a significant extent, catalytic borylation of aromatic C-H bonds has addressed many of the 
shortcomings of the aforementioned strategies.  
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Transition metals such as Pd, Co, Fe, Zn, Ru, Ni, Pt, Rh, Mn, and Ir have now been shown to catalyse 
this process (Scheme 4)*.[27–35] However, complexes based on Ir have been particularly effective in 
constructing C-B bonds. This represents the methodology investigated in this project, and the following 
section briefly discusses the development of this area.  
1.4 Introduction to Ir Catalysed C-H Borylation  
 
In 2002, independent publications by Smith et al. alongside Hartwig, Ishiyama, Miyaura, et al. (HIM) 
described the catalytic borylation of aryl C-H bonds by IrIII trisboryl complexes (Scheme 5).[36,37] This 
was built on earlier work using other iridium boryl complexes.[38–40] Smith’s system employed (Ind)Ir(cod) 
as the precatalyst (cod = 1,5-cyclooctadiene, Ind = indenyl), 1,2-bis(dimethylphosphino)ethane (dmpe) 
as the ligand, and HBpin (49) as the boron reagent (Scheme 5a). The HIM system employed [Ir(cod)Cl]2 
as the precatalyst, 2,2'-bipyridine (bpy) as the ligand, and B2pin2 as the boron reagent (Scheme 5b). 
Maximum turnover numbers (TON) in the original Smith system were ca. 4500, and ca. 8000 in the 
original HIM system. Reflecting this and subsequent developments, most C-H borylations are 
conducted with [Ir(cod)(OMe)]2 (precatalyst), a ligand derived from bipyridine, and B2pin2 or HBpin 
(boron reagent).[41,42] 
1.5 Mechanism 
The generally accepted mechanism for this process is given in Scheme 6.[43–47] The reaction involves a 
catalytic cycle that oscillates between IrIII/IrV intermediates.  
                                                     
* The structures of these complexes and their associated ligands among others are provided in section 5.3. 
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Combination of the precatalyst, ligand, boron reagent, and solvent produces the resting state of the 
catalyst 50. This is a hexacoordinate IrIII trisboryl complex, bearing two ancillary donor species and a 
weakly bound cyclooctene (coe) ligand. The production of 50 occurs during an induction period, in which 
cod is reduced to coe and the boron reagent enables oxidation of the IrI precatalyst. Following this, coe 
dissociates to form a pentacoordinate active species 51, which possesses a vacant coordination site. 
C-H bond cleavage occurs at 51 via rate limiting oxidative addition to form an IrV heptacoordinate 
complex 52. Reductive elimination of the carbon fragment with a boryl ligand produces an aryl boronate 
and an IrIII bisboryl hydride 53. Finally, the cycle is completed via the oxidative addition of B2pin2 or 
HBpin, followed by the reductive elimination of HBpin or H2, respectively. B2pin2 reacts preferentially 
over HBpin, and therefore the catalysis can be divided into two distinct cycles according to the boron 
reagent involved. 
1.6 Scope and Reactivity 
The reaction shows good selectivity for aromatic C-H bonds, with C-Cl, C-Br, and C-I bonds being 
acceptable. Groups such as nitrile, silyl, ketone, amide, ester, amine, some alcohols, and others are 
generally well tolerated (vide infra). However, nitro, sulphonyl, alkenes, alkynes, and enolisable protons 
can be problematic. The reaction can be conducted in a variety of solvents, although polar solvents 
have an inhibitory effect. Of the two most employed ancillary ligands, 3,4,7,8-tetramethyl-1,10-
phenanthroline (tmphen, 55) confers greater reactivity than 4,4′-di-tert-butyl-2,2′-dipyridyl (dtbpy, 56) at 
elevated temperature. This is due to tmphen possessing a more constrained geometry, although the 
effect is less pronouned at room temperature.[41]  
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Electron-deficient arenes are typically more active than electron-rich arenes, and this has been 
demonstrated in a competition borylation between a 1:1 mixture of 57 and 58 (Scheme 7).[43] Despite 
both substrates possessing equally accessible C-H bonds on steric grounds, the GCMS conversion of 
electron deficient 57 was >65%, compared to the <6% conversion of 58. The result of this study reflects 
the activating effect of electron-deficient arenes toward C-H oxidative addition. Most heteroarenes show 
even greater reactivity and will rapidly borylate under mild conditions. However, there are exceptions to 
this, and a discussion of the C-H borylation of heteroarenes is provided in section 1.7.3. 
1.7 Regiochemistry 
In the Ir-catalysed C-H borylation, intrinsic selectivity is substrate dependent, and C-H bonds with 
distinct steric and/or electronic properties can be cleaved preferentially. In carbocyclic arenes, the 
regiochemistry is generally governed by steric effects, although electronics can manifest. The selectivity 
can be altered through modification of the catalyst and/or substrate to produce C-H activation at 
otherwise less reactive C-H sites. This is referred to as directed borylation and is discussed in section 
1.7.2. For simplicity, this section divides the discussion of regiochemistry in carbocyclic arenes by 
systems which display intrinsic or directed regiocontrol. The regiochemistry observed in heteroarenes 
is subsequently overviewed. For a given system, a greater manifestation of sterics/electronics is 
reflected in the distributions of aryl boronate regioisomers.   
1.7.1 Intrinsic Selectivity 
1.7.1.1 Steric Selectivity 
Owing to the crowded nature of the active catalyst 51, many carbocyclic arenes borylate with steric 
regiocontrol.[48] In some instances, this provides an orthogonal method to directed ortho metalation 
(DoM) and electrophilic aromatic substitution (SEAr) strategies.[49]  
1 Introduction 
20 
 
 
At elevated temperature, the borylation of mono-substituted arenes such as toluene 61 leads to 
statistical product outcomes (Scheme 8a). The borylation of symmetrical 1,2- disubstituted arenes and 
1,3- disubstituted arenes 64 and 66 proceeds at the uncongested C-H bonds and affords a single 
product. This is because C-H cleavage ortho to substituents which are moderate/large in size is 
disfavoured (Scheme 8b, 8c). However, if the catalyst is not offered an unhindered C-H site, C-H 
activation ortho to moderately sized substituents can occur, and this is observed in the borylation of 
1,4-disubstituted 68 (Scheme 8d). Borylation ortho to small substituents (F, CN) is facile, for instance 
nitrile 70 is selectively borylated at the C-H bond ortho to the nitrile group (Scheme 8e).[48,50,51]  
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Systems have been described which offer improved steric selectivity in substrates with multiple reactive 
C-H bonds. For instance, para selective borylation can be achieved by establishing a more congested 
environment around the active catalyst. An example of this uses bulky phosphine ligand 73, which forms 
an active species which roughly mimics an enzyme active site, sterically inhibiting access of the catalyst 
to the ortho and meta C-H bonds (Scheme 9).[52,53] Furthermore, the para selective C-H borylation of 
aromatic esters, amides, and pyridines has been developed using cooperative Ir/Al catalysis.[54] 
Selectivity is primarily conferred by a bulky Al Lewis acid methylaluminumbis(2,6-di-tert-butyl-4-
methylphenoxide) (MAD), which forms an adduct 78 with the substrate.  
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Selectivity is enhanced with the ligand 4,4'-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,2'-
bipyridine ((Bpin)2bpy, 76), owing to the large size of the Bpin substituents. The authors suggested that 
steric repulsion between the catalyst and the adduct blocks the ortho and meta positions (Scheme 10). 
Other systems which offer ortho, meta, and para selectivity have been developed; however the 
remainder discussed in section 1.7.2 exploit a chelation-controlled directing effect. 
1.7.1.2 Electronic Selectivity 
Some carbocyclic arenes borylate under electronic control, and this is most evident in reactions that 
are conducted at ambient temperature. For example, benzodioxole 79 borylates with near complete 
selectivity for the more hindered ortho position, despite the presence of uncongested C-H sites 
(Scheme 11a). Computational and experimental results conducted by Smith and co-workers indicated 
that the transition state of C-H cleavage possesses significant proton transfer character, and is 
facilitated by boryl basicity.[55] This suggested that regioselectivity of this reaction may be controlled to 
a degree by C-H acidity.  
Later, Steel and co-workers reported that monosubstituted and unsymmetrical 1,2-disubstituted arenes 
undergo borylation with significant electronic selectivity at room temperature.  
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For example, aryl methoxy ketone 82 shows high selectivity for one C-H site, despite the fact that sterics 
would afford a statistical (1:1) product distribution (Scheme 11b). This selectivity was eroded at elevated 
temperature, reverting to normal steric selectivity. This study led to the general observation that π-
electron acceptors (-M) favour para borylation, and π-donors (+M) (also σ-acceptors) favour meta 
borylation. Therefore, the selectivities offered by ±M substituents are orthogonal to those found in SEAr. 
Mirroring Smith’s conclusion, C-H acidity values correlated well with site-selectivity.[44] In particular, 
electronic selectivity manifests frequently in the borylation of heteroaromatic substrates. For instance, 
the borylation of N-methylpyrazole 85 shows high selectivity for the sterically hindered alpha position 
(Scheme 11c). Recently, Houk and co-workers used a distortion/interaction analysis to probe the 
selectivities in the Ir C-H borylation of aromatic C-H bonds. It was shown that regioselectivity is primarily 
governed by the interaction energy of the substrate and the active species in the transition state. The 
transition state of C-H oxidative addition was calculated to be late and to possess an Ir-C bond that is 
largely formed. Therefore, Ir-C bond strengths were shown to correlate well with the activation energy, 
giving a robust predictor of regiochemistry.[56]  
1.7.2 Directed Borylation 
Systems which have been designed to alter the intrinsic selectivity of the catalyst show special 
regiochemistry. Classes of directing systems can be divided into inner-sphere and outer-sphere, and 
both of these are presented. Systems are discussed according to their relevance to heteroaromatic 
borylation. For consistency, specific examples in this section relate to carbocyclic arenes, and the 
presented systems have been chosen according to their relevance to heteroaromatic C-H borylation, 
which is the primary focus. A full discussion of directed borylation is not presented, although a review 
has been published by Lassaletta and co-workers.[57] 
1.7.2.1 Inner-Sphere Direction 
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Inner-sphere directed borylation refers to a substrate interaction with the Ir metal centre which promotes 
regioselective borylation, and this tends to promote ortho borylation. Reported strategies typically 
involve the design of a four-coordinate active species with two vacant coordination sites.  A basic 
functionality on the substrate acts a DG (directing group) and ligates at this site, which kinetically 
facilitates the selective cleavage of a C-H bond (Figure 4). For example, ortho-selective borylation is 
possible with Silica-SMAP (Silica-supported Silicon-constrained Monodentate Trialkylphosphine). This 
is a phosphine ligand immobilised on a heterogeneous silica-supported surface. The ligand selectively 
forms a mono-phosphine-ligated active species, permitting substrate coordination. This has been 
employed extensively in the site-selective borylation of arenes with various coordinating groups, such 
as aryl esters (Scheme 12), carbamates, ethers, acetals, carbonates, sulphonates, phosphoramides, 
chlorides, quinolines, and quinoxalines (see sections 1.7.3.2.2 and 1.7.3.4.1).[58–61]  
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Other non-nitrogen based ligands can similarly facilitate ortho direction. For instance, the ortho selective 
borylation of heteroaryl esters may be achieved using a labile ligand, such as AsPh3.[62]  The 
development of this system was built on previous work on ortho directed C-H borylation using related 
P and As ligands.[63,64] A communication which describes C-H borylation utilising AsPh3 employs 
heteroaromatic substrates only, so it is discussed in section 1.7.3.3. Nitrogen-based ligands also feature 
in inner-sphere direction, and this has been achieved with hemi-labile N,N pyridine-hydrazone ligands 
such as 94. Whilst the pyridine moiety remains tightly bound at iridium, the hydrazone portion readily 
dissociates from the catalyst as shown in 96a and 96b, enabling the coordination and subsequent ortho 
(bis)borylation of substrates with a variety of functional groups, including N,N-dimethylhydrazones, 
quinolines and pyridines (Scheme 13) (see section 1.7.3.2).[65–67]  
Ancillary ligands which bind in modes other than dative coordination have also been shown to promote 
inner-sphere direction. For example, iridium complexes with silyl and phosphorus chelates have been 
isolated by treating the precatalyst [Ir(cod)(OMe)]2 with ligand 99, forming 101 (Scheme 14). 
Presumably, cod dissociates from 101 allowing oxidative addition of B2pin2 to form the putative 
tetravalent active species, which possesses two vacant coordination sites. This enables the ortho C-H 
borylation of arenes with a library of functional groups. These include amides (Scheme 14), ethers, 
esters, N-alkoxyamides, and quinolines (section 1.7.3.2).[68] Notably, silyl and nitrogen donors can also 
be used in a similar manner.  
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In a similar fashion, complexes bearing pyridine tethered silyl borane ligands such as 103 have been 
employed in the ortho selective borylation of aromatic esters (Scheme 15). Furthermore, carbamates, 
acetates, amides, imides, pyridines, amines, oximes, and hydrazones also undergo directed C-H 
borylation with excellent selectivities.[69] Another strategy for inner-sphere direction involves removal of 
the ancillary ligand so that a weakly coordinating, monodentate substrate can take its place. For 
example, cyclic S,S-acetals 107 facilitate the ortho-directed borylation of (hetero)arenes with a variety 
of substitution patterns (Scheme 16). Whilst further mechanistic evidence is required, this is presumably 
an inner-sphere direction with the substrate binding at S as a labile ligand. 109 was proposed to be an 
intermediate in the catalytic cycle, rationalising the selectivity.[70] 
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Relay direction is a special sub-class of inner-sphere system which employs substrates with Si-H 
bonds. A hydrosilyl tether at the substrate 110 (either pre-functionalised or generated in situ) adds to 
the active species, likely by oxidative addition or σ-bond metathesis. Following the expulsion of HBpin, 
a remote site is rendered kinetically more reactive (Scheme 17). Inner-sphere relay is distinct from the 
other methods in this section because binding of the directing group with the metal centre does not 
necessarily require two vacant coordination sites. Substrate scope includes benzylic, phenolic, anilino, 
N-heterocyclic, and polycyclic aromatic hydrosilanes.[71–73] For example, substituted naphthalenes 113 
undergo regioselective peri borylation to form 114.[74,75] 
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1.7.2.2 Outer-Sphere Direction 
 
Outer-sphere directed borylation refers to a substrate interaction with an ancillary/boryl ligand on the 
active species which promotes regioselective borylation (Figure 5). This approach tends to promote 
ortho and meta borylation. Reported strategies involve the design of substrates and/or ligands that 
recognise each other via non-covalent interactions, which kinetically facilitates selective C-H cleavage. 
For example, building on previous work on the ortho borylation of NHBoc anilines, the ortho borylation 
of NHBpin anilines 120 has been described (Scheme 18).[76,77] Whilst other N-H bonds undergo 
borylation via a mechanism that is analogous to the C-H borylation (see section 1.5), anilines 
spontaneously react with HBpin without catalysis. A calculated transition state 119 indicated that ortho 
selectivity originates from a hydrogen-bond between the in situ N-borylated aniline 120 and a boryl 
ligand on the catalyst (Scheme 18). This approach constitutes a traceless directing group strategy, as 
the N-B bond is hydrolysed on work-up, reforming the aniline 118. N-Bpin was shown to be a superior 
director over NH2, and N-Boc.  
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However, in the absence of a para blocking group regioisomeric mixtures were obtained. It is noteworthy 
that N-borylation of azoles also led to regioselective borylation, and this is discussed in section 1.7.3.3. 
Recently, the selectivity of this process was improved significantly by replacing the director NHBpin with 
the ethylene glycol (eg) ester derivative NHBeg.[78] This likely operates in a similar manner for most 
substrates; however removal of the gem dimethyl groups in Bpin optimises hydrogen-bonding with 
reduced steric interference. This study was built on previous work involving the ortho borylation of 
phenols 121 with and B2pin2 and B2eg2, with the latter offering superior selectivity.[79] In a similar fashion, 
this method relies on the in situ borylation of a heteroatom followed by outer-sphere direction. However, 
the origin of ortho selectivity was hypothesised to arise from an unusual electrostatic interaction 
between the OBeg group and the bpy ligand, rather than from hydrogen-bonding. Substrates without 
blocking groups bisborylated at the ortho positions, and purifications were simplified by isolating 
boronates as their pinacol esters (Scheme 19). 
Outer-sphere direction can also be used to access the meta position in aromatic systems. For example, 
a strategy involving the hydrogen bond recognition between a pendant urea ligand 126 and aromatic 
amides has been developed which improves meta selectivity relative to dtbpy (Scheme 20).[80] 
Presented evidence suggests that the secondary substrate-ligand interaction places the Ir centre in 
close proximity to a meta C-H bond.  
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Another example of meta selective borylation utilises an ionic sulphonate bipyridine ligand 130 in 
conjunction with a substrate recognition unit. Substrates bearing ammonium salts in an electrostatic 
‘ion pairing mode’ (Scheme 21a) and amides in a ‘hydrogen bond accepting mode’ (Scheme 21b) show 
meta selective borylation.[81–84] The latter is an electronically inverted strategy to the meta selective C-
H borylation described previously using ligand 126. 
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Despite incurring high entropic penalties, arenes bearing recognition units with flexible linkers were 
tolerated, and up to three (hydrogen bond) or four (ion pair) membered carbon chains displayed largely 
good to excellent selectivities. Borylations conducted with 130 provided superior meta selectivity over 
dtbpy (ion pair, hydrogen bond) and tmphen (ion pair). Substrate-ligand recognition has also been 
employed for para-selective borylation. One example involves L-shaped bipyridine ligand 135 with a 
pendant quinolone, which enabled the para-selective borylation of aromatic esters.[85] The authors 
proposed that regiocontrol was established via a non-covalent interaction between the quinolone and 
the substrate. Selectivity was increased significantly in the presence of KOtBu, and it was suggested 
that a favourable interaction of K+ with the substrate promoted the non-covalent interaction (Scheme 
22). Despite often presenting a greater challenge, directed systems have also been employed to alter 
the intrinsic regiochemistry of heteroarenes. In contrast to the sterically governed selectivity observed 
in carbocyclic systems, heteroarenes show a high degree of intrinsic electronic regiocontrol. Indeed, 
sterically congested C-H bonds can be activated over unencumbered ones, and the position/nature of 
constituent heteroatoms can significantly affect regiochemistry. Other reviews of this area are 
acknowledged, and the next section provides an updated discussion of Ir C-H borylation regiochemistry 
in heteroarenes.[86,87]   
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1.7.3 Borylation of Heteroarenes 
Compounds bearing heteroaromatic scaffolds feature prevalently in pharmaceuticals, bioactive 
molecules, ligands for metal complexes, natural products, agrochemicals, and functional materials, in 
addition to others.[88–94] Therefore, atom economical, streamlined syntheses of these molecules are of 
commercial value. The Ir-catalysed C-H borylation can lend itself well to the late-stage functionalisation 
of these motifs because the reactivity of heteroarenes is typically high, and proceeds with moderate to 
excellent regioselectivity. This review outlines the regiochemistry in the Ir C-H borylation of 
heteroarenes, and substrate classes are divided according to ring type ring size (5/6), and number of 
heteroatoms (1/2). Heteroarenes that do not fit into these categories are discussed in the miscellaneous 
section 1.7.3.5.  
1.7.3.1 Five-Membered Heteroarenes with One Heteroatom 
1.7.3.1.1 Pyrrole, Thiophene and Furan 
Pyrroles, thiophenes, and furans generally have high activity and undergo borylation alpha to the 
heteroatom. Employing [Ir(cod)(Cl)]2, HIM described that even using 10 equivalents of arene in the C-
H borylation of the parent heterocycles leads to the formation of a mixture of mono- and bisborylated 
products (Table 1, Entries 1, 2, 3).[95] Unidentified 3-boryl regioisomers were noted in the borylation of 
furan alongside 139c and 140c. In the borylation of thiophene 138b, reducing arene equivalents to 2.5 
is deleterious to selectivity, whilst increasing the equivalents to 20 improves selectivity but reduces yield 
(Entries 4, 5). This reduction was attributed to an inhibitory effect of sulphur on the catalyst. Pyrrole and 
thiophene are exhaustively borylated in the presence of excess B2pin2 to afford the corresponding 2,5- 
diborylated products 140a and 140b (Table 1, Entries 6, 7). However, furan affords a mixture 2,5- and 
2,4- diborylated products 140c and 141c, and this may reflect an enhanced electronic reactivity of the 
arene (Table 1, Entry 8). It was subsequently shown that all of the parent heterocycles undergo facile 
and selective bisborylation at room temperature using the related [Ir(cod)(OMe)]2 precatalyst (Table 1, 
Entries 9-11).[42,48] The corresponding 2-substituted heterocycles also selectively undergo alpha 
borylation, and this is observed in the borylation of 2-methyl derivatives (Scheme 23a).[96] 
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Entry 138 X (Eq.) Y Eq. B2pin2 T/ oC t / h 139:140:141†  Yield /% 
1 a  NH (10) Cl 1 80 16 ca. 85:15:0 67 
2 b   S (10) Cl 1 80 16 ca. 85:15:0 83 
3 c O (10) Cl 1 80 16 ca. 85:15:0 83*  
4 b S (2.5) Cl 1 80 16 56:44:0 - 
5 b  S (20) Cl 1 80 16 93:7:0 69 
6 a  NH (1) Cl 1.1 80 16 0:>99:1 80 
7 b  S (1) Cl 1.1 80 16 0:>99:1 80 
8 c  O (1) Cl 1.1 80 16 0:87:13 71 
9 a  NH (1) OMe 1.0 25 0.5 0:100:0 75 
10 b  S (1) OMe 1.0 25 0.5 0:100:0 83 
11 c  O (1) OMe 1.0 25 1 0:100:0 93 
*Isolated alongside unidentified 3-boryl regioisomers 
† Isomeric purities were determined with GCMS and NMR 
Table 1: C-H Borylation of Pyrrole, Thiophene, and Furan 
Other C-substituted pyrroles and furans have been seldom reported. However, some examples are 
presented in Scheme 23.  3- and 2,3- substituted furans alpha borylate selectively in the presence of 
an ethyl ester/methyl group in the 3- position. Furthermore, the crude borylation mixtures were 
amenable to a one-pot Suzuki-Miyaura cross-coupling, affording arylated furans 150a and 150b 
(Scheme 23c, d).[97] In contrast to substituted pyrroles and furans, the borylation of thiophenes with a 
variety of substitution patterns has been described in some detail.[98,99] As with the other heterocycles, 
2- and 2,3- substituted thiophenes undergo alpha borylation selectively.  
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Entry 151 R 152:153 Total Yield /% 
1 a CN 1:1.3 54 
2 b   Cl 3.5:1 66 
3 c  Br 8.9:1 72 
4 d  Me 8.9:1 67 
5 e  p-Tol >32:1 74 
6 f CO2Me >99:1 95 
Table 2: Borylation of 3-Substituted Thiophenes 
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In the presence of excess heteroarene, the borylation of 3-substituted thiophenes is generally selective 
for the uncongested 5- position, reflecting steric control. The borylation of nitrile 151a is an exception 
to this rule, because CN has a low steric requirement (Table 2, Entry 1). This regiochemistry may reflect 
an activating effect of nitrile on the C-2 C-H bond. 3-Substituted thiophenes bearing moderately sized 
functionalities afford a mixture of 2- and 5-boryl isomers in a ratio which seems to reflect the size of the 
substituents, although electronics cannot be ruled out (Table 2, Entries 2, 3, 4). The borylation of 
thiophenes bearing larger 3-substituents, such as p-Tol 151e or CO2Et 151f proceeds with higher 
selectivities based on steric effects (Table 2, Entries 5, 6).  
Furthermore, symmetrical and unsymmetrical 2,5-disubstituted thiophenes undergo C-H borylation at 
the beta positions. Owing to the presence of a sterically encumbering ortho substituent, the room 
temperature borylation of 2,5-disubstituted thiophenes is slower than mono- or unsubstituted 
derivatives. For example, 2,5-dibromothiophene 154a borylates at room temperature to afford 155a 
(Table 3, Entry 1). Conversely, the corresponding dimethylthiophene 154b is inactive under the same 
conditions, presumably owing to the larger size of Me. However, efficient borylation can be achieved 
under more forcing conditions (Table 3, Entry 2). Unsymmetrically substituted heterocycles borylate 
with predominantly steric regiocontrol, and the less congested position is borylated selectively (Table 
3, Entries 3-6). To date, a 2,5-disubstituted furan has not been investigated, although comparable 
selectivity is predicted.  
 
Entry 154 R R’ 155:156 Total Yield /% 
1 a Br Br - 56 
2 b Me Me - 97* 
3 c Cl Br 2.0:1 87 
4 d Cl Me 2.3:1 95 
5 e Cl I 5.7:1 89 
6 f Cl TMS >99:1 93 
*Reaction Conditions: 2 mol% Ir/dmpe, 1.5 equiv. HBpin, 150  oC, 16 h 
Table 3: Borylation of 2,5-Disubstituted Thiophenes 
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Normal alpha selectivity in pyrroles can be modulated by using N-substituents which have a steric 
requirement. For instance, N-methyl pyrrole 157a is reported to borylate at the 2- and 3- positions in a 
76:24 ratio (Scheme 24a). Substituents such as TIPS, Boc, and Bpin block alpha borylation, and beta 
borylated products are afforded exclusively (Scheme 24a-c).[77,95,100–102] Whilst TIPS and Boc are 
employed as stepwise protecting groups, Bpin may be installed to form 163 and removed analogously 
to the traceless ortho direction of anilines discussed in 1.7.2.2 (Scheme 24c). Pyrrole does not undergo 
N-H borylation with HBpin or via catalysis, so the NBpin adduct 163 is pre-formed by stirring with base-
activated HBpin. Although it is likely that Bpin and TIPS are true steric directors, the degree to which 
Boc exerts an electronic directing effect is unclear. This is discussed further in chapter 2.  
As in other heteroarenes, alternative selectivities in pyrroles, thiophenes, and furans may be obtained 
via directing effects. This is generally achieved with carbonyl derivatives, except in Li’s sulphur directed 
borylation of S,S-acetal 165 (Scheme 25a).[103] Furthermore, Si, P, N donor ligands and Silica SMAP 
can override alpha selectivity in favour of ortho borylation in pyrrole, thiophene, and furan esters 
(Scheme 25b, Table 4). It is noted that in the latter system, the directing effect is pronounced enough 
to facilitate borylation ortho to two substituents in the presence of an alpha position (Table 4, Entry 
3).[61,68] 
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However, the enhanced C-H acidity in furan ester 169e led to some alpha selectivity (Table 4, Entry 5). 
The ortho selective borylation of pyrrole, thiophene, and furan derivatives with a large variety of 
substitution patterns may be achieved using AsPh3, and selected examples are shown in Table 5.[62] 
This method probably relies on the lability of the ligand to produce an open coordination site and 
subsequent inner-sphere direction. Control experiments revealed that the use of AsPh3 provides 
complementary regiochemistry to dtbpy.  
 
Entry 169 X R1 R2 Total Yield /% 
1 a S H H 74 
2 b S H Cl 99 
3 c S Me H 92* 
4 d NTIPS H H 96 
5 e O H H 56† 
*Obtained alongside 3% 5- isomer 
† Obtained alongside 21% 5- isomer 
Table 4: ortho Selective Borylation of Pyrrole, Thiophene, and Furan Derivatives with Si-SMAP 
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In all cases, ortho selectivity is >99:1, except for chloride derivatives such as 171d (Table 5, Entry 4). 
To account for this, the authors proposed that Cl competes for coordination, enabling ortho direction. 
Evidence for this can be found in related inner-sphere systems, where Cl acts a director.[58]  
Selectivities other than ortho can be achieved in these heterocycles, although fewer approaches are 
available for this. For example, hydrogen-bond direction using urea ligand 126 improves the C-4 
selectivity in 2-amidopyrrole 174 relative to dtbpy (Scheme 26a).[80] However, it was challenging for this 
system to overcome the intrinsic selectivities in other heterocycles. Furthermore, C-5 selectivity can be 
obtained by judicious choice of ligand and additive. For example, ligand 135 non-covalently enhances 
alpha selectivity in 177 (Scheme 26b), and ligand 76 seems to improve C-5 selectivity in conjunction 
with the Lewis acid MAD in 179 based on steric effects (Scheme 26c).[54,85]  
 
 
Entry 171 X R1 R2 Total Yield /% 
1 a O Me Me 92 
2 b O Me OMe 51 
3 c S Et CF3 75 
4 d S Et Cl 46* 
5 e NCO2Et Et Me 92 
6 f NCO2Et OMe Me 43 
*Isomer ratio 172:173 74:26 
Table 5: ortho Selective Borylation of Pyrrole, Thiophene, and Furan Derivatives with AsPh3 
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1.7.3.1.2 Indole, Carbazole, Benzothiophene, and Benzofuran 
The presence of carbocyclic aryl moeitie(s) in indole, carbazole, benzothiophene, and benzofuran 
introduces the potentiality for borylation at multiple sites. However, there is a marked preference for 
borylation at the heterocyclic ring where possible. Like their non-benzofused analogues, indole 181a, 
benzothiophene 181b, and benzofuran 181c selectively alpha borylate with excess heteroarene (Table 
6, Entries 1-8). However, in parallel with furan, benzofuran shows some selectivity for the beta position 
at elevated temperature (Table 6, Entry 3).[42,48,95] Bisborylation of indole affords the 2,7-disubstituted 
product 184a, and Smith has suggested that C-7 selectivity originates from N-chelation to the catalyst, 
followed by inner/outer-sphere direction.[104]  
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Entry 181 X (equiv.) Y R (eq.) T/ oC t / h 182:183:184  Total Yield /% 
1 a NH (4) Cl Bpin (1) 80 16 >99:1:0 92 
2 b S (4) Cl Bpin (1) 80 16 >99:1:0 89 
3 c O (4) Cl Bpin (1) 80 16 >97:3:0 91 
6 a NH (2) OMe Bpin (1.1) 25 0.5 100:0:0 88 
7 b S (2) OMe Bpin (1.1) 25 0.5 100:0:0 83 
8 c O (2) OMe Bpin (1.1) 25 0.5 100:0:0 84 
9 a NH (1) OMe H (2.2) 25 0.5 0:0:100 90 
Table 6: Borylation of Indole, Benzothiophene, and Benzofuran 
However, some observations bring this conclusion into question. For instance, ortho and peri 
substituents are known to hinder N-chelation in pyridines and quinolines, and why this does not seem 
to disrupt chelation in indole is unclear (see section 1.7.3.2.1). This is further illustrated in the iterative 
borylation of carbazole 185, which is selective for the analogous C-8 position following C-1 despite the 
high degree of peri steric hindrance at N from the boryl group and the carbocycle in the C-1 
monoborylated intermediate (Scheme 27a).[105]  
Furthermore, the calculated free energies of relative anionic stability in 2-phenylindole 188 indicate that 
C-7 (-10.96 kcal/mol) should intrinsically be the most reactive C-H site when contrasted to other 
uncongested C-H sites (0.0-9.4 kcal/mol).[106] Reflecting this, 188 borylates selectively at C-7 and this 
additionally demonstrates an electronic preference for the heteroaromatic carbocycle over the benzene 
substituent (Scheme 27b). Moreover, impure 2-borylfuran 190 also displays high selectivity for C-7, and 
it is probable that this regiochemistry is intrinsic based on the intrinsic ortho selectivity observed in the 
C-H borylation of benzodioxole (27c). Therefore, further studies are required to rule out intrinsic 
selectivity and support an N-chelation model in the borylation of indole 181a. 
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Owing to the prevalence of indole in bioactive molecules such as pharmaceutical agents and natural 
products, the Ir C-H borylation of many substituted indole derivatives has been well 
documented.[104,105,107–112] Providing that steric congestion is not introduced, other alpha substituted 
indoles (such as those with C-3, C-4, or C-5 substituents) also borylate at C-7. To date, the intrinsic 
borylation regiochemistry of substituted benzothiophenes has not been investigated, although C-7 
selectivity is predicted in analogy to the borylation of 190. 3-Alkyl indoles retain selectivity for the 2-
position, and therefore borylate with a high degree of electronic control.[113–117] For example, the 
borylation of 193 efficiently affords the 2-boryl product 194 alongside some of the C-7 bisborylated 
material 195 (Scheme 28a).  Furthermore, iterative borylation of 3-methylindole 196 with 5.0 equivalents 
of B2pin2 leads to a third borylation event at C-5 which is sterically controlled (Scheme 28b). Blocking 
C-2 and C-7 is possible with an N-TIPS group in 198, and this leads to non-selective borylation at C-5 
and C-6 in 3-substituted indoles. Site-selectivity can be significantly enhanced in systems such as 
indole 198 by switching the ligand from dtbpy/tmphen to 1,10-phenanthroline (phen), and this is 
additionally observed in the borylation of carbazole 201 using all three ligands (Scheme 28c, d). 
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These substrates possess a structure that is comparable to a 1,2-disubstituted arene, in which intrinsic 
selectivity can be governed to a high degree by electronic effects, albeit at room temperature. This 
ligand-mediated selectivity is almost certainly electronically controlled, although further studies are 
required to determine its origin.[118] Other N-substituents can modify the regiochemistry in indole, and 
this is observed in the borylation of N-methylindole 204a which affords a mixture of C-2 and C-3 
functionalised products 205a and 206a (Table 7, Entries 1, 2). 
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Entry 204 X (eq.) Y R (eq.) T/ 
oC 
t / h Solvent 205:206  Total Yield 
/% 
1 a Me (xs) Cl Bpin (1) 80 16 octane 89:11 - 
2 a Me (30) Cl H (1) 80 6 neat 55:45 81* 
3 b TIPS (4) Cl Bpin (1) 80 16 octane 0:100 83 
4 c Bpin (1.0) OMe H (2.0) 80 4 THF 0:100 57† 
5 d Boc (1) OMe H (2.00) 60 8 hexane 0:100 65 
*3.0 mol% bpy as the ligand 
† The substrate is indole 181a, C-H Borylation preceded by N-borylation with HBpin and Et3N 
Table 7: Borylation of N-Substituted Indoles 
Independent reports give incongruent selectivities for this process, although this is probably explained 
by the use of different reaction variables in each system, such as solvent, ligand, and reaction time.[95,111] 
Like their pyrrole analogues, TIPS indole 204b, Bpin indole 204c, and Boc indole 204d borylate with 
complete beta selectivity, and 204c is prepared in a similar manner to NBpin pyrrole 163 (Table 7, 
Entries 3, 4, 5).[77,95,101,119]    
The intrinsic selectivities of indole, benzothiophene, benzofuran, and carbazole derivatives can be 
altered using directing effects. For example, Li’s S directed borylation of 2-substiuted benzothiophene 
207 leads to an ortho functionalised product 208 (Scheme 29a). Furthermore, N-borylation of indole 
with B2eg2 affords 209, which undergoes selective borylation at the alpha position to afford 210 (Scheme 
29b). This outcome matches intrinsic selectivity, although it is still probably electronically directed 
because the corresponding NBpin indole 204c affords the beta product. Using Silica-SMAP, 2-, 3- and 
N-substituted carbonyl derivatives of these heterocycles undergo ortho or peri borylation. For example, 
N-substituted carbazole 211 efficiently borylates at C-1 (Scheme 29c).[61]  
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Furthermore, hydrosilyl heteroarenes also undergo selective borylation under relay direction, and the 
hydrosilyl group can be generated in situ or pre-installed. Examples that employ the former strategy 
include N-hydrosilyl carbazoles, and N-hydrosilyl indoles with substituents at the C-3/C-4/C-5 positions. 
For example, the borylation of chloroindole 213 is completely C-7 selective despite the presence of an 
intrinsically reactive heterocyclic ring (Scheme 29d).  Furthermore, 3-hydrosilyl indole and 
benzothiophene 215a and 215b undergo peri-selective borylation at C-4. Outer-sphere systems can 
also alter the selectivity in substituted indole derivatives. For instance, ion-pair recognition confers a 
near tenfold greater meta selectivity over dtbpy in ammonium indole 217 using ligand 130 (Scheme 
29f). Moreover, borylation with L-shaped ligand 135 leads to essentially complete alpha selectivity in 
N-methyl indole ester 220, compared to the 8:1 selectivity using dtbpy (Scheme 29g).[85,120]  
1.7.3.2 Six-Membered Heteroarenes with One Heteroatom 
This section introduces heteroarenes which contain azinyl (a.k.a. azine, basic) nitrogen atoms. Unlike 
azole N atoms, borylation is electronically disfavoured alpha to an azinyl N, and this can crudely be 
likened to the steric inhibitory effect of a substituent. In a given substrate, the degree to which alpha-
azinyl borylation occurs is dependent on the electron density at N, and on steric constraints in the rest 
of the molecule. DFT calculations of the reaction pathway for the C-2 borylation of pyridine show ca. 1 
kcal/mol higher barrier compared to borylation at the other sites.[121] As this is a relatively small 
difference, the lack of alpha-azinyl products may also be attributed to the poor stability of 2-
azaarylboronates. These are known to decompose via several pathways, including protodeborylation, 
and this also facilitates secondary decomposition of the catalyst.[122] However, the installation of a boryl 
group in the alpha-azinyl position may be promoted by stabilising groups, and these are typically 
electron-withdrawing groups such as other N ring atoms, sulphonyl, trifluoromethyl, and halides.  
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1.7.3.2.1 – Pyridine 
 
In the seminal report on the Ir C-H borylation of heteroarenes, pyridine 222 stands out as an unusually 
inactive substrate, requiring increased temperature and affording products in relatively low yield 
(Scheme 30).[95] A statistical mixture of beta and gamma borylated products was detected, with no 
evidence of C-2 functionalised products. The poor reactivity of pyridine may be attributed to the rapid 
decomposition of in situ C-2 borylated products, and the reversible deactivation of the active catalyst 
through substrate ligation. The latter phenomenon has been studied in the C-H borylation of 2,6-lutidine 
225, which normally undergoes facile C-H borylation to form 228. In this study, the addition of small 
amounts of 4-tertbutylpyridine 226, which is essentially inert toward C-H borylation at low temperature, 
efficiently inhibits the reaction through coordination to the vacant site on the catalyst shown in 227 
(Scheme 31). 
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Substrate ligation is most commonly prevented with a 2-substituent. This sterically or electronically 
prevents substrate coordination, enabling C-H borylation activity. For instance, 2-phenylpyridine 229 
borylates at room temperature with complete selectivity for the heteroarene in a 1:1 mixture of C-4 and 
C-5 isomers (Scheme 32).[123] This regiochemistry was showcased using a one-pot borylation/cross-
coupling sequence, affording arylated isomers 230 and 231. This provides another useful comparison 
between the reactivity of heteroarenes vs. carbocyclic arenes. 
 
Entry 232 R (eq.)  X 233:234:235:236  Total Yield /% 
1 a OMe  0.5 73:27:0:0 42 
2 a OMe  1.2 43:31:17:9 100 
3 b F  0.5 57:19:2:5 89* 
4 b F  1.2 45:10:15:19 100† 
*With 17% 3-borylisomer 
†With 11% 3-borylisomer 
  
Table 8: Borylation of 2-Substituted Pyridines 
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Whilst regiochemistry at the pyridine is approximately statistical, other 2-substituted pyridines borylate 
with a significant contribution from electronics.[124] For example, in the presence of 0.5 equiv. B2pin2, 2-
methoxypyridine 232a and 2-fluoropyridine 232b show greater selectivity for the 4-position (Table 8). 
Moving from 0.5 to 1.2 equiv. B2pin2, bisborylation occurs with varying selectivities (Entries 3, 4). 2-
Fluoropyridine undergoes facile borylation to afford a mixture of isomeric products, including C-6 
functionalised 235b. The capacity for 232a and 232b to promote alpha-azinyl regiochemistry is reflected 
in their reduced basicities relative to pyridine. The products obtained from the borylation of 232b were 
also accompanied with 3-substituted isomers, owing to low steric requirement of fluorine.  
2,3-Disubstituted pyridines borylate with steric control at C-5. Some electron-deficient systems display 
a small amount of alpha-azinyl site-selectivity, for example pyridine 237 borylates rapidly to afford 91% 
isomer 238 alongside 9% C-6 isomer 239 (Scheme 33a). Electron-deficient 2,4-disubstituted pyridines 
tolerate borylation at C-5 providing that the C-4 substituent has an acceptable steric requirement, and 
this may be seen in the borylation of 2,4-dichloropyridine 240a (Scheme 33b). In the C-H borylation of 
240b, the larger size of the trifluoromethyl group switches regiochemistry to C-6 (Scheme 33b). 
Similarly, providing it is not bound at the catalyst, dtbpy 56 borylates under more forcing conditions at 
the alpha azinyl positions (Scheme 33c). The regiochemistry was confirmed using a one-pot Suzuki-
Miyaura cross-coupling to deliver arylated product 243. Considering that the related 4-tertbutylpyridine 
226 is inactive, the 2-pyridyl unit in 56 likely facilitates the activity of dtbpy, possibly through an electron-
withdrawing effect. Replacing tBu with OMe gives the ortho functionalised products 245 and 246, and 
this reflects the lower steric hindrance of OMe (Scheme 33d). 2,5-Disubstituted pyridines rely on small 
to moderately sized substituents for activity. For example, the borylation of 2-cyano-5-bromopyridine 
247 proceeds efficiently to afford C-3 and C-4 boronates 248 and 249 (Scheme 33e).[50]  More 
congested substrates, such as 2,4-lutidine 250 show poor conversion under comparable conditions, 
although still afford C-4 boronates selectively (Scheme 33f). Finally, blocked 2,6-disubstituted pyridines 
generally have good activities and exhibit C-4 selectivity. For example, the borylation of 2,6-
dichloropyridine 252 affords C-4 boronate 254 in 93% yield as determined by GCMS with ligand 253 
(this is also possible with bipyridine ligand derivatives). (Scheme 33g).[125] 
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Pyridine derivatives can show different site-selectivities in directing systems. For instance, 
aminopyridines undergo rapid NH borylation to form the corresponding NHBpin adduct. This 
intermediate facilitates ortho selective C-H borylation in 2,4- and 2,5-aminopyridines, and this may be 
seen in the borylation of 255, which forms 257 in situ (Scheme 34a). It is suggested that HBpin is more 
efficient for N-H borylation, whilst B2pin2 is more efficient for C-H borylation, rationalising the use of both 
boron reagents in this reaction. In addition, the borylation of 2,5-hydroxypyridine 258 is ortho selective 
following traceless O-borylation with B2pin2 to afford 260 (Scheme 34b).[77,78] It is unclear to what extent 
the regiochemical outcomes of these processes differ from intrinsic regiochemistry. Notably, traceless 
ortho direction is not displayed with 2,6-aminopyridine derivatives, and intrinsic C-4 borylation 
analogous to the borylation of 252 occurs instead. 
Furthermore, 2-substituted pyridines show higher C-4 or C-5 selectivity under outer-sphere directing 
systems. For example, by employing ionic ligand 130 the C-4 selectivity in pyridine amides and 
trialkylammoniums is increased, and this may be observed in the borylation of 261.[82–84] Following C-4 
borylation, the powerful electron-withdrawing capacity of trimethylammonium can facilitate borylation at 
C-6, affording 263. Analysis of the crude reaction mixture revealed that a small amount of the C-4 
borylated product was also generated (Scheme 34c). C-4 selectivity may also be raised with ligand 126, 
which facilitates meta direction in pyridine amides and esters. For example, in the borylation of amide 
264 there is marked increase in C-4 selectivity when compared to dtbpy.[80] Alternatively, C-5 selectivity 
may be improved in pyridines such as ester 267 with L-shaped ligand 135 and KOtBu (Scheme 34e).  
Finally, pyridine derivatives may undergo regioselective borylation via coordination of the azine N in 
inner-sphere directing systems. Using this approach, the electronic preference for borylation at the 
pyridine can be overcome in favour of a carbocyclic substituent. For example, hemi-labile ligand 94 
efficiently facilitates borylation to the ortho position on the phenyl ring in 2-phenylpyridine 229, 
producing N-B ylide 269 (Scheme 34f). Similarly, the borylation of 229 using Si, P, and N donor chelates 
affords 269 (Scheme 34g). N,B bidentate ligand 103 also promotes the selective borylation of 226, and 
was additionally shown to promote remote borylation in substrates with a C or O spacer, as seen in 270 
(Scheme 34h). The specially engineered ligands involved in the directed borylation of pyridines are 
provided in Figure 7. 
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1.7.3.2.2 – Quinoline and Isoquinoline 
Unlike pyridine, quinoline 272 is an active substrate in the C-H borylation because the peri C-H bond of 
the carbocycle blocks inhibitory ligation to the active catalyst.[95] Like other benzofused heteroarenes, 
quinoline is selectively borylated at the heteroaromatic ring. In the presence of excess heteroarene, C-
3 selectivity is observed (Scheme 35a), whilst in the presence of excess boron quinoline bisborylates 
at C-3 and C6/C7 in a 1:1 ratio (Scheme 35b). Unlike benzofused azoles which show selectivity for C-
7, the analogous C-8 position in quinoline is unreactive. A possible explanation for this is that the C-8 
position is electronically encumbered by the azinyl N.  
Blocking C-3 activation with a C-2 substituent shifts the site-selectivity to C-4 and C-6/C-7, and this 
occurs in the borylation of 2-methylquinoline 276a and 2-trifluoromethylquinoline 276b (Scheme 35c).[44] 
In the latter substrate an increased selectivity for the carbocycle was observed, suggesting that the 
electron-withdrawing effect of the trifluoromethyl group is exerting an electronic influence on the 
selectivity. 2,6-Disubtituted quinolines borylate exclusively at C-4, and this is observed in the borylation 
of 279 (Scheme 35d). The regiochemical outcome of this reaction suggests that a nitrile group may 
offer greater steric hindrance than a peri C-H bond. Similarly, some 2,7-disubstituted quinolines show 
selectivity for C-4. For example, 2,7-dimethylquinoline 281a borylates with near complete C-4 selectivity 
(Scheme 35e).  
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Lower selectivity is observed in the C-H borylation of 2-methyl-7-trifluoromethylquinoline 281b, which 
affords an isomeric mixture of C-4 and C-5 borylated products (Scheme 35e). This is likely caused by 
the reduction of C-5 acidity at the carbocycle by the CF3 group. Indeed, the calculated C-H acidities of 
C-4 (38.6) and C-5 (39.7) in 281b show a good correlation with experimental site-selectivity. All C-H 
sites in 4,7-disubstituted quinolines are encumbered, so successful borylation generally requires forcing 
conditions and/or small to moderately sized substituents. For example, the borylation of 284a bearing 
a chloro group at C-4 is completely selective for C-3 under microwave heating (Scheme 35f).  
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More congested and quinolines give lower conversion under the same conditions, and this is seen in 
the borylation of 284b (Scheme 35f).  
Silica-SMAP directs borylation to the otherwise unreactive C-8 position in a library of mono-, di-, and 
trisubstituted quinolines.[60] Remarkably, the system affords C-8 regiochemistry even in congested 
substrates with a substituent at C-7, and this is observed in the borylation of 286 (Scheme 36a). More 
recently, aminoquinoline 288 has been shown to undergo ortho selective borylation at C-7 via an NHBeg 
intermediate (Scheme 36b).[78] The intrinsic regiochemistry of isoquinolines has not been investigated, 
and this is probably due to the fact that they are catalyst inhibitors unless substituted at C-1 or C-3, 
leaving two remaining C-H sites at the pyridine ring. However, 2-substituted isoquinolines have been 
regioselectivity functionalised using inner-sphere systems. Similar to 2-arylpyridines, hemi-labile 
ligands facilitate remote borylation of 2-aryl isoquinolines, and this is observed in the borylation of 291 
which is selective for the naphthyl ring (Scheme 36c).[66] Furthermore, relay direction enables the peri 
C-H borylation of hydrosilylated isoquinolines such as 293 (Scheme 36d).[72] 
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1.7.3.3 Five Membered Rings with Two Heteroatoms 
1.7.3.3.1 Pyrazole, Imidazole, and Oxazole 
The borylation of imidazole, pyrazole, and oxazole is generally alpha selective to a heteroatom that 
contributes a lone pair or electrons to the pi system.[126] Free NH imidazole does not borylate, and this 
could be due to rapid N-borylation to form the corresponding congested N-Bpin adduct. However, N-
methylated imidazoles borylate efficiently at C-5, and this is observed in the borylation of 295 in the 
presence of 1.5 equivalents of HBpin (Scheme 36a).  Interestingly, using 2.5 equivalents of HBpin leads 
to a second borylation event at the ortho C-H site on the phenyl ring (Scheme 36b). This could be 
mediated by an outer-sphere directing effect involving the azinyl N, although the origin of this selectivity 
awaits further study. Whilst alpha-azinyl regiochemistry is disfavoured, it may be facilitated with an N 
blocking group such as sulphamoyl, and this is observed in the borylation of 299 (Scheme 36c).[122] 
Other imidazole C-4 directors such as Boc produce alpha-azinyl functionalised products such as 302 
that can be more challenging to isolate (Scheme 36d). 
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Free NH pyrazole beta borylates owing to the rapid formation of the bulky N-Bpin species 305, which 
sterically blocks alpha borylation (Scheme 37a).[77] Unlike indole, this does not require exogenous base, 
and spontaneous N-H borylation occurs initially through a mechanism that is analogous to the C-H 
borylation discussed in section 1.5. 303 can also react with HBpin without catalysis to form 305. Like 
Bpin, the Boc group of 306 directs beta borylation to produce 307 (Scheme 37b).  
In a similar fashion, N-methyl pyrazole derivatives such as 85 and 308 selectively alpha borylate, and 
308 surprisingly shows tolerance for C-H borylation at C-5 which possesses two ortho substituents 
(Scheme 37c). This is unprecedented in carbocyclic arenes, and may be possible due to the less 
congested relationship between substituents in five-membered rings. Substituted 2- and 2,5-subsituted 
NH pyrazoles such as 311a borylate with selectivity for C-4, however trifluoromethyl pyrazole 311b 
alpha borylates (Scheme 46d).[121] It is unclear why this is the case, although if Bpin is truly a steric 
director 311b may not undergo spontaneous N-H borylation. 
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Significantly fewer oxazole derivatives have been reported in the C-H borylation, although some 
examples are given in Scheme 38. In these substrates, there is a normal preference for borylation at 
the most acidic site alpha to O.[126] The inner-/outer-sphere borylation of imidazole, pyrazole, or oxazole 
derivatives has not been investigated.  
1.7.3.3.2 Indazole 
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Free NH indazole does not borylate, and it has been suggested that this is due to an inhibitory effect of 
the azinyl N on the catalyst.[127] This is surprising because more basic heteroarenes such as N-
methylimidazole have high activity. Furthermore, the related heteroarene pyrazole is active and 
borylates at C-4 owing to spontaneous N-H borylation. Moreover, the basicity of indazole (pKa [HA]+ = 
1.25) is comparable to pyrimidine (pKa [HA]+ = 1.1), which shows some activity in the C-H borylation 
(see section 1.7.3.4.1).  
If indazole is indeed an inhibitor, it is likely that it does not undergo spontaenous N-H borylation, and 
this could be due to low BrØnsted acidity.[77] In support of this idea, N-substituted indazole derivatives 
undergo facile borylation, and N-methyl-1H-indazole 315 and N-methyl-2H-indazole 317 show 
complete selectivity for the heteroaromatic moiety (Scheme 39a, b).[128] Surprisingly, in 315 the steric 
inhibition of the ring-junction combined with the electronic inhibition of the azinyl N is overridden by this 
preference. However, when compared to pyridine/quinoline, the inhibitory effect of the azinyl N in 315 
is reduced by the electron-withdrawing effect of the azole N.  
Moving from N-Me to other substituents, such THP, SEM, or 3,5-dimethylbenzyl does not alter this 
regiochemistry in 1H and 2H indazoles, although the corresponding C-3 boronates are challenging to 
purify due to protodeborylation. To mitigate this, the electron-withdrawing effect of the Ms group was 
employed to stabilise boronate 320, permitting isolation in 62% yield (Scheme 39c). Furthermore, at 
elevated temperature in the presence of 2 equiv. of B2pin2, N-SEM-2H-indazole 321 iteratively borylates 
at C-5/C-6 following C-3 in a 5:1 ratio (Scheme 39d). Finally, substitution at C-4 in 324 introduces peri-
like congestion at C-3, which leads to C-H borylation at C-6 (Scheme 39e).  
1.7.3.3.3 Benzoxazole, Benzothiazole, and Benzimidazole 
The borylation of benzoxazoles, benzothiazoles, and benzimidazoles requires a substituent at C-2 in 
order to prevent substrate ligation to the catalyst. In 2-methylbenzoxazole 326, borylation is selective 
ortho to O (C-7) (Scheme 40a), and other derivatives with substituents at C-4 or C-5 also show this 
regiochemistry.[121] This is consistent with the ortho selectivity observed in benzodioxole 79, and it has 
been proposed that C-7 selectivity originates from C-H acidity (see section 1.7.1). 2-
Methylbenzothiazole 328 is comparably less active towards C-H borylation and displays poorer intrinsic 
selectivity (Scheme 40b).  
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The requirement for elevated temperature and catalyst loadings likely reflects the deactivating effect of 
sulphur, mirroring the relatively low activity of thiophene (see section 1.7.3.1). In contrast, 2-
methylbenzimidazole 330 efficiently undergoes distal borylation at C-5 (alternatively C-6 since 
tautomerism is rapid), and this regiochemistry is observed in other 2-substituted derivatives (Scheme 
40c). The lack of C-4/C-7 selectivity could be attributed to the formation of an N-Bpin adduct, which 
sterically hinders the peri position. This is supported by the requirement for increased equivalents of 
B2pin2 for efficient borylation. Furthermore, the remaining peri C-H bond may be inhibited by the azinyl 
N in analogy to the lack of intrinsic C-8 selectivity in quinoline. Alternatively, the rapid tautomerism in 
330 may impart azinyl-character to both ring nitrogen atoms, causing both to electronically inhibit peri 
borylation. 
1.7.3.4 Six Membered Rings with Two Heteroatoms 
1.7.3.4.1 Diazines 
The presence of two N ring atoms renders diazines less Lewis basic then pyridine, permitting greater 
activity. Indeed, parent pyrimidine 332 borylates at room temperature using tmphen as a ligand, albeit 
in low NMR yield. In analogy to the C-H borylation of other azinyl systems, the catalyst avoids the alpha-
azinyl positions and delivers C-5 functionalised boronate 333 selectively (Scheme 41a).   
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Blocking ligation of diazine substrates improves reactivity, and this may be seen in the comparably 
more efficient borylation of 2-methylpyrimidine 334 (Scheme 41b). Likewise, the borylation of 6-
methylpyridazine 336 is efficient and selective for C-4 (Scheme 41c). In contrast to pyridines, 
substituted pyrazine have been shown to borylate at the alpha-azinyl C-H bond without necessarily 
requiring electron-withdrawing substituents and this is enabled by the additional ring N atom. For 
example, pyrazine 338 efficiently borylates in at C-6, despite the presence of an ortho azinyl N and 
methyl group (Scheme 41d). Finally, in parallel with the transformation of quinolines,  the borylation of 
quinoxaline has been reported under the Si-SMAP system, affording bisborylated product 341 via inner-
sphere coordination of the azinyl N atoms (Scheme 41e).[60] 
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1.7.3.4.2 Azaborine and Borazaronaphthalene 
 
The Ir C-H borylation is amenable to the functionalisation of boron containing heteroarenes, including 
azaborine and 2,1-borazaronaphthalene. In analogy to other azoles, azaborine 342 borylates 
selectively alpha to N at C-6 (Scheme 42a), and this is unaffected by substitution at B.[129] Notably, this 
selectivity correlates well with calculated gas-phase acidity, rationalising why the introduction of a less 
C-H acidic phenyl group in 344 is selective for the heterocycle (Scheme 42b).  
1 Introduction 
62 
 
2,1-Borazaronaphthalenes are benzofused analogues to azaborine, and this motif differs from other 
benzofused heteroarenes in the C-H borylation as regioselectivity is observed for the carbocyclic ring. 
For instance, the carbocycle of 346 is more reactive than the azaborine and benzothiophene systems, 
and undergoes selective borylation at C-8 (Scheme 42c).[106] The use of excess boron leads to 
bisborylation at C-8 followed by C-6, and this is observed in 348. To account for C-8 selectivity, it has 
been suggested that the ring N-H may play a role in an inner/outer-sphere directed process. However, 
in 2-phenyl-2,1-borazaronaphthalene it has been calculated that C-8 offers the greatest anionic charge 
stabilisation compared to other uncongested C-H sites, which suggests that the selectivity may be 
intrinsic in origin. The methylation of the ring N-H to form analogue 350 does erode C-8 borylation 
selectivity, and this has been offered as evidence for an N-H mediated directing effect. This could 
alternatively be due to a peri steric effect on the C-8 site (Scheme 42d).  
1.7.3.5 Miscellaneous 
1.7.3.5.1 Azaindole, Azaindazole and Deazapurine 
In free NH 4- and 7-azaindole, N-H acidity is elevated by the presence of the azine N, facilitating 
spontaneous N-H borylation. Consequently, the corresponding N-Bpin adduct blocks C-2, leading to C-
3 selective borylation in 352a and 352b (Scheme 43a).[77,101,121] The C-H borylation of N-
methylazaindazole 354 is C-3 selective and affords 355. Notably, the sterically hindered pyrazole ring 
displays greater reactivity than the pyridine ring. (Scheme 43b). 
7H-Pyrrolo[2,3-d]pyrimidine (deazapurine) is related to 7-azaindole, except one C-H unit is replaced 
with an N atom to form a fused pyrimidine. Whilst the C-H borylation activity of deazapurines is variable, 
some disubstituted deazapurines borylate alpha to the azole N (C-6).[130,131] For example, the borylation 
of 356 tolerates the steric hindrance of an ortho benzyl group, and is selective for the heteroarene 
(Scheme 43c). The presence and nature of the substituents plays a role in determining activity, for 
example C-4 substituted free N-H deazapurines such as 358 do not borylate. Spontaneous N-H 
borylation may account for the lack of C-6 functionalisation, although it is unclear why the phenyl C-H 
bonds do not undergo C-H borylation (Scheme 43d). 
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1.7.3.5.2 Porphyrins and Corroles 
Porphyrins and corroles are closely related macrocycles consisting of four modified pyrrole units. 
Therefore, they share aspects of borylation regiochemistry with 2,5-disubstituted pyrroles.[132–136] For 
example, the borylation of porphyrin 360 is selective for the beta position to N, affording major 
monoborylated isomer 361 alongside two minor bisborylated isomers 362a and 362b in a 1:1 ratio 
(Scheme 44a). Notably, the borylation also tolerates Ni and Cu coordinated analogues of 360, affording 
products with similar selectivities. Judicious meso substitution blocks the corresponding peri positions, 
permitting a degree of regiochemical control in iterative borylation reactions.  
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For instance, one borylation event occurs in the reaction of corrole 363 because the other C-H sites are 
sterically hindered by the meso pentafluorophenyl substituents (Scheme 44b). In porphyrins, 
substitution with benzene derivatives at all four meso positions shuts down reactivity at the macrocycle.  
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1.8 Summary 
Organoboron compounds are versatile intermediates to the synthetic organic chemist. Seventeen years 
on from its inception, the Ir-catalysed C-H borylation remains a state-of-the-art tool for the regioselective 
installation of C-B bonds, as it overcomes the limitations of traditional syntheses. The crowded nature 
of the catalyst permits sterically controlled borylation of carbocyclic C-H bonds, and the least hindered 
sites are generally the most reactive.  
Whilst the site-selectivity observed in the borylation of heteroarenes carries a degree of steric control, 
a larger contribution from electronic effects is apparent in some systems. This is evident by the 
observation that more congested C-H bonds can undergo borylation selectively, and this this most 
prevalent in heteroaromatic substrates. Factors such as Ir-C bond strength, relative anionic 
stabilisation, and C-H acidity in conjunction with sterics are useful predictors of heteroaromatic site-
selectivity. The intrinsic selectivities of aromatics can be altered using directing effects, and a common 
strategy involves replacing the commonly employed bipyridine-derived ligands with others that facilitate 
inner-/outer-sphere direction. The reactivity and site-selectivity of other aromatic systems in the Ir C-H 
borylation will undoubtedly be the subject of future studies. 
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[131] M. Klečka, L. P. Slavětínská, M. Hocek, European J. Org. Chem. 2015, 7943–7961. 
[132] H. Hata, S. Yamaguchi, G. Mori, S. Nakazono, T. Katoh, K. Takatsu, S. Hiroto, H. Shinokubo, 
A. Osuka, Chem. Asian J. 2007, 2, 849–859. 
[133] H. Hata, H. Shinokubo, A. Osuka, J. Am. Chem. Soc. 2005, 127, 8264–8265. 
[134] S. Hiroto, I. Hisaki, H. Shinokubo, A. Osuka, Angew. Chem. Int. Ed. 2005, 44, 6763–6766. 
[135] J. Chen, N. Aratani, H. Shinokubo, A. Osuka, Chem. Asian J. 2009, 4, 1126–1133. 
[136] G. Mori, H. Shinokubo, A. Osuka, Tetrahedron Lett. 2008, 49, 2170–2172. 
 
 
 
2 Previous Work and Aims 
74 
 
2 Previous Work and Aims  
2.1 Previous Work 
 
Previous work in the group has investigated the reactivity and site-selectivity in the Ir C-H borylation of 
heteroarenes containing azinyl N atoms, such as pyridine, quinoline, and indazole. Takagi described 
that the borylation of pyridine requires elevated temperature, and affords an approximately statistical 
ratio of C-3 and C-4 boronates (Scheme 1a).[1] Our group and others have shown with competition 
experiments that the poor reactivity of pyridine may be attributed to N-coordination to the active catalyst, 
impeding reactivity (see section 1.7.3.2.1).[2,3] However, this coordination can be blocked by a C-2 
substituent, enabling the facile C-H borylation of pyridines such as 2-methoxypyridine 232 (Scheme 
1b). Further studies by Sadler, Tajuddin, and others attribute the lack of C-2 functionalised boronates 
in the C-H borylation of pyridine to dipolar repulsion in the transition state, and to the rapid 
decomposition of the corresponding alpha-azinyl boronate via protodeborylation pathways. 
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However, reducing the electron density at N promotes alpha-azinyl selectivity, and this may be achieved 
by the introduction of electron-withdrawing substituents. For example, the C-H borylation of electron-
deficient pyridine 240b is C-6 selective due to the combined electron-withdrawing effects of the Cl and 
CF3 groups (Scheme 1c). Furthermore, other ring N atoms also facilitate alpha-azinyl regiochemistry, 
and this is observed in the C-3 selective C-H borylation of indazole 315 (Scheme 1d).[4,5] In this example, 
the use of 0.5 equiv. of B2pin2 is possible since the catalyst may also turnover HBpin. The related 
heteroarene pyrazole does not show alpha-azinyl regiochemistry due to the presence of other 
unencumbered C-H sites with relatively high C-H acidity. Instead, pyrazole first undergoes rapid N-H 
borylation to form NBpin adduct 305, which sterically directs borylation to C-4 (Scheme 2a).[77] Reducing 
the steric demand of the N-substituent shifts selectivity to the electronically activated C-5 site, and this 
is observed in the borylation of N-methylpyrazole 85 (Scheme 2b). Pyrazole is a ubiquitous scaffold in 
bioactive molecules, agrochemicals, natural products, and few reports have studied pyrazole substrates 
in the Ir C-H borylation. Therefore, we sought to develop this area by investigating the borylation 
reactivity and site-selectivity of pyrazole derivatives.  
2.2 Aims 
As discussed in the previous section, past studies in the group concerning the Ir C-H borylation of azinyl 
heterocycles led to our interest in the pyrazole scaffold. As part of an ongoing collaboration with Pfizer 
laboratories, we were interested to investigate how an amino substituent in 3- and 5-aminopyrazoles 
would affect reactivity and/or site-selectivity in the Ir C-H borylation.  
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Aminopyrazoles are considered to be privileged structures in chemical biology, and 3- and 5-
aminopyrazole motifs are particularly important scaffolds in a variety of drug molecules, such as D1-D4 
(Figure 1).[7-12] Traditionally, the synthesis of 3- and 5-aminopyrazoles is achieved de novo via the 
condensation of a hydrazine with a 1,3-dielectrophile (generally a conjugated nitrile). For example, D1 
precursor D1c was synthesised by treating α-cyanoketone D1a with methylhydrazine under acidic 
conditions, which concurrently afforded isomer D1b (Scheme 3a).[9] Similarly, D2 precursor D2c was 
synthesised de novo ring α-cyanoketone D2a and hydrazine, followed by acylation and N-alkylation 
(Scheme 3b).[10] The alkylation step also led to the formation of isomer D2b in significant quantity. 
These approaches carry some drawbacks, such as use of N-substituted hydrazines which can lead to 
the formation of intractable pyrazole regioisomers. When using the parent hydrazine, subsequent N-
functionalisation can raise the same issue. To an extent, this issue can be mitigated by reaction 
optimisation, although this is a laborious and costly endeavor. Furthermore, the range of functionalities 
that may be introduced prior to the formation of the pyrazole core is limited by the conditions of the ring 
assembly, introducing complexity into synthetic routes. Therefore, we aimed to develop an Ir C-H 
borylation/Suzuki-Miyaura cross-coupling methodology for the late-stage, regioselective introduction of 
aryl groups into aminopyrazole scaffolds. 
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Taking inspiration from previous work, we set targets to (a) determine the intrinsic Ir C-H borylation 
regiochemistry in 3- and 5- aminopyrazoles, (b) develop processes that deliver the C-B bond 
regioselectively (c) provide complementary selectivity to the regiodselectivity obtained in (b). In order 
to showcase the utility of this approach, we decided to employ Suzuki-Miyaura cross-coupling in order 
to obtain all isomers in their arylated forms, and Figure 2 presents this. This project was conducted in 
collaboration with Andrew Hones (Durham), Alpay Dermenci, David Blakemore, and Andrew Flick 
(Pfizer, CT, acknowledgement also given to the C-H borylation and Suzuki-Miyaura team there).     
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3 Results and Discussion  
As discussed in section 2.2 the goal of this study was to develop new methodologies for the 
regioselective elaboration of 3- and 5-aminopyrazoles using Ir C-H borylation and Suzuki-Miyaura 
cross-coupling. The first aim was to establish the intrinsic C-H borylation selectivity in these 
heterocycles. Following this, this intrinsic selectivity would be reversed in order to synthesise a total of 
four arylated aminopyrazole isomers 2, 3, 5, and 6 (Figure 1). 
 
3.1 Intrinsic Selectivities 
3.1.1 3(5)-Aminopyrazole 
Initially, the Ir C-H borylation of the parent scaffold 3(5)-aminopyrazole 369 was investigated. It was 
suggested that this substrate may not be active, because the 5-tautomer 369b contains an 
unencumbered basic azinyl N, which carries the potential to coordinate to the catalyst and inhibit C-H 
activation (Figure 2).[1] This is in analogy to the C-H borylation of free N-H indazole, which is likely to be 
inactive for similar reasons (see section 1.7.3.3.2).[2] 
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On the other hand, N-H borylation precedes C-H borylation in pyrazole 303, forming the N-Bpin adduct 
305 which undergoes C-H borylation at C-3 due to steric effects (Scheme 1a). Furthermore, primary 
aromatic amines such as 366 can undergo N-H borylation to form NHBpin adduct 368, and this enables 
outer-sphere ortho selective C-H borylation to form 367 (Scheme 1b).[3,4] Therefore, it was hypothesised 
that these phenomena could jointly facilitate the C-H borylation of 369 at C-3 and afford 370 (Scheme 
1c).  
To test this idea, a set of standard borylation reactions were conducted using [Ir(cod)(OMe)]2, tmphen, 
and boron reagents. The catalyst mixture was combined with the substrate, and each reaction was 
monitored using 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as an internal standard. 
Conducting the reaction with B2pin2 at 80 ºC led to quantitative substrate recovery (Table 1, Entries 1 
and 2). In both cases, the dark shade of the catalyst turned to a light red colour over the course of the 
reaction, and this commonly suggests catalyst decomposition. Switching the boron reagent to HBpin 
led to decomposition of the substrate to unknown materials, and this was evident from the crude 1H 
NMR spectrum (Table 1, Entry 3). Recently, addition of the substrate to the catalyst at elevated 
temperature has been described by Hartwig for the N-H/C-H borylation of heteroarenes such 7-
azaindole.  
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Entry Boron Reagent (eq.) Solvent t/ h NMR Yield 370 /% NMR Yield 372 /% 
1 B2pin2 (2.2) THF 1 - - 
2 B2pin2 (2.2) THF 16 - - 
3 HBpin (4) 2-MeTHF 1 - - 
4 HBpin (3) 2-MeTHF 1 10* 0 
*Following addition of the substrate to the catalyst the temperature was decreased from 80 oC to rt.  
Table 1: C-H Borylation Screen of 369 
Whilst the reasons for this are not obvious, addition of 369 to a solution of the catalyst and HBpin at 80 
oC led to rapid gas evolution, which was presumed to be H2 and was tentatively attributed to N-H 
borylation (Table 1, Entry 4).[4] The reaction temperature was subsequently reduced, and after 1 h a 
10% NMR yield of 370 was evident in the crude 1H NMR spectrum by a singlet at 7.53 ppm displaced 
downfield from the C-5 proton in 369, consistent with the deshielding effect (ca. 0.1-0.5 ppm) that Bpin 
substituents exert on ortho protons. Evidence of this product could also be found in the EI and ESI 
mass spectra, with peaks at m/z = 209.2 and 210.2 m/z attributed to the [M]+ and [M+H]+ molecular 
ions, respectively. This could suggest that the addition of the substrate to the pre-heated catalyst 
permitted rapid N-H borylation at one or more of the N-H bonds and facilitated C-H borylation at C-4. 
Whilst the C-H borylation of 369 was possible, approximately 50% of the substrate had decomposed 
into unknown side-products after 1 h. Attempts to isolate the small quantity of 370 produced using SiO2 
gel chromatography were unsuccessful, and this was attributed to the affinity of the N-H bonds for the 
chromatographic media. In order to rectify this, attention was turned to N-substituted pyrazoles. 
3.1.2 N-Methyl-3-Aminopyrazole 
Five-membered azoles such as pyrrole, imidazole, and pyrazole generally display alpha C-H borylation 
selectivity in the absence of a sterically large N-blocking group (such as Bpin, TIPS, etc.) (see section 
1.7.3.1). On this basis, the C-H borylation of N-methyl-3-aminopyrazole 373 was predicted to be C-5 
selective.  
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As expected, 373 C-H borylated efficiently at C-5 affording boronate 374 in quantitative NMR yield after 
1 h at 80 ºC. Regiochemistry was assigned based on the presence of a boron-shifted singlet at 5.98 
ppm in the crude 1H NMR spectrum, attributed to the C-4 hydrogen.* One-pot borylation/Suzuki-Miyaura 
(SM) cross-coupling enabled the isolation of arylated adduct 375, albeit in low yield (Scheme 2).† 13C 
NMR analysis of purified 375 displayed a characteristic signal at 94.3 ppm, which was attributed to C-
4. Furthermore, this signal displayed a 1J interaction in the 2D 1H-13C HSQC spectrum with the C-4 
hydrogen found at 5.76 ppm in the 1H NMR spectrum, supporting C-5 site-selectivity. The inefficiency 
of this process was attributed to protodeborylation during the arylation and to contamination by other 
pinacol derivatives, which jointly led to intractable product mixtures. 
 
                                                     
* Boronate ester was also isolated in 51% yield under modified conditions by collaborator Alpay Dermenci 
† The 6-quinolyl adduct was obtained using 6-bromoquinoline by Alpay Dermenci in 81% isolated yield under identical coupling conditions. 
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The goal of future studies is to determine the origin of protodeborylation. In particular, this process may 
be catalysed by Pd, so a control experiment on 374 which includes the reagents in the arylation except 
Pd could probe this. The event of inseperable contaminants was attributed to the interaction of the free 
amine with pinacolatoboryl contaminants (e.g HOBpin), so protection as the corresponding Boc 
carbamate 376 was undertaken in an attempt to simplify purification. Neat Boc protection of 373 was 
achieved in quantitative yield with Boc2O at 50 oC. Subsequent C-H borylation of Boc carbamate 376 
then efficiently delivered the C-5 functionalised boronate 377, and this was evident by the presence of 
a boron-shifted singlet in the crude 1H NMR spectrum (Scheme 3). Unfortunately, attempts at 
chromatographic purification of 377 again led to decomposition. To address this problem, Suzuki-
Miyaura cross-coupling of the crude borylation reaction mixture was undertaken, affording 378 in 
excellent NMR yield, as evident by the presence of a single pyrazole C-H signal at 6.64 ppm attributed 
to C-4. Attempted purification of 378 was challenged by the presence of pinacol derivatives (such as 
pinacol, HOBpin, pinBOBpin), so the crude material was globally deprotected with TFA. Whilst this 
permitted the isolation of 379, this was accompanied by significant decomposition, lowering the overall 
efficiency of the sequence. The generation of 379 was evident by a signal in EI GCMS spectrum with a 
m/z = 231.1 corresponding to the [M]+ molecular ion. 13C NMR analysis of purified 379 displayed a 
characteristic signal at 98.5 ppm, which was attributed to C-4. 
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Furthermore, this signal displayed a 1J interaction in the 2D 1H-13C HSQC spectrum with the C-4 
hydrogen found at 6.87 ppm in the 1H NMR spectrum, supporting C-5 site-selectivity. In addition, the 
presence of a primary amine in 379 was evident from two bands at 3385 and 3278 cm-1 displayed in 
the infrared spectrum. Whilst the cross-coupling process requires further optimisation, this small study 
established that N-methyl-3-aminopyrazoles are active substrates in the Ir C-H borylation, affording the 
corresponding C-5 boronates selectively and in excellent NMR yield. Focus then moved to the 
corresponding C-5 regioisomer, N-methyl-5-aminopyrazole 380.  
3.1.3 N-Methyl-5-Aminopyrazole 
 
The borylation selectivity of 380 was difficult to predict because related systems give orthogonal 
selectivities. For example, N-methyl-1H-indazole 315 shows selectivity for C-3 (Scheme 4a), whilst 
NHBpin may act as an ortho (C-4) director in the event of N-H borylation (section 1.7.2). However, the 
borylation of 380 efficiently delivered C-3 boronate 381 with complete selectivity, suggesting that site-
selectivity may be governed either by the ortho directed borylation of the corresponding NHBpin adduct 
382, the electronic preference to avoid the alpha-azinyl position, or a combination of both effects 
(Scheme 4b). At this time, the in situ formation of 382 from 380 was not investigated, although the N-H 
borylation of related aminopyrazoles was later explored. A control experiment involving C-3 methylated 
381 could be used to more conveniently to determine if N-H borylation of these systems is possible. A 
boron-shifted singlet at 7.48 ppm in the crude 1H NMR spectrum, and a signal in the EI mass spectrum 
with m/z = 223.2 attributed to the [M]+ molecular ion supported the assignment of 381. However, 
attempts to isolate or cross-couple 381 caused decomposition to unknown materials, so 380 was 
protected as a Boc carbamate 383 in order to promote the cross-coupling step (Scheme 5).  
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It was hypothesised that 383 would display the same C-4 borylation regiochemistry as 380 because 
NHBoc acts as an ortho director in a similar fashion to NHBpin. Pleasingly, the synthesis and borylation 
of 383 was efficient and ultimately led to the isolation of boronate 384 in high yield. This was evident 
from the 1H NMR spectrum, which displayed a boron-shifted singlet at 7.62 ppm attributed to the C-3 
hydrogen. Furthermore, crude boronate 384 could be arylated under a one-pot borylation/cross-
coupling protocol (Scheme 6).* Despite an extended reaction time, the cross-coupling reaction did not 
proceed to completion, and ca. 30% of 384 was recovered. The 1H NMR spectrum of 385 contained a 
pyrazole C-H singlet at 7.67 ppm, which is characteristically high due to the electron-withdrawing effect 
of the alpha azinyl N. These studies established the excellent Ir C-H borylation regioselectivity and 
reactivity of N-methyl-3-aminopyrazole 373 and N-methyl-5-aminopyrazole 380 and their Boc-protected 
derivatives, and our next focus was to achieve complementary selectivities in these systems. 
 
 
                                                     
* 6-Bromoquinoline and 3-bromopyridine were also reported by Alpay Dermenci to couple under the same conditions in 73% and 63% yield, 
respectively 
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3.2 Orthogonal Selectivities 
3.2.1 N-H Borylation 
 
An understanding of the intrinsic C-5 borylation regiochemistry in N-methyl-5-aminopyrazole 373 was 
first required in order to develop a method with complementary site-selectivity. It was hypothesised that 
373 does not display C-4 selectivity because the primary amine does not undergo N-borylation to afford 
a corresponding NHBpin adduct required for directed ortho C-H borylation (Figure 3). From the initial 
C-H borylation of 373 a signal at 27.6 ppm in the 11B NMR was attributed to the NHBpin adduct, and 
this shift is characteristic in systems containing N-B bonds.[5,6] Furthermore, two signals at 1.32 and 
1.33 ppm in the in the crude 1H NMR spectrum were assigned as the C-5 Bpin and NHBpin CH3 signals 
in 387, respectively. However, a disparity in their relative integrations was measured, and it was 
hypothesised that N-B hydrolysis upon exposure of the reaction to adventitious moisture could account 
for this. 
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To test this, the reaction was conducted in heptane whilst minimising air exposure during analysis and 
this revealed that 387 forms quantitatively (Scheme 7). This was evident by the presence of 
characteristic signals at 27.6 and 22.5 ppm in the 11B NMR spectrum, corresponding to boron nuclei in 
the N-B and C-B bonds, respectively. Stirring crude 387 in MeOH led to the disappearance of the signal 
at 27.6 ppm only, and this is indicative of N-B methanolysis.* These experiments indicate that the 
primary amine in 373 does undergo N-H borylation at some stage of the reaction but does not facilitate 
directed C-H borylation to C-4. 
3.2.2 Urea-Directed Borylation 
3.2.2.1 Aminopyrazole Ureas 
The next study aimed to understand why the N-borylation of 373 does not enable ortho borylation at C-
4. Comparing the rotamers associated with the (C-3)-N bond rotation in the NHBpin adduct 388a 
suggested that coulombic repulsion between the boryl O and the azinyl N leads to the significant 
population of conformer 388b, which may prevent directed borylation and sterically block the C-4 C-H 
bond (Scheme 8a).  
 
                                                     
* Experiment performed and data collected by Alpay Dermenci (Pfizer) 
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In order to overcome this effect, a model involving a urea 389 was suggested. In this model, a remote 
portion of the directing group could favourably hydrogen bond with the azinyl N, rather than repel it 
(Scheme 8b). Consequently, the fixed orientation of the urea would provide the N-H bond necessary 
for hydrogen-bond mediated ortho directed C-H activation. To test this hypothesis, urea 391 was 
synthesised by stirring 373 with 4-methoxyphenylisocyanate (PMPNCO) in MeCN for 16 h (Scheme 9). 
Formation of the urea was evident from the IR spectrum, which displayed an absorption at 1674 cm -1 
attributed a urea carbonyl stretching frequency. Furthermore, a peak at m/z = 247.1183 was found in 
the ASAP mass spectrum, and this was attributed to the [M+H]+ molecular ion. With urea 391 
successfully synthesised, focus turned to the C-H borylation reaction. Using HBpin and tmphen the C-
H borylation of 391 showed reactivity at C-4, and this was confirmed via isolation and characterisation 
of C-4 boronate 392 following standard workup and chromatography (Scheme 9).  A through-space 
interaction of the C-5 hydrogen with the N-CH3 hydrogens was observed in the 2D 1H-1H NOESY 
spectrum, and indicated that the C-5 C-H bond remained intact. Furthermore, the presence of a boron-
shifted singlet at 7.53 ppm in the 1H NMR spectrum provided additional evidence for C-4 selectivity. 
Subsequently, 392 was arylated using Suzuki-Miyaura cross-coupling with 2-chloropyridine, affording 
394 in modest yield (Scheme 10). X-ray analysis of 394 provided good evidence for key intramolecular 
N-H hydrogen bond between the pyrazole and the urea, suggesting that C-4 selectivity may originate 
from a directing-effect.* 
 
                                                     
* Experiment performed by Alpay Dermenci 
3 Results and Discussion 
89 
 
The low yield of 392 was a concern, and a more detailed analysis of the crude 1H NMR spectrum 
revealed that the formation of 392 was accompanied by C-5 boronate 393 in a 2:3 ratio 392:393. The 
generation of 393 was evident from a boron-shifted singlet found at 6.26 ppm in the crude 1H NMR 
spectrum, and by the presence of two signals with similar m/z patterns displayed in the HPLC spectrum.* 
Furthermore, despite the complete conversion of parent urea 391 measured by 1H NMR, purification of 
the reaction mixture led to substrate recovery. Therefore, it was reasoned that 393 had undergone 
protodeborylation during SiO2 gel chromatography. Following this discovery, the next goal was to gain 
a further understanding of the observed C-4 site-selectivity. It was posited that if ortho C-H borylation 
relies on an intramolecular hydrogen-bond network, then substitution of the urea nitrogens should 
diminish it.  
 
 
 
394 
Scheme 10: Suzuki-Miyaura Cross-Coupling of 392 
                                                     
* HPLC analysis conducted by Alpay Dermenci 
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To test this, each N-H bond in parent urea 391 was selectively methylated (Scheme 11). On the basis 
that each N-H bond in 391 may possess distinct acidities, a selective alkylation with LiHMDS (1.20 
equiv.) and MeI (1.00 equiv.) was conducted (Scheme 11a). Pleasingly, this furnished N-alkylated urea 
395 as indicated by the appearance of an additional CH3 signal at 3.34 ppm in the 1H NMR spectrum, 
for a total of three CH3 signals. Furthermore, a through-space interaction of the C-4 hydrogen with the 
urea N-CH3 hydrogens was observed in the 2D 1H-1H NOESY spectrum, confirming the selectivity of 
this process (Figure 4). It was noted during SiO2 gel purification of the crude reaction mixture that the 
isolation of 395 was accompanied by ca. 10% bismethylated urea 396. Therefore, a modified alkylation 
procedure was conducted using LiHMDS (2.40 equiv.) and MeI (10.0 equiv.), which generated 
bismethylated urea 396 in good yield (Scheme 11b). Evidence for the methylation of both N-H bonds 
was found in the 1H NMR spectrum, which displayed two new CH3 signals at 3.18 and 3.05 ppm, for a 
total of four CH3 signals.  
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Figure 4: Key nOe Interaction in 395 
The synthesis of the final control urea 398 presented a greater challenge because it could not easily be 
obtained from 391. In order to overcome this, urea 398 was assembled by treating anisidine 397 with 
triphosgene, generating the corresponding carbamoyl chloride in situ. The reaction mixture was then 
combined with N-methyl-3-aminopyrazole 373, affording 398 in acceptable yield (Scheme 11c). 
Evidence for the generation of a monomethylated urea was found in the 1H NMR spectrum, which 
displayed a signal at 3.27 ppm attributed to the N-CH3 protons for a total of three CH3 signals. 
Furthermore, the 1H and 13C NMR spectra of 395 and 398 resemble each other but possess different 
shifts, and this provided good evidence that both monomethylated isomers were synthesised 
successfully. 
The next goal was the investigation of the site-selectivity of each control urea in the C-H borylation. In 
contrast to the parent urea 391, the reaction of mono-methylated isomers 395 and 398 displayed 
complete C-5 selectivity, providing good evidence that the borylation regiochemistry of 391 is governed 
to some extent by an ortho directing-effect (Table 2, Entries 1, 2). The borylation regiochemistry of 395 
and 398 was evident from the crude borylation 1H NMR spectra, which displayed boron shifted singlets 
at 6.31 and 7.01 ppm, respectively. In order to obtain more evidence for C-5 selectivity, one-pot Suzuki-
Miyaura cross-couplings of boronates 395a and 398a was conducted with methyl 4-iodobenzoate, and 
this led to the isolation of arylated isomers 395b and 398b. Evidence for C-5 selectivity in the arylation 
of 395a was evident in the 1H NMR spectrum, which displayed a singlet at 6.03 ppm attributed to the 
C-4 hydrogen. 
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Entry R1 R2 Boronate NMR Yield /% SM Isolated Yield /% 
1 (395) Me H >99 37 
2 (398) H Me >99 35 
3 (396) Me Me n.r. - 
Table 2: Control Experiments with Methylated Ureas 
Furthermore, a 1J through-bond coupling of this signal with the characteristic C-4 carbon signal at 95.8 
ppm in the 13C NMR spectrum was displayed in the 2D HSQC 1H-13C spectrum. Similarly, the C-4 proton 
in 398b was displayed as a singlet at 6.77 ppm in the 1H NMR spectrum, and exhibited a 1J through-
bond coupling with the characteristic C-4 carbon at 97.0 ppm in the 13C NMR spectrum (Figure 5). 
Despite multiple reaction attempts, the borylation of bismethylated urea 396 led to quantitative substrate 
recovery, even with prolonged reaction times (Table 2, Entry 3). One explanation for this is that the urea 
group aligns over the pyrazole ring and sterically blocks access of the catalyst to the C-H sites. Indeed, 
this conformation is predicted to be favoured in the ground state by DFT calculations, and it is 
speculated that this is promoted by pi-stacking interactions between the two aromatic rings (Figure 6).* 
The outcome of these control experiments demonstrate that the N-H bonds in 391 are essential for 
ortho C-H borylation, lending credence to the idea that C-4 site-selectivity is facilitated by a hydrogen-
bonding network. Encouraged by these results, we sought to improve the C-4 selectivity of the directed 
borylation by varying different reaction parameters. It has been observed in our laboratory that different 
boron reagents can confer modified C-H borylation selectivities in some fluorinated systems.[7] 
                                                     
* Performed by Boye Zhu 
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Figure 5: Key 1H-13C HSQC Interactions in 395b (Left) and 398b (Right) 
Therefore, HBpin was replaced with B2pin2, and this led to no change in selectivity at 80 oC and room 
temperature (Table 3, Entries 2 and 3). The replacement of HBpin with HBcat led to complete 
decomposition to unknown materials at room and elevated temperature (Table 3, Entries 4 and 5). An 
explanation for this could be the elevated Lewis-acidity of catecholatoboryl derivatives, which may 
promote side-reactions. Baran has described that different bipyridine-derived ligands can alter intrinsic 
selectivities in the C-H borylation of indoles and carbazoles such as 198 (Scheme 12). Indole substrates 
were judiciously substituted with steric blocking groups at N-1 and C-3 in order to investigate the 
selectivity between the C-5 and C-6 sites. Therefore, different ligands were screened to mediate 
electron density at the catalyst and promote C-4 selectivity. Whilst this was successful in improving 
regioselectivity, an increased quantity of undesired isomer for 393 was observed with electron-
rich/electron-neutral bipyridines (Table 3, Entries 9-11), and an electron-deficient monodentate 
phosphine (Table 3, Entry 12). 
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Entry Ligand  Boron 
Reagent (eq) 
T / oC t / h NMR Yield /% 392:393 
1 tmphen  HBpin (4) 80 1 >99 40:60 
2 tmphen  B2pin2 (2) 80 1 90 40:60 
3 tmphen B2pin2 (2) rt 18 90 40:60 
4 tmphen  HBcat (4) 80 1 - - 
5 tmphen  HBcat (4) rt 1 - - 
9 bpy B2pin2 (2.2) 80 5 min >99 35:65 
10 dtbpy  B2pin2 (2.2) 80 5 min >99 30:70 
11 
 
B2pin2 (2.2) 80 0.25 >99 25:75 
12* 
 
B2pin2 (2.2) 120 1 70 15:85 
* 3 mol% ligand used 
Table 3: Modification of Different Variables in the C-H Borylation of Urea 391 
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One possible explanation for this is that the modification of the ligand ultimately alters the electron-
density at the boryl ligands, and this may disrupt the putative hydrogen-bond network. However, further 
studies are required to determine the origin of ligand-controlled intrinsic C-H selectivity differences. This 
study demonstrated that altering reaction variables in the C-H borylation of 391 including temperature, 
ligand, and boron reagent does not improve C-4 selectivity. Following this, it was hypothesised that 
increased steric congestion at C-5 may improve C-4 selectivity as the catalyst is sensitive to steric 
effects. The bulky 3,5-dimethylbenzyl (Xyl(Me)2) group was selected in order to investigate this. Notably, 
Sadler previously described that the Ir C-H borylation of indazole 399 exhibits good tolerance towards 
this group, and this provided good precedent for this selection.[2] This group was chosen over the 
simpler benzyl group as the methyl groups were designed to prevent unwanted C-H borylation events 
and to increase steric bulk. Therefore, attention was given to the synthesis of urea 401 and how the 
3,5-dimethylbenzyl group may affect the C-H borylation selectivity.  
It was predicted that direct alkylation of 3(5)-aminopyrazole 369 would be non-selective, so an 
alternative approach was developed. A retrosynthetic analysis on urea 401 revealed novel nitropyrazole 
403 as the first target (Scheme 14a). Precedent for this was obtained from a report from Chroder, who 
described the N-1 selective benzylation of 3(5)-nitropyrazole with NaH (Scheme 14b). On this basis, a 
modified procedure which employed lower temperature was developed based on this which afforded 
403 with complete isomeric purity in good yield (Scheme 14c). N-1 selectivity was evident by a through-
space interaction of the C-5 hydrogen with the benzylic methylene hydrogens in the 2D 1H-1H NOESY 
spectrum. To prevent competitive hydrogenolysis of the 3,5-dimethylbenzyl group, the reduction of 403 
was performed with Fe over the more standard Pd/H2 system, which afforded primary amine 402 in 
good yield. With 402 in hand the C-H borylation was investigated using HBpin and tmphen.  
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This afforded two distinct C-5 borylated products, which was evident by the presence of two shifted 
singlets at 6.03 and 6.49 ppm with equal intensity in the crude 1H NMR spectrum (Scheme 15). The 
latter signal was assigned as N-borylated adduct 407, and this is supported by the presence of an 
additional Bpin CH3 signal at 1.30 ppm in the 1H NMR spectrum, and by the presence of a signal at 
28.2 ppm in the 11B NMR spectrum attributed to the N-Bpin group.  
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A peak in the ESI LCMS spectrum with m/z = 202.1 attributed to the [M+H]+ ion provided good evidence 
for the successful reduction of 403. C-4 selectivity was ruled out by the absence of boron-shifted C-5 
hydrogen, which would otherwise appear shifted ~0.1-0.5 ppm downfield from 7.12 ppm. Furthermore, 
one peak with m/z = 327.3 corresponding to the [M]+ ion was displayed in the crude EI GCMS spectrum, 
supporting the production of a single isomer since the N-B bond in 407 likely cleaved during EI 
analysis.[8] Unfortunately, multiple attempts to isolate the product of this reaction and arylate the crude 
reaction mixture led to protodeborylation. Therefore, our attention turned to the synthesis of urea 
derivative 401, which was performed analogously to the synthesis of parent urea 391 and was obtained 
in excellent yield. With the urea in hand, the next focus became the C-H borylation of 401. Unfortunately, 
this gave similar selectivity to the parent urea 391 at 80 oC (Table 4, Entry 1). Performing the reaction 
at room temperature led to higher selectivity for undesired isomer 409, although C-4 selectivity was 
raised somewhat at 100 °C (Table 4 Entries 2, 3). From this study, it was concluded that C-4 selectivity 
is not improved with steric hindrance introduced by N-substitution with a 3,5-dimethylbenzyl group in 
401 or 402.  
 
Entry T /oC t/ h NMR Yield 408:409 
1 80 1 80 60:40 
2 rt 16 >99 30:70 
3* 100 1 90 50:50 
*2-MeTHF used as a solvent 
Table 4: Synthesis and C-H Borylation of 401 
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Following this study, it was hypothesised that removal of the benzylic methylene spacer in 401 may 
incur increased steric congestion at C-5 and therefore improve the regioselectivity in the urea-directed 
C-H borylation. In order to test this, p-methoxyphenyl pyrazole 410 was synthesised following a 
modified Ullmann coupling originally developed by Prestat from 3(5)-aminopyrazole.[9] Subsequently, 
410 was treated with PMPNCO under standard urea-formation conditions, affording 411 in acceptable 
yield following recrystallisation from THF. The successful synthesis of 411 was evident from the purified 
1H NMR spectrum, which displayed two sets of two PMP doublets at 7.50, 7.44, 6.99, and 6.89 ppm. 
Furthermore, two pyrazole C-H signals were displayed at 7.70 and 5.55 ppm in the 1H NMR spectrum. 
Unlike the previously investigated pyrazole ureas, 411 displayed no conversion in the C-H borylation at 
room temperature, whilst repeated attempts at elevated temperature led to decomposition to unknown 
materials (Scheme 16). Therefore, it was suggested that substitution at the azole N with a six-
membered ring was deleterious to C-H borylation activity. In conjunction with efforts to improve C-4 
selectivity in the urea-directed C-H borylation, this was tested by switching PMP for tetrahydropyran 
(THP). A retrosynthetic analysis led to the identification of THP nitropyrazole 413 as the first target 
required to achieve this. 413 had previously been reported in a patent by Agostino, and attempts to 
reproduce this procedure led to the formation of regioisomers 413 and 414 (Scheme 17).[10] The 
generation of two isomers was evident from the crude 1H NMR spectrum, which displayed two sets of 
pyrazole signals at 7.68/6.88 ppm (413) and 7.64/6.85 ppm (414). Furthermore, two peaks with m/z = 
197.1 attributed to the [M]+ ions were displayed in the EI GCMS spectrum.  
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Generally, 3- and 5-substituted pyrazoles may be distinguished based on the magnitude of the 3J 
coupling between C-4 and C-5 protons in the 3-substituted isomer, which is larger than the 3J coupling 
between the C-3 and C-4 protons in the corresponding 5-substituted isomer. Accordingly, the pyrazole 
C-H 3J coupling was measured at 2.6 Hz in 413 and 2.5 Hz in 414, although the associated error of 
these measurements rendered assignments somewhat dubious. Unfortunately, further characterisation 
was not possible as the crude mixture was challenging to separate, so focus was given to developing 
a more selective protection. Slade had previously described the regioselective THP protection of 
indazoles, and this system furnished N-1 protected indazoles such as 416 selectively (Scheme 18a).[11] 
This was suggested to operate through the room temperature equilibration of the N-1 and N-2 isomers 
via indazolium 417 promoted by the strong acid p-TsOH. These conditions were adopted in order to 
improve the selectivity in the THP protection of 3(5)-nitropyrazole 404, and this pleasingly furnished 
413 with complete selectivity and excellent yield (Scheme 18b).  
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A through-space interaction of the C-5 hydrogen with the pyranyl methine C-H was observed in the 2D 
1H-1H NOESY spectrum, which supported the assignment of 413. The reduction of 413 via Pd-catalysed 
hydrogenation afforded aminopyrazole 418, which was subsequently C-H borylated to afford 419 with 
complete C-5 selectivity in excellent NMR yield (Scheme 19). This was evident by the presence of a 
boron-shifted singlet in the 1H NMR spectrum at 6.06 ppm, and indicated that the additional congestion 
at C-5 incurred by THP does not alter the C-H borylation selectivity in the primary amine. Unfortunately, 
attempts to chromatographically purify and cross-couple 419 led to protodeborylation, so focus was 
turned to the synthesis and C-H borylation of THP urea 420. In order to achieve this, 418 was treated 
with PMPNCO in MeCN to in analogy to the synthesis of parent urea 391 (Scheme 20).* The subsequent 
C-H borylation of 420 under standard conditions led to slightly improved selectivity for C-4 boronate 
421 and conducting the reaction at room temperature provided the same selectivity with lower 
conversion. This selectivity was evident by the presence of two boron-shifted singlets at 7.77 and 6.31 
ppm in the crude 1H NMR spectrum attributed to 421 and 422, respectively. This suggested that the 
THP group may assist C-4 selectivity in the urea-directed C-H borylation of 420 on steric grounds. 
Chromatographic separation of the two isomers led to the isolation of C-4 boronate 421 in a higher yield 
than parent urea C-4 boronate 392, and this may have been facilitated by the increased C-4 selectivity. 
A through-space interaction between the C-5 hydrogen and pyranyl methine hydrogen observed in the 
1H-1H 2D NOESY spectrum provided good evidence for C-4 selectivity.  
                                                     
* 1H NMR shifts quoted in CDCl3, compound reported in d6-DMSO. 
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Despite the complete conversion deduced using 1H NMR spectroscopy monitoring experiments, a 
considerable quantity of the starting heteroarene could also be recovered after chromatography, 
suggesting that 422 protodeborylates on SiO2 gel. This instability was consistent with the observation 
that multiple attempts to arylate 421 under Suzuki-Miyaura cross-coupling led to complex, intractable 
mixtures typically accompanied by significant degrees of protodeborylation. However, C-5 arylated urea 
423 could be obtained following one-pot Suzuki-Miyaura cross-coupling of the crude mixture of 
boronates using 6-bromoquinoline (Scheme 21). Whilst the THP group offered a small increase in C-4 
selectivity, this study demonstrated that the regiochemistry in the urea-directed C-H borylation of 
aminopyrazole ureas was challenging to modulate using steric effects. It was speculated that the 
directing effect was not pronounced enough to overcome the intrinsic electronic selectivity for the most 
acidic C-5 C-H site, even in the presence of bulky substituents at the azole N.  
 
3 Results and Discussion 
102 
 
Based on the C-4 selectivity observed in three different pyrazole ureas, it was hypothesised that the 
urea directing effect may also manifest in other heteroarenes. 
3.2.2.2 Other Heterocyclic Ureas 
 
Entry 424 R R1 T / oC t/ h Conversion /% Isolated Yield /% 
1 a CF3 H 80 1 >99 18* 
2 a CF3 H rt 16 >99 72 
3 b F H 80 1 >99 -† 
4 b F H rt 22 >99 59‡ 
5 c Cl H 80 1 >99 52 
6 c Cl H rt 16 >99 - 
7 d OMe H 80 4.5 95 - 
8 e Me H 80 1 >99 - 
9 e Me H rt 16 24 - 
*Crude mixture obtained as a 87:13 mixture of C-4:unknown boronates. 
† Crude ratio of C3:C4 isomers 7:13 
‡ Isolated as a mixture of C3:C4 isomers in a 6:5 ratio 
Table 5: Borylation of Aminopyridines 
To test this, the borylation of various heteroaromatic amines was undertaken in order to first determine 
their intrinsic selectivities for reference. Our focus began with pyridines owing to the group’s ongoing 
interest in this important scaffold. Previously, it has been reported by Sadler and others that the 
borylation of 2,6-disubstituted pyridines is selective for C-4.[3,12] Consistent with this observation, all of 
the studied 2,6-aminopyridines 424 displayed selectivity for C-4 in the C-H borylation with dtbpy and 
B2pin2 (Table 5, Entries 1-9). However, the borylation of trifluoromethylpyridine 424a led to the formation 
of an unknown C-H borylated isomer. It was speculated that this could be C-5 isomer 425b afforded via 
ortho direction of the in situ NHBpin adduct 426 (Scheme 22). This assignment is supported by the fact 
that C-H borylation ortho to a CF3 group is unprecedented due to steric effects.  
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Furthermore, 2-fluoro-6-aminopyridine 424b additionally displayed C-3 selectivity as expected owing to 
the small size of F, affording a mixture of isomeric boronates 426c and 426d (Table 5, Entries 3, 4). 
Moreover, elevated temperature was required for the efficient borylation of methoxypyridine 424d, and 
this is consistent with the higher barrier associated with the C-H activation of electron-rich aromatics 
(Table 5, Entry 7). Where possible, boronates 425 were isolated via binary solvent recrystallisation 
according to a modified procedure by Smith, although purification was sometimes challenging due to 
protodeborylation. Concurrently, the C-H borylation of 2,5-aminopyridines was explored. The 
heterocycles 427 investigated in this study showed no activity in the C-H borylation even under forcing 
conditions, and this was attributed to steric effects (Scheme 23).* Having successfully established the 
C-H borylation selectivities and activities in aminopyridines, the next focus became synthesis and C-H 
borylation of aminopyridyl ureas. It was speculated that the urea-directed C-H borylation may be more 
selective in pyridines as the beta and gamma C-H pKa values are generally more comparable than the 
alpha and beta C-H pKa values in pyrazoles.[13,14] Pyridyl ureas were synthesised under standard 
conditions by the reaction of an aminopyridine with an aromatic isocyanate in MeCN (Table 6).  
 
 
                                                     
* The C-H Borylation of other aminopyridines was performed by Andrew Hones 
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Entry Substrate R R1 Ar Isolated Yield /% 
1 424c Cl H Ph 65 
2 424e Me H Ph 93 
3 424f Et H Ph 96 
4 424e Me  H PMP 99 
5 427a H Me PMP 91 
6 427d Me Me PMP 81 
Table 6: Synthesis of Pyridyl Ureas 
Typically, the low solubility of the products permitted isolation by filtration with Et2O, in acceptable 
purity.* Following this, the C-H borylation of the ureas was explored, and conversions were measured 
via 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as an internal standard (Table 7). All of the 
investigated 2,6-pyridylureas exhibited C-4 borylation selectivity like their aminopyridine analogues, and 
did not display ortho directed regiochemistry. Changing the nature of the urea aryl group did not affect 
this result (Table 7, Entries 1-11). The generally poor solubility of the pyridyl ureas necessitated more 
polar solvents (2-MeTHF, THF) over methyl tert-butyl ether (mtbe) in the majority of reactions. In 
analogy to their aminopyridine analogues, 5-substituted pyridyl ureas were inactive and eventually 
decomposed over prolonged reaction periods (Table 7, Entries 12-16). Attempts to purify the aryl 
boronates with chromatography and/or recrystallisation led to protodeborylation. This outcome was also 
observed after attempts to derivatise the boronate esters with Suzuki-Miyaura cross-coupling. Notably, 
after 6 hours at room temperature the conversion of 429e was 60% and the reaction produced a colour 
change from a homogenous dark solution to a heterogeneous orange solution (Table 7, Entry 13). This 
was accompanied by the appearance of a new set of proton signals in the crude 1H NMR spectrum. 
These proton signals possessed identical splitting patterns and integrations to the substrate shifted 
downfield ca. 0.2 ppm, except for the absence of one N-H signal. 
                                                     
* The synthesis of and C-H borylation of other ureas was performed by Andrew Hones 
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Entry Substrate R R1 Ar Solvent T / oC t/ h Conversion /% 
1 429a Cl H Ph 2-MeTHF 80 3 50 
2 429b Me H Ph 2-MeTHF 40 23 40 
3 429b Me H Ph THF 30 16 0 
4 429b Me H Ph 2-MeTHF 40 18 40* 
5 429b Me H Ph mtbe 80 1  100 
6 429d Me H PMP 2-MeTHF 80 2 60† 
7 429d Me H PMP 2-MeTHF 40 16 10† 
8 429d Me H PMP mtbe 80 2 60‡ 
9 429g Me H p-CF3Ph 2-MeTHF 60 1 72§ 
10 429c Et H Ph 2-MeTHF 40 2 10 
11 429c Et H Ph 2-MeTHF 80 16 75 
12 429e H Me PMP mtbe 80 0.5 0§ 
13 429e H Me PMP 2-MeTHF rt 6 60§∩ 
14 429h H CO2Me Ph 2-MeTHF 80 1 0§ 
15 429f Me Me PMP 2-MeTHF 80 2 0§ 
16 429f Me Me PMP 2-MeTHF 120 3 0§ 
*3 equiv. HBpin was used instead of B2pin2 
† Reaction conditions: [Ir(cod)(OMe)]2 (1.0 mol%), tmphen (4.0 mol%), HBPin (3.0 equiv.) 
‡ Isolated C-4 boronate ester in 8% yield 
§ Prolonged reaction periods led to decomposition 
∩ Converted into an adduct with no evidence of C-H borylation 
Table 7: Borylation of Pyridyl Ureas 
Therefore, a C-H borylated product was ruled out. Concurrently, a new up-field shifted signal appeared 
at 6.02 ppm in the 11B NMR spectrum, and this indicative of four-coordinate boron. Furthermore, leaving 
this reaction mixture to stand for 16 h d6-DMSO led to a decrease in the concentration of this species 
and to an increase in the concentration of the substrate, suggesting that the unknown compound can 
revert into 429e. 
3 Results and Discussion 
106 
 
 
Therefore, the identity of this species was tentatively assigned as 431, containing a pseudo-aromatic 
six-membered N-B-O ring system (Figure 7). Attempts to gain further evidence for this (EI/ESI MS, 
purification and isolation) were unsuccessful, and this likely reflects the propensity of 431 to deborylate. 
The formation of putative adduct 431 may suggest that the N-H bonds in pyridyl ureas can undergo 
borylation, which would disrupt an intramolecular hydrogen-bonding network. This may explain the lack 
of ortho directed borylation in these systems, although further evidence of N-H borylation in other ureas 
could not be obtained. This study established that aminopyridyl ureas undergo regioselective C-H 
borylation at C-4. However, ortho selective C-H borylation to the urea group was not observed via the 
urea directing effect developed for pyrazole ureas. It was also suggested that the larger bond angles in 
six-membered heterocycles may kinetically disfavour directed C-H borylation.  
Therefore, it was hypothesised that the urea directing effect may manifest in other heteroaryl ureas 
which possess substituents that are closer together in space.*  To test this, the synthesis of 
aminoisoxazole and aminoindazole ureas 433 was conducted, and this was achieved in analogy to the 
synthesis of the previously presented heteroaryl ureas from the corresponding heterocyclic amines 
(Table 8). With ureas 433 in hand, the C-H borylation was subsequently investigated. Isoxazole ureas 
433a and 433b displayed no activity under the reaction conditions using dtbpy and tmphen, and the 
reaction of 433b led to discolouration of the catalyst solution (Scheme 24a, b). This was surprising as 
related five-membered heteroarenes such as oxazole undergo facile C-H borylation with alpha 
selectivity.  
                                                     
* The synthesis and C-H borylation of other heteroaryl ureas was performed by Andrew Hones 
3 Results and Discussion 
107 
 
 
Entry 432 Het-NH2 Ar Isolated Yield /% 
1 a 
 
Ph >99% 
2 a 
 
PMP 95 
3 b 
 
Ph 95 
Table 8: Synthesis of Other Heteroaromatic Ureas 
This led to the conclusion that isoxazole ureas 433a and 433b may be catalyst inhibitors, although the 
mechanism of this inhibition remains unclear. Following this result, it was hypothesised that the urea-
directing effect may enable peri–selective C-H borylation, since mutually peri substituents are closer in 
space than ortho ones.[15] Previous work on the C-H borylation of indazoles led to the investigation of 
indazole urea 433c in the C-H borylation (Scheme 24c). This produced a complex mixture by 1H NMR 
spectroscopy, which seemed to consist of the substrate, two monoborylated isomers in a 4:1 ratio, and 
some trace bisborylation. However, the unambiguous regiochemistry of this process was challenging 
to determine. The aim of future studies is to determine the regiochemistry of this process. Finally, the 
C-H borylation of quinolin-2-one 435 was investigated. Whilst 435 contains a lactam and not a urea, it 
was hypothesised that it may undergo peri-selective C-H borylation at C-8 since it possesses a structure 
that is comparable to the hydrogen-bond network in the parent pyrazole urea 391. Whilst complete 
conversion was recorded by 1H NMR monitoring after 3 h, 435 had decomposed during the C-H 
borylation at 80 oC into unknown materials (Scheme 24e). Attempts to lower the reaction temperature 
did not lead to C-H borylation, and 435 was recovered after an extended period.  
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The results from the study into urea-directed C-H borylation suggested that whilst the directing effect 
manifests in pyrazole ureas, it does not extend in a general fashion to other (hetero)arenes. Further 
evidence is required to understand these observations, although a possibility for the lack of direction is 
deleterious borylation at the urea N-H bonds, disrupting the intramolecular hydrogen-bonding network. 
Given these challenges, other methods were explored in order to reliably afford orthogonal C-H 
borylation regiochemistry in N-substituted aminopyrazoles with improved selectivities. 
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3.2.3 Protecting Group Switch 
As discussed in the previous section, the directed C-H borylation of aminopyrazole ureas was found to 
give modest C-4 selectivity, and did not extend in a general fashion to other heteroarenes. At this stage, 
we had reversed the intrinsic regiochemistry of N-methyl-5-aminopyrazole 373 (intrinsic C-5 borylation 
selectivity) to a degree using the parent urea 391. However, the developed method was complicated 
by the concurrent generation of C-4 and C-5 regioisomeric boronates. Therefore, the next goal was to 
develop a more efficient method that would provide complementary C-H functionalisation selectivities 
in 373 and N-methyl-5-aminopyrazole 380 (intrinsic C-4 borylation selectivity).  
One related method for altering regiochemistry in pyrazoles had been described by Sames. This 
involved the use of a labile N-substituent which is cleaved upon quaternisation of the azinyl N with an 
alkylating reagent. For example, the Pd C-H arylation of SEM pyrazole 437 was intrinsically selective 
for C-5, affording pyrazole 438. On treatment of 438 with strong alkylating agent followed by SEM 
deprotection, the net C-3 functionalised 440 was isolated (Scheme 25). It was hypothesised that this 
protecting group switch process could be adopted in order to achieve complementary selectivities in N-
SEM aminopyrazoles by a C-H borylation/arylation/alkylation/deprotection sequence. The goal was to 
apply this method to aminopyrazoles for the efficient synthesis of the remaining two targets of this 
project, 444 and 448 (Scheme 26a, b). 
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3.2.3.1 3-Aminopyrazoles 
To test this, the synthesis of N-SEM-3-aminopyrazole 450 was first investigated. The synthesis of 
nitropyrazole precursor 449 had previously been reported by Spring.[16] Following this reported 
procedure enabled the synthesis of 449 from 3(5)-nitropyrazole 404 to be achieved in excellent yield. 
(Scheme 27). Subsequent Pd-catalysed hydrogenolysis led to the isolation of aminopyrazole 450 again 
in excellent yield. The structure of this compound was unambiguously confirmed by a single crystal 
from X-ray analysis (Figure 8). Having completed the synthesis of target 450, focus turned to the C-H 
borylation reaction. Using B2pin2 and tmphen, this led to the isolation of C-5 boronate 451 as expected, 
and this was evident by the presence of a boron-shifted singlet in the 1H NMR spectrum at 6.09 ppm 
attributed to the C-4 hydrogen. Furthermore, this signal displays a HSQC interaction with a 
characteristic C-4 carbon signal at 103.9 ppm, supporting C-5 site-selectivity. Whilst the borylation of 
450 was efficient, the modest yield was attributed to slow protodeborylation during chromatographic 
purification.  
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Multiple attempts to cross-couple boronate 451 with Suzuki-Miyaura arylation led to intractable product 
mixtures containing protodeborylated 450 and contaminant pinacol and pinacolatoboryl derivatives 
(such as HOBpin). It was hypothesised that these contaminants could not be separated because they 
remained coordinated to the primary amine. Owing to the high oxophilicity of boron, it was suggested 
that competitive coordination from an alcoholic solvent may simplify purification. Therefore, the crude 
product mixtures were stirred in MeOH/H2O for extended periods. Whilst this method led to a significant 
reduction in the quantities of contaminants following chromatographic purification, complete separation 
of the arylated aminopyrazole products remained challenging. In order to overcome this challenge, 450 
was protected as the corresponding Boc carbamate 452 in 63% yield under similar conditions to 
previously presented neat Boc protections. As expected, the C-H borylation of 452 was selective for C-
5, and this was evident by the appearance of a boron-shifted singlet at 7.01 ppm in the crude 1H NMR 
spectrum. 
 
Figure 8: Crystal Structure of 450 
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Entry ArX SM t / h SM Isolated Yield /% 
1 
 
3 56 
2 
 
16 47 
3 
 
16 39 
Borylation Conditions A: [Ir(cod)(OMe)]2 (1.0 mol%), tmphen (4.0 mol%), B2pin2 (2.00 equiv.), 2-MeTHF, 80 oC, 1 h  
SM Coupling Conditions B: Pd(dppf)Cl2, K3PO4(aq) (2.00 equiv., 3M), 2-MeTHF, 80 oC 
Table 9: One-Pot Borylation/Arylation of SEM Pyrazole 452 
One-pot Suzuki-Miyaura cross-coupling of the crude boronate 453 pleasingly led to product mixtures 
that were amenable to purification with SiO2 gel chromatography, and this enabled the isolation of 
arylated adducts 454a-c in moderate to good yields (Table 9, Entries 1-3). With the arylated adducts in 
hand, the next goal became to test a protecting group switch sequence by first quaternising the azinyl 
N of 454a using Me3OBF4 (Scheme 28a). In refluxing CH2Cl2, this pleasingly furnished pyrazolium salt 
455, and this was evident from the 1H NMR spectrum which displayed a signal at 3.96 ppm attributed 
to the NCH3 hydrogens. However, further data on 455 could not be obtained owing to decomposition 
during solvent removal under vacuum.  
In order to understand the reasons for this, the quaternisation was repeated on the less precious 
aminopyrazole 453. Using the same conditions, pyrazolium salt 456 was afforded in quantitative mass 
balance with complete substrate conversion (Scheme 28b). This was apparent from the crude 1H NMR 
spectrum, which contained a new signal at 3.96 ppm corresponding to the N-CH3 hydrogens. Further 
evidence of this product could be found in the ESI mass spectrum, with a peak at m/z = 328.2 attributed 
to the pyrazolium cation. Similar to 455, 456 was found to possess low thermal stability and complete 
decomposition to unknown materials was observed on concentration.  
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Attempts to undertake the deprotection of 456 in situ using a variety of deprotection conditions including 
HCl, TFA, TBAF, MgBr2 /MeNO2, NaOH, and triethylamine trihydrofluoride (TREATHF), all led to rapid 
(<5 min) decomposition of the substrate (Scheme 29a). The reasons for this could not be elucidated 
but it was subsequently speculated that the decomposition of 456 may be attributed to the collapse of 
the Boc protecting group to afford 457 (Scheme 29b). It was speculated that 457 may decompose by 
pathways such as polymerisation. To test this, the Boc group was replaced with the more robust acetyl 
protecting group. This was achieved by treating 451 with neat Ac2O, affording acetamide 458 in high 
yield. The next focus became the quaternisation of 458, which was conducted under standard 
conditions using Me3OBF4 affording pyrazolium salt 459 in 79% mass balance following removal of the 
volatiles (Scheme 30). This was evident from the crude 1H NMR spectrum, which contained a new 
signal at 4.01 ppm corresponding to the N-CH3 protons. 
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Further evidence of this product was found in the ESI mass spectrum, with a peak at m/z = 270.2 
attributed to the pyrazolium cation. Unfortunately, attempts to deprotect 459 with HCl and TBAF also 
led to decomposition. Whilst aminopyrazolium salts 455, 458 and 459 could efficiently synthesised, this 
study led to the conclusion that they possessed an intrinsic sensitivity toward deprotection and 
prolonged storage.  
However, other pyrazolium salts do not possess this sensitivity. For instance, Begtrup described the 
synthesis of pyrazolium tosylate 462 via the alkylation of chloropyrazole 461 with MeOTs (Scheme 
31a). In contrast to the poor stability of aminopyrazolium salts, 462 was subsequently used in a 
nucleophilic displacement reaction, affording 463.[17] Based on this precedent, the quaternisation of 452 
with other alkylating reagents was investigated in order to improve the stability of the corresponding 
pyrazolium salt (Scheme 31b). Unfortunately, attempts to alkylate 452 with MeOTs and (Me)2SO4 also 
led to decomposition, and MeI and EtI did not react even under forcing conditions.  
Since the stability of 464 bearing different counterions could not readily be assessed, focus was turned 
to other possible variables responsible for the decomposition of aminopyrazolium salts. It was 
hypothesised that SEM removal may also be challenging for aminopyrazoles 452 and 458. In order to 
test this, the SEM deprotection of each pyrazole with standard reagents including HCl, TBAF, TFA, 
TREATHF, and CsF was conducted, with all leading to substrate decomposition (Scheme 32a). In order 
to rule out other sources of error, the SEM deprotection of an isomeric mixture of phenylpyrazoles 465a 
and 465b previously reported in a related procedure by Rault was successfully reproduced (Scheme 
32b).[18] At this time, it was noted that Grainger had also met difficulty with SEM deprotection during the 
final step in the total synthesis of kottamide E.[19]  
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Consistent with attempts to deprotect 451 and 457, a range of conditions led to the fragmentation of 
the target 468 to unknown by-products (Scheme 32c). It is noteworthy is that all of the SEM-protected 
substrates which decompose during deprotection contain N-H bond(s). Therefore, it was speculated 
that the sensitivity of each substrate toward deprotection reflected an unknown instability associated 
with this functional group.  
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Consequently, it was suggested that double-protection of the primary amine in 450 may facilitate the 
intended protecting group switch process. To test this, 450 was treated with 2,3-dimethylmaleic 
anhydride in basic refluxing THF, which furnished doubly-protected maleimide 470 in high yield. Two 
bands at 1729 and 1705 cm1 attributed to the symmetric and asymmetric stretches of the imide were 
displayed in the IR spectrum, and provided good evidence for the successful protection. The same 
protection could be performed “on water”, affording 470 in 95% yield. With 470 in hand the 
quaternisation was subsequently attempted under standard conditions with Me3OBF4. However, the 
product of this reaction was not a pyrazolium salt as expected, and this was evident from the absence 
of signals in the crude 19F and 11B NMR spectra. Following chromatographic purification, switched 
product 471 was isolated in moderate yield (Scheme 33). This was evident from the 1H NMR spectrum, 
in which a single CH3 signal at 3.71 ppm could be observed. Furthermore, there were no signals 
originating from a SEM group. Evidence for the presence of a maleimide was displayed in the IR 
spectrum as two bands at 1731 and 1708 cm-1, which were attributed to the symmetric and asymmetric 
C=O stretches. Furthermore, the identity of 471 was confirmed via an independent synthesis via the 
direct “on water” protection of 380. Pleasingly, the data obtained for both compounds from each 
experiment was identical (Scheme 34). Since an intermediate pyrazolium salt was not observed 
following prompt analysis, it was speculated that the SEM group may collapse during the reaction or 
upon exposure to adventitious moisture. From this study, it was concluded that it was the presence of 
N-H bonds that had impeded the protecting group switch, and double protection overcame this 
challenge. 
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Having successfully conducted a protecting group switch which employed a maleimide group as a 
suitable amine protector, it was necessary to test this group in a C-H borylation sequence. Therefore, 
attention was subsequently turned to the C-H borylation of maleimide protected aminopyrazole 470. 
Under standard conditions, this afforded exclusively C-5 borylated products in excellent NMR yield 
(Scheme 35). However, a significant amount of reduction at the maleimide during the reaction led to a 
complex and intractable product mixture. The generation of the three boronates was evident by the 
presence of three sets of signals corresponding to analogous protons environments in each product 
found in the crude 1H NMR spectrum. In particular, the presence of three overlapping boron-shifted 
singlets at 6.77 and 6.78 ppm indicated C-5 selectivity, and new characteristic multiplets at 2.52-2.62 
and 3.05-3.04 were assigned as the imide C-H protons. Furthermore, three peaks were displayed in 
the crude EI GCMS chromatogram, each with m/z = 376.2, 376.2, and 374.2, respectively. Accordingly, 
these masses were attributed to the [M]+ ions of the boronates 472, 473a, and 473b. An attempt to 
cross-couple this mixture with 4-bromotoluene also led to a complex product mixture.  
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Whilst the maleimide protecting group had facilitated the protecting group switch, it was not tolerated in 
the C-H borylation. In order to overcome this challenge, an alternative protecting group was considered. 
It was hypothesised that a succinimide protecting group would be inert in the C-H borylation whilst 
providing the required double-protection of the primary amine. As 2,3-dimethylsuccinic anhydride was 
not commercially available, succinic anhydride was initially selected. To test a protection with this 
reagent, 450 was treated with succinic anhydride in basic refluxing THF. This led to rapid precipitation 
of a white solid after 5 min, so the reaction was left for 1 h before removal of the volatiles. Subsequent 
purification led to the isolation of the linear gamma-amidocarboxylate 474, in contrast to the facile 
formation of the corresponding maleimide previously observed under the same conditions (Scheme 
36a). This was evident by the presence of a broad O-H stretch at 3296 cm-1 in the infrared spectrum. 
This difference in reactivity was attributed to a larger entropic penalty for cyclisation in 474 owing to the 
greater conformational freedom of the saturated γ-amidocarboxylate chain. A screen of protection 
conditions on the less precious N-methyl-5-aminopyrazole including the use of solvents such as PhMe 
and DMF was undertaken. However, despite the use of catalysts including DMAP and elevated 
temperatures, this similarly led to the isolation of 474. It was found that cyclisation of 475 could be 
facilitated by transforming the carboxyl group into an acid chloride using oxalyl dichloride catalysed by 
DMF, although this process was accompanied by significant decomposition. Recrystallisation of the 
crude reaction mixture from EtOH furnished 476, albeit in low yield (Scheme 36b). 
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A modified cyclisation was subsequently performed on 474, which initially formed succinimide 477. This 
was evident by the presence of a characteristic succinimide methylene signal at 2.02 ppm in the crude 
1H NMR spectrum. Following chromatographic purification 474 was recovered, suggesting that 477 
ring-opened during the isolation attempt, and this was unchanged by switching SiO2 gel for Al2O3 gel. 
This generated concern that 477 may similarly decompose during the Suzuki-Miyaura cross-coupling 
via base-mediated hydrolysis, so it was subsequently abandoned. This study demonstrated that 
protection with succinic anhydride was not appropriate for the intended borylation/arylation/switch 
sequence, so an alternative method was pursued.  
Previously, it was established that the C-H borylation tolerates primary amines, so it was hypothesised 
that the borylation reaction could precede protection. To test this, a one-pot 
borylation/arylation/protection sequence was conducted. First, 450 was C-H borylated as previously 
described, and subsequently the crude boronate 451 was arylated using Suzuki-Miyaura cross-coupling 
with 4-bromotoluene. Following complete conversion of the substrate by TLC analysis, the crude 
arylated amine 478 was treated with 2,3-dimethylmaleic anhydride, which afforded arylated maleimide 
479 in excellent yield over three steps following purification with SiO2 gel chromatography. The 
successful cross-coupling was evident from the 1H NMR spectrum, which displayed a singlet at 2.40 
ppm attributed to the tolyl CH3 hydrogens. Furthermore, successful protection was evident from the IR 
spectrum, which displayed two bands at 1728 and 1713 cm1 attributed to the asymmetric and symmetric 
stretches of the imide. Having successfully circumvented the issue of maleimide reduction during the 
C-H borylation, attention was subsequently turned to a protecting group switch. Pleasingly, treatment 
of 479 with Me3OBF4 under standard quaternisation conditions afforded the corresponding switched C-
3 arylated 5-aminopyrazole 480 in good yield. This was evident by the presence of a singlet at 3.75 
ppm in the 1H NMR spectrum, attributed to the NCH3 hydrogens. 
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As previously described, the C-H borylation of other N-substituted 5-aminopyrazoles was C-4 selective, 
so the net functionalisation at C-3 was a pleasing result. From this study, it was demonstrated that the 
developed protecting group switch developed could be efficiently extended to arylated aminopyrazole 
479. Amine double-protection had facilitated a successful borylation/arylation/protection/switch 
sequence in SEM protected aminopyrazoles. Building on this development, it was hypothesised that 
groups other than SEM may be suitable for this process, and this was desirable owing to the high cost 
of SEMCl ($4.60/ mmol, TCI). To test this, our attention first turned to THP-protected aminopyrazole 
418, which was previously synthesised during the study on urea-directed C-H borylation (see section 
3.2.2.1) (Scheme 38). Notably, DHP is >hundredfold cheaper  ($0.04/ mmol, TCI) than SEMCl. 
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It was previously established that 418 displayed C-5 selectivity in the C-H borylation, and that attempts 
to arylate the corresponding C-5 THP boronate 419 was challenging. It was suggested that prior 
protection of the amine may facilitate the Suzuki-Miyaura reaction. Previous studies had shown that 
succinimide and 2,3-dimethylmaleimide were unsuitable protecting groups, so the installation of a more 
robust imide was investigated. It was hypothesised that the ring-opening observed in succinimide 477 
could be prevented by ring-substitution, as predicted by the Thorpe-Ingold effect (Scheme 40a). To test 
this, the protection of 418 as the corresponding 2,2-dimethylsuccinimide was investigated. Initial 
attempts to protect 418 using 2,2-dimethylsuccinic anhydride in basic refluxing THF did not give efficient 
conversion. However, the use of higher temperatures (refluxing DMF) afforded 485 in high yield 
(Scheme 40b). A through-space interaction of the pyranyl methine hydrogen with the pyrazole C-5 
hydrogen was observed in the 2D 1H-1H NOESY spectrum, and this provided good evidence that no 
isomerisation had taken place during the reaction. Furthermore, the formation of 485 was evident from 
ESI LCMS, which displayed a peak with m/z = 278.7 corresponding to the [M+H]+ molecular ion. 
Alternatively, 485 could be synthesised via the selective protection of 369 using 2,2-dimethylsuccinic 
anhydride in refluxing DMF.  
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The corresponding succinimide 486 was subsequently protected with DHP and p-TsOH in CH2Cl2, 
affording 485 in high yield (Scheme 41). The data obtained for the products of both methods was 
identical. In both cases. Noteworthy is that 485 was purified with SiO2 gel chromatography, which led 
to ring opening of the unsubstituted succinimide ring in pyrazole succinimide 477. This supports the 
claim that the gem-dimethyl substituents kinetically stabilise the imide in 485 toward ring-opening. 
With 485 successfully synthesised, attention was turned to the C-H borylation reaction and whether the 
imide would remain inert. Pleasingly, 485 underwent C-5 functionalisation under standard borylation 
conditions with 96% selectivity in 86% NMR yield (against 1,3,5-trimethoxybenzene as an internal 
standard), and this was evident by the presence of a boron-shifted singlet at 6.68 ppm in the crude 1H 
NMR spectrum. Attempts to chromatographically purify 487 led to protodeborylation, so the crude 
boronate was arylated with Suzuki-Miyaura cross-coupling (Table 10). Whilst the efficiency of this 
process was hampered by protodeborylation, the isolation of C-5 arylated adducts 488 was possible. 
With the arylated adducts 488 in hand, focus was turned to the protecting group switch of a THP-
protected aminopyrazole. To test this, the tolyl derivative 488a was treated with Me3OBF4 under 
standard quaternisation conditions (Scheme 42). Pleasingly, this furnished switch C-5 aminopyrazole 
489 in acceptable yield, which was evident by a through-space interaction of the C-4 hydrogen with the 
tolyl hydrogens in the 2D 1H-1H NOESY spectrum.  
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Entry ArX SM Isolated Yield /% 
1 
 
11* 
2 
 
18† 
3 
  
16‡ 
Borylation Conditions A: [Ir(cod)(OMe)]2 (1.0 mol%), tmphen (4.0 mol%), B2pin2 (1.00 equiv.), 2-MeTHF, 80 oC, 2 h  
*SM Conditions: Pd(dppf)Cl2, K3PO4(aq), 2-MeTHF, 80 oC, 2 h, product obtained in 85% isomeric purity. 
† SM Conditions: Pd(dba)2, PCy3HBF4, , K3PO4, dioxane, 80 oC, 16 h 
‡SM Conditions: Pd(dppf)Cl2(CH2Cl2 Complex), KOCHO, K3PO4, dioxane, 80 oC, 16 h 
Table 10: One-Pot Borylation/Arylation of 485 
Whilst the Suzuki-Miyaura cross-coupling would require further optimisation, this study demonstrated 
that the SEM protecting group switch of aminopyrazoles could also extend to a significantly cheaper 
THP-protected aminopyrazole. Furthermore, 2,2-dimethylsuccinimide was shown to be a more robust 
protecting group than the corresponding unsubstituted succinimide due to the Thorpe-Ingold effect. 
Based on this result, it was subsequently hypothesised that a carbonyl may also be used as an 
alternative to SEM in a switch process. Notably, N-carbonyl imidazoles such as 490 undergo a related 
switching process following quaternisation, lending credence to this idea (Scheme 43a). 
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Attracted by the low cost of Boc2O ($0.16/ mmol, TCI), Boc was chosen as a potential transposition 
group. Notably, Boc has been used to direct beta C-H borylation in 3-substituted  N-Boc pyrazoles such 
as 493a (containing ca. 10% 5-methyl isomer 493b), so it was predicted that Boc may also facilitate C-
H borylation selectivity at C-4 rather than C-5 (Scheme 43b).[8] To test this, the synthesis of Boc pyrazole 
496 was investigated. This commenced by treating 3(5)-nitropyrazole 405 with LiHMDS followed by 
Boc2O. The serendipitous use of LiHMDS over NaH led to the production of 495 alongside the 
corresponding Boc protected 5-nitropyrazole isomer in 95:5 ratio (Scheme 44). Accordingly, the major 
isomer with pyrazole C-H coupling constant 2.9 Hz was assigned to be 495, whilst the minor isomer 
with pyrazole C-H coupling constant 2.5 Hz was assigned to be the corresponding N-Boc-5-
nitropyrazole. This is discussed in greater detail in section 3.2.3.3. Chromatographic purification 
followed by recrystallisation enabled the isolation of 496 in modest yield which was analysed by single 
crystal X-ray diffraction, confirming its structure. Standard Pd-catalysed hydrogenation of 495 afforded 
amine 496 in good yield, and this was evident from the presence of two bands at 3460 and 3316 cm-1 
in the infrared spectrum. With the target amine 496 in hand, the C-H borylation was subsequently 
investigated. Using tmphen and B2pin2, this led to formation of C-4 functionalised boronate 497 in 
excellent NMR yield. This regiochemistry was evident from the crude 1H NMR spectrum, which 
displayed a boron-shifted singlet at 8.08 ppm.  
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495 
Scheme 44: Synthesis and C-H Borylation of Boc Pyrazole 495 
Attempts to protect and arylate crude boronate 497 led to substrate decomposition, so the route was 
redesigned to include the installation of a 2,2-dimethylsuccinimide protecting group prior to the C-H 
borylation and arylation reactions. It was hypothesised that the high steric requirement of 2,2-
dimethylmaleimide may alter the C-4 C-H borylation selectivity. In order to investigate this, 3-
succinimidepyrazole 486 was treated with Boc2O and DMAP in MeCN. After 1 h, the presence of the 3- 
and 5-substituted Boc protected isomers in a 9:1 ratio was evident from the crude 1H NMR. This isomer 
assignment was made based on the pyrazole C-H 3J coupling constants, which were measured to be 
2.8 Hz in the major isomer 498, and 2.3 Hz in the minor isomer 499. The selectivity of this process was 
increased to >99:1 by leaving the reaction for 16 hours, suggesting that the reaction conditions may 
promote equilibration between the two isomers (Scheme 45a). Next the C-H borylation of 500 under 
standard conditions was investigated. Surprisingly, C-4 functionalised boronate 501 was afforded with 
95% selectivity in 90% NMR yield and could be isolated in 76% yield (Scheme 45b).  
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The regiochemistry was evident by a boron-shifted singlet at 8.40 ppm in the purified 1H NMR spectrum. 
Furthermore, no C-4 carbon signal at ca. 100 ppm was observed in the 13C NMR spectrum, which is 
consistent with the peak-broadening effect of boryl substituents on carbon atoms.  
 
Entry ArX SM Isolated Yield /% 
1 
 
49 
2 
 
66 
3 
 
 
35 
Table 11: Suzuki-Miyaura Arylation of 500 
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Our next focus became to arylate the purified boronate 500 with Suzuki-Miyaura cross-coupling, and 
this pleasingly afforded arylated adducts 501a-c in moderate yields (Table 11). This was evident in the 
synthesis of 501b by an nOe interaction between C-5 and the ortho aryl C-H. One-pot 
borylation/arylation produced the arylated adducts in lower yields. Having successfully arylated the C-
4 position in 498, the protecting group switch of 501b and 501c was subsequently investigated under 
standard alkylation conditions using Me3OBF4 (Scheme 46). Pleasingly, this led to the formation of 
switched aminopyrazoles 502a and 502b, and this was evident by the appearance of a signal at 3.73 
and 3.71 ppm in each 1H NMR spectrum attributed to the NCH3 hydrogens, respectively. It was 
surprising that the seemingly high steric requirement of the succinimide in 498 did not alter the C-4 C-
H borylation selectivity conferred by Boc. This led to a small study which sought to understand the origin 
of this C-H borylation beta direction to form 500. DFT calculations predicted that the succinimide ring in 
498 twists out of planarity with the pyrazole ring, reducing the steric congestion at C-4 incurred by the 
succinimide (Figure 9). Furthermore, it was hypothesised that the tBu group in 498 may block C-5 and 
deliver C-4 selectivity on steric grounds. To test this, replacement of the tBu with OMe and Me was 
conducted via the synthesis of 503 and 505, respectively (Scheme 47). 
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This was performed using similar procedures to the synthesis of Boc analogue 498. In each acylation 
reaction, the concurrent formation of the corresponding 5-aminopyrazole isomer was evident in crude 
1H NMR spectra, which permitted the structural assignment of 503 and 505 based on pyrazole C-H 3J 
coupling constants. However, both major isomers could be obtained as single components following 
chromatography. Following the synthesis of these two control aminopyrazoles, the C-H borylation 
reactions were investigated. In the C-H borylation of these two compounds, some evidence of C-4 
selectivity was displayed by appropriately boron-shifted singlets in the crude 1H NMR spectra (Scheme 
48). However, the poor (<10% conversion) borylation activity of both pyrazoles necessitate further 
investigation, which was not possible in the timeframe of this project.  
This study demonstrated that alongside THP and SEM, Boc may also be employed as a protector for 
the protecting group switch of aminopyrazoles. Unlike the former two groups, Boc directs borylation to 
C-4, despite the presence of a bulky succinimide. This provided an alternative route for the synthesis 
of C-4 arylated 5-aminopyrazoles 502 (see section 3.1.2). Provisional control experiments provided 
some evidence to suggest that this selectivity may be electronic in origin, although this requires further 
study.  
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3.2.3.2.1.1 Other Studies 
Concurrent with the successful approach described above, other avenues were pursued in an effort to 
facilitate a protecting group switch of 3-aminopyrazolium salts. It was hypothesised that previously 
synthesised nitropyrazole 449 could act as a suitable amine surrogate and facilitate a SEM switch 
(Scheme 49a).  
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However, NO2 is commonly considered to be too oxidising to be tolerated in the C-H borylation, so the 
substrate activity was initially investigated. Surprisingly, 449 underwent rapid (<5 min) borylation under 
standard conditions, forming C-5 boronate 512 exclusively. This was apparent from the crude 1H NMR 
spectrum, which displayed a boron-shifted singlet at 7.32 ppm attributed to the C-4 hydrogen. 
Subsequent Suzuki-Miyaura cross-coupling of the crude reaction mixture under standard conditions 
with methyl 4-iodobenzoate led to complete protodeborylation. Through experimentation, it was 
discovered that a rapid deborylation event occurred upon addition of H2O, so it was excluded from the 
reaction. In conjunction with raising the Pd loading, arylated nitropyrazole 513 could be isolated, albeit 
in low yield (Scheme 49b). This was evident from the 1H NMR spectrum, which displayed a singlet at 
3.96 ppm attributed to the OCH3 hydrogens. The inefficiency of this process was attributed also to 
protodeborylation, suggesting that this process may also be promoted by one of the other reagents. 
Whilst further optimisation of this sequence may have provided a solution, the maleimide approach 
described in section 3.2.3.1 proved more novel and this “nitro” strategy was not pursued further. 
Furthermore, preliminary investigations into the protecting group switch of aminopyrazoles with other 
azole protecting groups such as methyl pivalate 514 and methyl acetate 515 were halted in the interest 
of time so that attention could be focused on synthesising the final target isomer of this project via 5-
aminopyrazoles (Figure 10). 
3.2.3.2 5-Aminopyrazoles 
As discussed in section 3.2.3.1, appropriately protected 3-aminopyrazoles undergo efficient C-H 
borylation with excellent selectivities. The pyrazole boronates may be arylated with Suzuki-Miyaura 
cross-coupling and subsequently quaternised/deprotected in situ, affording switched aminopyrazole 
products. Our next focus became to apply this method to 5-aminopyrazoles in order to synthesise target 
isomer 519 with a greater efficiency than offered by the urea-directed process (Scheme 50).  
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However, this presents a greater challenge because the N-functionalisation of 3(5)-substituted 
pyrazoles generally carries greater selectivity for the less hindered 3-substituted isomer (Scheme 51a). 
Furthermore, some 5-aminopyrazoles such as 523 are known to thermally isomerise into the 
corresponding 3-aminopyrazole isomer 524 (Scheme 51b).[20] Aware of these potential challenges, the 
initial goal was to synthesise N-SEM-5-aminopyrazole 526 in order to ultimately conduct a SEM switch. 
At the time, nitropyrazole 525 was a novel compound so a new synthesis of this precursor was required. 
Previously, it was noted that the use of LiHMDS in the acylation of 3(5)-nitropyrazole 404 gave a mixture 
of 3- and 5-subsitituted isomers. Therefore, 404 was treated with LiHMDS followed by SEMCl in THF, 
and this pleasingly furnished a mixture of two 3- and 5-substituted isomers 525 and 450 (Scheme 52a). 
These were distinguished based on the relative magnitudes of the 3J pyrazole C-H coupling constants. 
By performing the reaction at room temperature, higher selectivity for the desired isomer was obtained, 
and chromatographic separation led to the isolation of 525 in acceptable yield. 
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Subsequently, 525 was reduced to 5-aminopyrazole 526 in high yield with Pd-catalysed hydrogenation 
(Scheme 52b). The structural assignment of 526 was supported by the distinct 1H NMR shifts and 
coupling constants from the corresponding 3-aminopyrazole isomer 450. In particular, the 3J pyrazole 
C-H coupling constant was measured in 526 to be 0.6 Hz lower than in 450. With the 5-aminopyrazole 
526 in hand, focus turned to the C-H borylation.  
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Initial experiments afforded C-4 functionalised boronate 527 in 50% NMR yield, and this was evident 
by the appearance of a boron-shifted singlet at 7.47 ppm in the crude 1H NMR spectrum (Scheme 53a). 
The fate of the rest of the material was not clear, and isomerisation was not observed. Numerous 
attempts to chromatographically isolate and arylate boronate 527 led to decomposition and 
protodeborylation, so various protection experiments were conducted in order to resolve this. Attempts 
to install 2,3-dimethylmaleimide led to no conversion at low temperature, whilst elevated temperature 
led to protodeborylation (Scheme 53b). It was suggested that the congested environment of the primary 
amine was responsible for this, so crude boronate 527 was treated with KHF2 in order to covert the Bpin 
group to the smaller and typically more stable BF3K group (Scheme 53c). Unfortunately, this also led 
to protodeborylation, and 529 was not detected. Since protection of the crude boronate proved difficult, 
the next focus became to protect 526 prior to the C-H borylation. However, it was suggested that the 
imide protecting groups previously employed in the 3-aminopyrazole series may alter the C-4 C-H 
borylation selectivity obtained for 526 on steric grounds. In order to prevent this issue, mono-protection 
was initially attempted with the goal to protect a second time following the arylation reaction and prior 
to the protecting group switch. Initial protection experiments focused on synthesis of Boc carbamate 
530. Unfortunately, repeated attempts at the Boc-protection of 526 under a variety of protocols did not 
proceed, and the use of elevated temperatures led to decomposition into unknown materials. However, 
it was found that by treating 526 with Boc2O, DMAP, and Et3N in CH2Cl2 for an extended period followed 
by chromatography over base-treated SiO2 gel afforded 530 with 37% crude mass recovery.  
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This was evident from differences in the 1H and 13C NMR data between 530 and previously synthesised 
452. Further attempts to manipulate 530 including dissolution in organic solvent led to isomerisation 
affording 452, precluding an investigation into the C-H borylation. Based on these observations, further 
attempts to synthesise and isolate 530 were halted so that the protection of aminopyrazole 526 as other 
carbonyl derivatives could be investigated. It was hypothesised that the protection of 526 as acetamide 
531 may be more facile, owing to the greater reactivity of reagents used for acetylation (Ac2O, AcCl) 
when compared to Boc2O. To test this, 526 was treated with neat Ac2O dropwise at reduced 
temperature. After 1 h, the substrate had been consumed by TLC analysis, and 531 was isolated 
following purification (Scheme 55). This was performed using base-treated SiO2 gel in order to prevent 
decomposition. In contrast to carbamate 530, no isomerisation of acetamide 531 was observed even 
after refluxing for prolonged periods in 2-MeTHF. With the successfully protected 5-aminopyrazole in 
hand, attention was turned to the C-H borylation reaction. Under standard conditions, the borylation of 
531 was relatively sluggish, and produced two boronates 532 and 533 in a total NMR yield of 70% 
(Scheme 55). This was evident from the crude 1H NMR spectrum, which displayed two boron-shifted 
singlets at 7.93 ppm and 6.95 ppm. Furthermore, two peaks were displayed in the EI GCMS 
chromatogram, and both possessed m/z = 381.2 attributed to the [M]+ ions of the products. 
Unfortunately, further characterisation was precluded by decomposition into unknown species during 
chromatographic purification and Suzuki-Miyaura cross-coupling.  
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The non-selective C-H borylation of acetamide 531 suggested that C-4 selectivity observed in 381 and 
383 may be controlled by an ortho directing effect (Scheme 56). Given the challenges that were 
encountered using SEM as an azole protecting group, focus was turned to the installation of a more 
robust alternative. Owing to previous success with Boc as an azole N protecting group, the synthesis 
of Boc-protected aminopyrazole 534 was subsequently investigated. (Scheme 57).  
 
 
534 
Scheme 57: Synthesis and X-ray Structure of 534 
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The synthesis of 534 had previously been reported in a patent by Berthel in good yield alongside a 
minor quantity of regioisomer N-Boc-3-aminopyrazole 496 (Scheme 57a). Under modified conditions, 
534 was produced in 75% isomeric purity alongside 3-substituted isomer 496, although difficulties 
during chromatographic separation led to a low isolated yield. Confirmation that the desired regioisomer 
had been formed was obtained by single crystal X-ray analysis, which unambiguously confirmed the 
structure of 534. Interestingly, this indicated a hydrogen-bond between the amine N-H and the carbonyl 
C=O. Having the synthesised the target aminopyrazole, the next focus became the C-H borylation 
reaction. Using tmphen and B2pin2, two pyrazole doublets and a Bpin CH3 singlet were observed after 
1 h at 7.38, 5.39, and 1.26 ppm in the crude 1H spectrum, respectively. This was accompanied by the 
appearance of a signal at 28.2 ppm in the 11B NMR spectrum, and these data suggest that 534 had 
undergone N-H borylation and not C-H borylation after 1 h. After a further 15 h the volatiles were 
removed, and 1H NMR analysis displayed two new doublets at 5.80 and 7.82 ppm with each possessing 
J = 2.9 Hz coupling constants. These signals are consistent with N-Boc-3-aminopyrazole 496, so it was 
concluded that extended reaction times led to isomerisation (Scheme 58). 
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As previously discussed, Boc-protected 3-aminopyrazole 496 is an active substrate and undergoes C-
4 selective C-H borylation, so the catalyst must have been rendered inactive at some stage of the 
reaction. To account for the inactivity of 534, it was hypothesised that the intramolecular hydrogen-bond 
may similarly feature in N-borylated adduct 535. This would position the boryl group in high proximity 
with the C-4 C-H bond, blocking access of the catalyst (Figure 11). This hypothesis may also be used 
to explain the poor selectivity obtained in the C-H borylation of acetamide 531. The lack of C-3 C-H 
borylation in 534 was attributed to the inhibitory effect of the azinyl N. It was hypothesised that protection 
of 534 may facilitate C-H borylation activity. However, attempted protections of the amine using either 
Boc2O or Ac2O in the presence of a base were not successful even with elevated temperature, returning 
the substrate. The use of acyl transfer catalysts such as DMAP and more reactive acylation reagents 
such as AcCl was also unsuccessful, leading to substrate isomerisation followed by decomposition. 
Whilst the reasons for the relatively low reactivity of 534 toward protection are unclear, the electron-
withdrawing effect of the Boc group may lower the nucleophilicity of the amine.  
These challenges led to the investigation of a suitable alternative azole N protector. Owing to the 
previous success with the developed THP-switch, THP was subsequently selected as the next azole 
protecting group to be investigated. Therefore, the next target became THP 5-aminopyrazole 537. 
Slade has developed the kinetically controlled THP protection of indazoles such as 415 catalysed by 
PPTS (Scheme 59a).  
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The N-2 selectively functionalised product 536 cannot isomerise under the reaction conditions, which 
would otherwise be possible with p-TsOH (see section 2.2.2). To test the kinetic preference of 404 
toward THP protection these conditions were adopted, and this pleasingly afforded THP-protected 5-
nitropyrazole 414 alongside 3-substituted isomer 413 in a 43:57 ratio with 80% substrate conversion 
(Scheme 59b). Chromatographic separation of these isomers led to the isolation of 414 in acceptable 
yield, and this was evident from the pyrazole C-H 3J coupling constant which was measured to be 0.7 
Hz lower than the corresponding coupling in 3-substituted isomer 413. Subsequently, the reduction of 
414 was conducted under Pd/C standard conditions to afford aminopyrazole 537. Unfortunately, the 
purification of 537 from a small amount of unidentified contaminants proved challenging and this was 
attributed to the interaction of the primary amine with the chromatographic media. In order to overcome 
this challenge, 537 was protected by treating the crude reaction mixture with Ac2O and Et3N, which 
permitted the chromatographic isolation of the acetamide 538 with base-treated SiO2 gel (Scheme 60). 
This was evident from an absorption in the infrared spectrum at 1668 cm-1, which was attributed to the 
amide C=O stretch.  
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Furthermore, the structure of 538 was evident by an nOe correlation of the acetamide CH3 hydrogens 
with the pyranyl methine hydrogen in the 2D 1H-1H NOESY spectrum. With the successfully protected 
pyrazole in hand, the C-H borylation of acetamide 538 became the next focus. This led to exclusive C-
H borylation at C-3 alpha to the azinyl N, and this was evident from the crude 1H NMR spectrum which 
displayed a boron shifted singlet at 6.90 ppm. This process was comparably slower than other C-H 
borylation reactions of aminopyrazoles, and this likely reflects the inhibitory effect of the azinyl N on the 
reaction rate. Whilst boronate 539 was not isolated, one-pot Suzuki-Miyaura cross-coupling led to the 
isolation of arylated adduct 540. This was evident from the presence of a signal at 95.2 ppm in the 13C 
NMR attributed to the C-4 carbon. Furthermore, this signal displayed a 1J interaction in the 2D 1H-13C 
HSQC spectrum with the C-4 hydrogen displayed at 6.88 ppm in the 1H NMR spectrum. In addition, a 
peak with m/z = 304.1 was found in the ESI LCMS spectrum, which was attributed to the [M+H]+ ion. 
The observation of complete C-3 selectivity in the C-H borylation of 538 was unusual, because 
previously studied 5-aminopyrazoles displayed reactivity at the ortho C-4 site. Based on the 
intramolecular hydrogen-bond discovered in Boc aminopyrazole 534, it was suggested that an 
analogous interaction may position the acetamide over the C-4 C-H bond and sterically block borylation 
at this site (Figure 12).  
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However, the nOe interaction observed in 538 between the acetamide and the THP group suggests 
that the C-3 C-H borylation selectivity may not originate from another effect. To gain a further 
understanding of this regiochemistry, the C-H borylation of crude amine 537 was investigated (Scheme 
61). Monitoring experiments with EI GCMS after 1 h displayed peaks with m/z = 167.1 and 293.2 
attributed to the [M]+ ions of the substrate and a monoborylated product, respectively. After 3 h, the 1H 
NMR spectrum displayed a single boron-shifted singlet at 5.91 ppm with no evidence of 537 or 
isomerisation into a 3-aminopyrazole derivative. Evidence for N-H borylation and C-H borylation to form 
541 was displayed as two singlets at 1.26 and 1.30 ppm in the crude 1H NMR spectrum, attributed to 
the NBpin and CBpin CH3 hydrogens. Attempts to protect 541 with Boc2O/Ac2O and/or arylate the crude 
reaction mixture led to intractable mixtures of the desired products with protodeborylated 537.  
In contrast to the C-4 ortho selectivity observed in other 5-aminopyrazoles, this study demonstrated 
that C-3 selectivity could be realised in the C-H borylation of 537 and 538. Whilst the origin of the 
selectivity is unclear, it was tentatively suggested that this manifested due to the steric congestion at 
the C-4 site caused by the amine protecting group. To better understand the role of sterics in conferring 
C-3 selectivity, the introduction of the 2,2-dimethylsuccinimide group was investigated. Whilst this group 
cannot hydrogen-bond to the O atom on the THP group, it was hypothesised that it would confer C-3 
selectivity owing its large steric requirement.  
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To test this, 542 was initially synthesised by treating succinimide 486 with DHP and PPTS. This also 
led to the formation of previously synthesised 3-substituted isomer 485, and the two isomers were 
chromatographically separated to afford the desired 5-aminopyrazole 542 in acceptable yield (Scheme 
62a). 542 was distinguished from 485 via differences in 1H and coupling constants of the pyrazole C-H 
signals. In particular, the major isomer with pyrazole C-H 3J = 1.9 Hz was attributed to 542, whilst the 
minor isomer with pyrazole C-H 3J = 2.5 Hz was attributed to 485. With the successfully synthesised 
imide 542 in hand, attention turned to the C-H borylation reaction. At 80 °C, this proceeded with 
complete conversion after 0.5 h as measured by GCMS monitoring experiments (Scheme 62b). Crude 
1H NMR analysis after 1 h displayed two boron-shifted signals at 6.67 and 7.83 ppm, which were 
attributed to C-3 and C-4 boronates 543 and 544. Isomerisation of 542 and 543 was ruled out by the 
comparison of the crude 1H NMR spectra with 3-imidoboronate 487 (Figure 13). In particular, the pyranyl 
methine signal in 5-imidopyrazole boronate 543 was displayed at 5.32 ppm, whilst the corresponding 
signal appeared at 5.78 ppm in 487. Further evidence for the generation of two isomeric boronates was 
found in the crude EI GCMS spectrum, which displayed two signals with m/z = 403.2 attributed to the 
[M]+ molecular ions of two monoborylated products. Unfortunately, attempts to isolate these isomers 
following Suzuki-Miyaura cross-coupling led to complex product mixtures containing protodeborylated 
substrate 542 alongside the corresponding arylated derivatives. Nevertheless, this study demonstrated 
that the nature of the amine protecting group can influence C-H borylation selectivity in THP protected 
pyrazoles. It was suggested that the imide and the pyrazole rings in 542 may share an orthogonal 
relationship in order to reduce unfavourable steric interactions with the ortho THP substituent. 
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This could relieve steric congestion at C-4, explaining why there is a degree of C-H borylation selectivity 
at this site (Figure 14). Evidence for restricted rotation about the C-5 N-C bond could be found in the 
1H NMR spectrum, which displayed splitting of the succinimide gem-dimethyl groups into two signals at 
1.41 and 1.43 ppm. This does not occur in the 1H NMR spectrum of the corresponding 3-imidoisomer 
485, which displayed a single CH3 signal at 1.39 ppm (vide supra). 
Collectively, the evidence gathered from the C-H borylation of studied 5-aminopyrazoles suggested C-
4 may be sterically congested by the amino protecting group. It was tentatively suggested that an 
intramolecular hydrogen-bond between the amine and the azole protecting group may create “peri-like” 
steric hindrance by forcing the amine protecting group (PG) into the plane of the C-4 C-H bond, inhibiting 
the approach trajectory of the catalyst (Figure 15). However, the role of other effects such as outer-
sphere direction was not ruled out. On this basis, it was hypothesised that an azole protecting group 
without an alpha heteroatom would overcome this challenge, since it would be unable to hydrogen bond 
to the amino substituent.  
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In order to investigate this, p-methoxybenzyl (PMB) protected 5-aminopyrazole 548 was initially 
selected due to previous success with benzyl-derived protecting groups. Since PMB does not possess 
a readily cleavable hemiaminal/carbonyl group, it was a concern that it may not collapse upon 
quaternisation of the azinyl N. However, Phipps has recently described the Pd-catalysed 
hydrogenolysis of PMB protected quaternary ammonium salts, which provided a good contingency in 
the event of difficulties with PMB removal (Scheme 63). Studies commenced with the C-H borylation of 
548, which was fully consumed under the reaction conditions after 3 h (Scheme 64). This was clear 
from EI and GCMS monitoring experiments. Over the course of the reaction, a peak with m/z = 329.2 
could be observed, which was attributed to a monoborylated adduct of 548.  
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However, a crude 1H NMR spectrum recorded at t = 3.5 h displayed signals corresponding to a doubly 
C-H borylated species 549 with C-4 selectivity at the azole and unknown selectivity at the PMB ring. 
This was evident by the presence of a boron-shifted 1H singlet at 7.54 ppm, and by the total integrals 
of the remaining aromatic signals summing to three. Attempts to purify and protect bisboronate 549 
were unsuccessful, so Suzuki-Miyaura cross-coupling was attempted. Pleasingly, the use of TBAB with 
Pd(dppf)Cl2 led to the isolation of bisarylated pyrazole 550 functionalised ortho to the benzylic 
methylene group at the PMB ring (Scheme 64). The product of a bisarylated pyrazole was evident by a 
signal with m/z = 392.2 found in the ESI LCMS spectrum attributed to the [M+H]+ ion. Furthermore, the 
regiochemistry at the PMB group was evident by two through-space interactions of the OCH3 groups 
with the ortho PMB hydrogens displayed in the 2D 1H-1H NOESY spectrum. One explanation for 
selectivity at a typically less reactive carbocyclic ring is an outer-sphere directing effect involving the 
NHBpin adduct 551, which may serve to direct ortho borylation to C-4 on the pyrazole and remote C-H 
borylation to the PMB group (Figure 16). Evidence for the N-H borylation of 548 was found in the crude 
11B NMR spectrum, which displayed a characteristic signal at 27.5 ppm. However, this would occur with 
a high entropic penalty. 
 
3 Results and Discussion 
145 
 
3.3 Conclusions and Future Work 
 
This project developed strategies for the synthesis of four arylated aminopyrazole isomers 2, 3, 5, and 
6 (Figure 17). These strategies incorporated iridium-catalysed C-H borylation, Suzuki-Miyaura cross-
coupling, and a protecting group switch.  
3.3.1 3-Aminopyrazoles 
Initially, it was shown that 3(5)aminopyrazole 369 was inactive in the C-H borylation. By introducing the 
substrate to the catalyst mixture at elevated temperature, low C-H borylation activity was achieved, 
although attempts to purify C-5 boronate 370 were unsuccessful (Scheme 65a). In contrast, the N-
substituted-3-aminopyrazoles studied (that were not ureas) exhibited high activity and intrinsic C-H 
borylation site-selectivity for the C-H bond alpha to the azole N (C-5), and this is consistent with the 
observation that aromatic C-H bonds with low pKa values are preferentially activated. This selectivity 
was not altered by increasing the steric bulk of the azole N substituent from Me to 3,5-dimethylbenzyl 
or THP (Scheme 65b). An exception to this rule was demonstrated following the substitution of a 
carbonyl group at the azole N. This led to a complete reversal in C-H borylation regioselectivity and 
afforded C-4 functionalised boronates, even in the C-H borylation of Boc protected pyrazole 498 with a 
bulky imide substituent at ortho position (C-3) (Scheme 65c). It was calculated that the imide in 498 
twists out the plane of the pyrazole ring, reducing steric congestion at C-4. Future studies should aim 
to elucidate the role of the N-Boc group in conferring C-4 C-H borylation selectivity. Whilst the C-H 
borylation efficiencies were typically excellent, the subsequent arylation using Suzuki-Miyaura cross-
coupling often led to protodeborylation which complicated purifications. 
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Therefore, future studies should aim to improve the efficiency of these processes by identifying systems 
that can create the desired C-C bond at a faster rate than protodeborylation. 
The N-H borylation of N-methyl-3-aminopyrazole 373 was shown to occur during the C-H borylation 
reaction. Despite the capability of NHBpin to act as an ortho C-H borylation director in other systems, 
no ortho (C-4) selectivity was observed.  
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It was speculated that unfavourable lone-pair repulsion between the azinyl N and the O of the N-boryl 
group disfavoured the rotamer 388a required for directed borylation and favoured rotamer 388b with a 
congested C-4 site (Scheme 66a). To overcome this, a urea model was developed in which an 
intramolecular hydrogen-bond would conformationally lock the N-H bond required for ortho directed C-
H borylation. Pleasingly, the C-H borylation of 3-aminopyrazole ureas delivered C-4 boronates, albeit 
with modest selectivity alongside the corresponding C-5 boronate (Scheme 66b). This directing effect 
was proposed to operate via an outer-sphere hydrogen-bonding system with the boryl ligands of the 
catalyst. Different variables were investigated in order to improve the selectivity of this process. 
However, selectivities that surpassed a 1:1 ratio of the two isomeric boronate products could not be 
achieved. Furthermore, this directing effect did not extend to other heterocycles, including pyridine, 
isoxazole, indazole, and quinolin-2-one. Future work should seek to enhance the C-4 selectivity of this 
directing effect in pyrazole ureas by varying further reaction parameters, such as solvent, 
ancillary/reactive ligands, and substitution at the urea carbocycle. 
3-Aminopyrazoles with labile protecting groups at the azole N including SEM, THP and Boc could be 
employed in a protecting group switch. This ultimately transposed the azole substituent and provided 
access to arylated aminopyrazoles which would otherwise be challenging to access directly using C-H 
borylation followed by Suzuki-Miyaura cross-coupling. Treatment of an arylated aminopyrazole such as 
502b with Me3OBF4 led to a quaternisation/deprotection cascade, which furnished switched pyrazole 
503b (Scheme 67). It was established that the presence of N-H bonds retarded the removal of the azole 
protecting group in SEM aminopyrazoles, and this could be circumvented via double protection of the 
amino substituent with a maleimide or a substituted succininimide. It is not clear why the presence of 
N-H bonds was deleterious to the protecting group switch, and elucidating this should be a goal of future 
studies. 
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3.3.2 5-Aminopyrazoles 
The regioselectivity exhibited in the C-H borylation of N-substituted-5-aminopyrazoles was comparably 
more challenging to control. However, the substitution of a hydrocarbon-based group (Me, PMB) at the 
azole N led to high C-4 selectivity at the pyrazole ring. Additionally, the C-H borylation of PMB pyrazole 
548 led to a second borylation event at a sterically congested position on the methoxybenzyl ring 
(Scheme 68a). Future studies should establish the role of NHBpin and NHBoc in affording these 
selectivities. A way to test if NHBoc and/or NHBpin act as directors would be to investigate the C-H 
borylation of acetamide 552 and the subsequent regiochemical outcome (Scheme 68b). This would 
constitute an effective control experiment because acetamides are not known to act as outer-sphere 
directors in the C-H borylation.  
Applying the switch methodology developed in 3-aminopyrazoles to 5-aminopyrazoles bearing azole 
protecting groups such as SEM, THP, and Boc presented challenges which lowered the C-H borylation 
efficiency and selectivity in some instances. One explanation offered to explain this was a hydrogen-
bond interaction between the azole protecting group and the amino-substituent, which led to increased 
steric congestion between C-4 and the amine protecting group. Evidence for this intramolecular 
hydrogen-bond was obtained from an X-ray analysis of 5-aminopyrazole 534 (Figure 18). 
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Figure 18: X-Ray Structure of 534 
Whilst this could explain the C-5 selective C-H borylation acetamide 538, further studies are required 
to establish the origin of this regiochemistry (Scheme 69a). Future studies should complete the 
investigation into suitable azole protecting groups for 5-aminopyrazoles in order to improve the C-H 
borylation efficiency/selectivity and subsequently facilitate a protecting group switch. This could be 
achieved by investigating the C-H borylation of trimethylbenzyl pyrazole 554. Whilst PMB pyrazole 548 
C-H borylates at the PMB ring, the corresponding sites in 554 are blocked by methyl substituents, so it 
is predicted that C-4 borylation at the pyrazole ring would occur exclusively. The development of a 
Suzuki-Miyaura arylation on the corresponding C-4 aryl boronate followed by a protecting group switch 
would furnish desired isomer 558 (Scheme 69b).  
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4 Experimental  
4.1 Chemical Synthesis 
4.1.1 General Notes 
Chemicals: [Ir(cod)OMe]2 was synthesised as previously described from IrCl3•3H2O, obtained from 
Precious Metals Online.[1] All other chemicals were purchased from commercial suppliers and were 
used without further purification unless otherwise stated.  
 
Dry Solvents: Tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), and methyl-tert-butyl-ether 
(mtbe) were purchased anhydrous from Fisher. All other dry reaction solvents were dried using an 
Innovative Technology Solvent Purification System and stored under argon.  
 
Column chromatography: Flash column chromatography was performed on a CombiFlash® System 
from Teledyne Isco equipped with an UV-light detector using prepacked silica RediSep Rf cartridges 
with the stated solvent gradient. Crude mixtures to be purified were dry loaded onto silica prior to loading 
on the column. 
  
ESI LC-MS: Purity of all final compounds was checked by LC-MS. LC-MS analyses were conducted on 
a TQD mass spectrometer (Waters Ltd, UK), which was equipped with an Acquity UPLC, using an 
Acquity UPLC BEH C18 (2.1 mm × 50 mm, 1.7 µm) column, and an electrospray ion source. 
Absorbance data were acquired from 210 to 400 nm using an Acquity photodiode array detector.  
 
EI GC-MS: GC-MS analyses were performed on a Shimadzu QP2010-Ultra using electron ionization 
(EI). The mass spectrometer was equipped with either an Rxi-5Sil MS column (0.15 µm × 10 m × 0.15 
mm) for non-polar compounds or an Rxi-17Sil MS column (0.15 µm × 10 m × 0.15 mm) for polar 
compounds.  
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ASAP: ASAP measurements were performed on a LCT Premier XE mass spectrometer and ASAP ion 
source.  
 
HRMS: HRMS measurements were carried out on a QToF Premier mass spectrometer (Waters Ltd, 
UK) with an electrospray ion source or a LCT Premier XE mass spectrometer with an ASAP ion source.  
 
IR spectroscopy: Infrared (IR) spectra were recorded on a Perkin-Elmer RX I FT-IR spectrometer via 
use of a Pike ATR accessory in the range of 3500 – 600 cm-1. Assigned peaks are reported in 
wavenumbers (cm-1).  
 
Melting points: Melting points were measured in open capillary tubes using a Thermo Scientific™ 
Melting Point Apparatus and are uncorrected.  
 
Microwave: Microwave reactions were performed in septum-containing, crimp capped sealed vials in 
an EmrysTM Optimizer microwave unit from Personal Chemistry. The reported times include hold times.  
 
NMR Spectroscopy: NMR-spectra were recorded in CDCl3, d6-DMSO, or CD3OD solutions on a Bruker 
Advance-400 (1H, 13C, 19F, DEPT, COSY), Varian Inova-600 (1 H, 13C, 19F, HSQC, HMBC, COSY, 
NOESY) or Varian VNMRS-700 (1H, 13C, 19F, HSQC, HMBC, COSY, NOESY) spectrometer, using the 
solvent peaks (CDCl3: δ = 7.26 ppm (1H), δ = 77.16 ppm (13C), d6-DMSO: δ = 2.50 ppm (1H), δ = 39.52 
ppm (13C) CD3OD: δ = 3.31 ppm (1H), δ = 49.00 ppm (13C) as reference. For some spectra 
tetramethylsilane (TMS) was used as an internal standard. 13C spectra were run in proton decoupled 
mode. Chemical shift values (δ) are reported in parts per million (ppm) and coupling constants (J) are 
given in Hertz (Hz). The multiplicity is indicated by singlet (s), doublet (d), triplet (t), quartet (q), multiplet 
(m), broad (br) or a combination thereof. Assignment of spectra was carried out using 2D HSQC, HMBC, 
COSY and NOESY techniques. 
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TLC: TLC analyses were performed on pre-coated aluminum-backed plates (Silica gel 60 F254, Merck). 
Signals were visualized with UV-light (254 nm and 365 nm) or by staining where necessary. 
4.2 Synthetic Procedures 
4.2.1 C-H Borylation and Suzuki-Miyaura Cross-Coupling of Aminopyrazole Derivatives 
General Procedure A for the Ir-catalysed Borylation of Aminopyrazole Derivatives: An oven-dried 
Schlenk tube was charged with [Ir(cod)(OMe)]2 (1.0 mol%), tmphen (4.0 mol%) and B2pin2 (2.20 equiv), 
sealed and subject to three N2 purge/refill cycles. Anhydrous, Ar degassed 2-MeTHF was added in the 
specified molarity, and the dark active catalyst solution was transferred to a sealed vial containing the 
substrate (1.00 equiv.). The reaction mixture was stirred at 80 oC for 1 h, followed by complete removal 
of the volatiles. The crude pyrazole boronic ester was then either purified, or cross-coupled directly. 
Where necessary, 1,3,5-trimethoxybenzene was added in order to assess the NMR yield. In most 13C 
spectra, no signal is observed for boron-bound carbon atoms. This is due to line broadening caused by 
10B and 11B quadrupolar nuclei.  
 
General Procedure B for the Suzuki Reaction of Aminopyrazoles with Aryl Halides: To an oven-
dried vial was added Pd(dppf)Cl2 (2.5 mol%) and K3PO4 (2.00 equiv.). The vial was subjected to three 
N2 purge/refill cycles. Aryl halide (1.10 equiv.) followed by a solution of crude pyrazole boronate ester 
in degassed 2-MeTHF (synthesised according to General Procedure A, see the borylation procedure 
for molarity) were added.  The resulting solution was cooled to 0 oC and degassed H2O (1.50 M) was 
added dropwise. The reaction mixture was stirred at 80 oC for the allotted time before removal of the 
volatiles and subsequent chromatographic purification.  
General Procedure C for the Suzuki Reaction of Aminopyrazoles with Aryl Halides: To an oven-
dried Schlenk tube was added XPhos Pd G4 (15 mol%) and Cs2CO3 (2 equiv.). The tube was subjected 
to three N2 purge/refill cycles, before addition of aryl halide (1.1 equiv.) followed by a solution of pyrazole 
boronate ester in degassed 1,4-dioxane (0.16 M).  H2O (2 M) was added and the mixture was stirred at 
50 oC for 16 h. The cooled reaction was diluted with EtOAc (5 mL) and H2O (5 mL) and the aqueous 
phase was extracted with EtOAc (3 x 5 mL).  
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The combined organic fractions were dried over MgSO4, filtered, and evaporated before 
chromatographic purification.  
1-Methyl-5-[3’-(trifluoromethyl)phenyl]-1H-pyrazol-3-amine (375) 
 
Synthesised from 1-methyl-1H-pyrazol-3-amine 373 (194 mg, 2.00 mmol, 0.5 M, 1.00 equiv.) according 
to General Procedure A followed by General Procedure B in a one-pot borylation/cross-coupling 
procedure using 1-bromo-3-(trifluoromethyl)benzene. After 16 h, the reaction was filtered over Celite® 
with EtOAc (10 mL) and diluted with H2O (5 mL). The aqueous layer was extracted with EtOAc (3 x 5 
mL), and the combined organic fractions were dried over MgSO4, filtered, and evaporated. SiO2 gel 
column chromatography (0 → 100 % EtOAc in hexanes) afforded the arylated pyrazole as a yellow oil 
(60 mg, 0.25 mmol, 13%); vmax (ATR) 3327 (NH2), 3213 (NH2), 2940, 1617, 1554, 1510, 1328, 1281, 
1225, 1166, 1120, 1074 cm-1; δH (700 MHz, CDCl3) 7.64-7.32 (2H, m, 2’-H, 4’-H), 7.58-7.56 (2H, m, 5’-
H, 6’-H), 5.76 (1H, s, 4-H), 3.69 (3H, s, CH3), 3.34 (2H, s br, NH2); δC (176 MHz, CDCl3) 132.0 (C-5’), 
131.7 (C-1’), 131.3 (q, J = 33 Hz, C-3’), 129.3 (C-6’), 125.6 (C-2’), 125.2 (q, J = 4 Hz, C-4’), 123.9 (q, J 
= 272 Hz, CF3), 94.3 (C-4), 37.04 (CH3); HRMS (ESI) m/z found [M+H]+ 242.0920, C11H11N3F3 requires 
M, 242.0905. The quaternary C-3 and C-5 signals are weak and as a result are not observed. 
 
Methyl 4-(3’-amino-1’-methyl-1H-pyrazol-5’-yl)benzoate (379) 
 
4 Experimental 
156 
 
Synthesised from tert-butyl N-(1-methyl-1H-pyrazol-3-yl)carbamate 377 (197 mg, 1.00 mmol, 0.50 M, 
1.00 equiv.) according to General Procedure A using 2.00 equiv. B2pin2 followed by General Procedure 
B in a one-pot borylation/cross-coupling procedure using methyl 4-iodobenzoate. After 16 h, the 
volatiles were moved and the residue was dissolved in CH2Cl2 (2.6 mL) before the addition of water 
(0.05 mL) and TFA (1.3 mL) dropwise. After stirring for 3 h, the volatiles were removed and CH2Cl2 (5 
mL) and saturated NaHCO3(aq) (5 mL) were added. The aqueous layer was extracted with CH2Cl2 (3 x 
5 mL), and the combined organic fractions were dried over MgSO4, filtered, and evaporated. SiO2 gel 
column chromatography (0 → 100% EtOAc in hexanes) afforded the arylated aminopyrazole as a yellow 
oil (5 mg, 0.02 mmol, 7%); vmax (ATR) 3385 (NH2), 3278 (NH2), 2966, 1727 (C=O), 1585, 1502, 1441, 
1286, 1217, 1187, 1157 cm-1; δH (700 MHz, CDCl3) 8.57 (1H, s br, NH), 8.15 (2H, d, J = 8.6 Hz, 2-H), 
7.53 (2H, d, J = 8.6 Hz, 3-H), 6.87 (1H, s, 4’-H), 3.96 (3H, s, OCH3), 3.84 (3H, s, 1’-CH3); δC (176 MHz, 
CDCl3) 166.5 (C=O), 144.2 (C-5’), 143.6 (C-3’), 134.1 (C-1), 130.7 (C-4), 130.2 (C-2), 128.8 (C-3), 98.5 
(C-4’), 52.5 (OCH3), 37.8 (1’-CH3); m/z (ESI) [M+H]+ found 232.2.  
 
Tert-butyl N-[1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-5-
yl]carbamate (384) 
 
Synthesised from tert-butyl N-(1-methyl-1H-pyrazol-5-yl)carbamate 383 (197 mg, 1.00 mmol, 0.50 M, 
1.00 equiv.) according to General Procedure A. SiO2 gel flash chromatography (40 → 60 % Et2O in 
CH2Cl2) afforded the borylated pyrazole as a colourless oil (288 mg, 0.89 mmol, 89%); νmax (ATR) 3260 
(NH) 2984, 1728 (C=O), 1578, 1503, 1477, 1459, 1395, 1374, 1252, 1144 cm-1; δH (700 MHz, CDCl3) 
7.62 (1H, s, 3-H), 6.70 (1H, s br, NH), 3.76 (3H, s, 1-CH3), 1.49 (9H, s, C(CH3)3), 1.28 (12H, s, 4’-CH3); 
δC (176 MHz, CDCl3) 153.5 (C=O), 143.9 (C-3), 143.2 (C-5), 83.4 (C-4’), 81.5 (C(CH3)3), 36.4 (1-CH3), 
28.3 (C(CH3)3), 25.0 (4’-CH3); HRMS (ESI) m/z found [M+H]+ 323.2137, C15H27BN3O4 requires M, 
323.2131. 
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Tert-butyl N-[1-methyl-4-(4’-methylphenyl)-1H-pyrazol-5-yl]carbamate (385) 
 
Synthesised from tert-butyl N-(1-methyl-1H-pyrazol-5-yl)carbamate 383 (60 mg, 0.30 mmol, 0.50 M, 
1.00 equiv.) according to General Procedure A followed by General Procedure B in a one-pot 
borylation/cross-coupling procedure using 1-bromo-4-methylbenzene. After 16 h, the volatiles were 
removed and SiO2 gel column chromatography (5 → 15 % acetone in PhMe) afforded the cross-coupled 
pyrazole as an off yellow solid (46 mg, 0.16 mmol, 53%); mp: 154-155 oC; vmax (ATR) 2954, 1728 (C=O), 
1560, 1408, 1371, 1308, 1248, 1171, 1074 cm-1; δH (700 MHz, CD3OD) 7.67 (1H, s, 3-H), 7.39 (2H, d, 
J = 8.2 Hz, 2’-H), 7.20 (2H, d, J = 8.2 Hz, 3’-H) 3.75 (3H, s, NCH3), 2.35 (3H, s, 4’-CH3), 1.53 (9H, s, 
C(CH3)3); δC (176 MHz, CD3OD) 156.4 (C=O), 137.5 (C-3), 137.4 (C-4’), 133.8 (C-5), 130.4 (C-1’), 130.3 
(C-3’), 127.5 (C-2’), 118.6 (C-4), 82.1 (C(CH3)3), 35.5 (1-CH3), 28.5 (C(CH3)3), 21.2 (4’-CH3); HRMS 
(ESI) m/z found [M+H]+ 278.1715, C16H22N3O2 requires M, 278.1712. 
1-(4’-methoxyphenyl)-3-[1’’-methyl-4’’-(4’’’,4’’’,5’’’,5’’’-tetramethyl-1’’’,3’’’,2’’’-dioxaborolan-2-yl)-
1H-pyrazol-3’’-yl]urea (392) 
 
Synthesised from 1-(4-methoxyphenyl)-3-(1-methyl-1H-pyrazol-3-yl)urea 391 (246 mg, 1.00 mmol, 0.5 
M, 1.00 equiv.) according to General Procedure A using HBpin (0.53 mL, 4.00 mmol, 4.00 equiv.) in 
place of B2pin2. SiO2 gel column chromatography (30 → 60% EtOAc in hexanes) afforded the borylated 
pyrazole as a white solid (94 mg, 0.25 mmol, 25%); mp: 161-162 oC; νmax (ATR) 3403 (NH), 2981, 1687 
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(C=O), 1624, 1573, 1509, 1319, 1263, 1235, 1144, 1103, 1032 cm-1; δH (700 MHz, CDCl3) 10.16 (1H, 
s br, NH), 7.51 (1H, s br, NH), 7.47-7.46 (3H, m, 2’-H, 5’’-H), 6.88 (2H, d, J = 9.0 Hz, 3’-H), 3.81 (3H, s, 
1’’-CH3), 3.79 (OCH3), 1.31 (12H, s, 4’’’-CH3); δC (176 MHz, CDCl3) 155.9 (C-4’), 154.6 (C-3’’), 152.7 
(C=O), 137.4 (C-5’’), 132.1 (C-1’), 122.1 (C-2’), 114.2 (C-3’), 83.9 (C-4’’’), 55.6 (OCH3), 38.9 (1’’-CH3), 
24.9 (4’’’-CH3); HRMS (ESI) m/z found [M+H]+ 372.2085, C18H26N4O410B requires M, 372.2083. 
Methyl 4-(3-{[(4-methoxyphenyl)carbamoyl](methyl)amino}-1-methyl-1H-pyrazol-5-yl)benzoate 
(395b) 
 
Synthesised from 1-(4-methoxyphenyl)-3-methyl-3-(1-methyl-1H-pyrazol-3-yl)urea 395 (132 mg, 0.50 
mmol, 0.20 M, 1.00 equiv) according to General Procedure A followed by General Procedure B in a 
one-pot procedure using methyl 4-iodobenzoate. After 1 h, the volatiles were removed and SiO2 gel 
column chromatography (15 → 30 % EtOAc in PhMe) afforded the arylated pyrazole urea as an off 
white solid (72 mg, 0.19mmol, 37%) Product contains ca. 4% of substrate 392; mp: 149-150 oC; νmax 
(ATR) 2981, 1741 (C=O), 1667 (C=O), 1609, 1562, 1551, 1509, 1478, 1281, 1235, 1109, 1023 cm -1; 
δH (600 MHz, CDCl3) 10.56 (1H, s br, NH), 8.15 (2H, d, J = 8.5 Hz, 3-H), 7.53 (2H, d, J = 8.5 Hz, 2-H), 
7.45 (2H, d, J = 8.9 Hz, 2’’-H), 6.87 (2H, d, J = 8.9 Hz, 3’’-H), 6.03 (1H, s, 4’-H), 3.96 (3H, s, CH3O2C), 
3.86 (3H, s, CH3N-5’), 3.79 (3H, s, CH3O-4’’), 3.37 (CH3N-3’); δC (151 MHz, CDCl3) 166.5 (CO2), 155.8 
(C-4’’), 153.4 (NCO), 151.7 (C-3’), 143.8 (C-5’), 134.1 (C-1), 132.6 (C-1’’), 130.7 (C-4), 130.2 (C-3), 
128.7 (C-2), 122.0 (C-2’’), 114.2 (C-3’’), 95.8 (C-4’), 55.6 (CH3O-4’’), 52.5 (CH3O2C), 37.7 (5’-NCH3), 
33.3 (3’-NCH3); HRMS (ESI) m/z found [M+H]+  395.1725, C21H23N4O4 requires M, 395.1719. 
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Methyl 4-(3-{[(4-methoxyphenyl)(methyl)carbamoyl]amino}-1-methyl-1H-pyrazol-5-yl)benzoate 
(398b) 
 
Synthesised from 1-(4-methoxyphenyl)-1-methyl-3-(1-methyl-1H-pyrazol-3-yl)urea 398 (274 mg, 1.00 
mmol, 0.20 M, 1.00 equiv) according to General Procedure A followed by General Procedure B in a 
one-pot procedure using methyl 4-iodobenzoate. After 3 h, the volatiles were removed and basic Al2O3 
gel column chromatography (20 → 30 % EtOAc in PhMe) afforded the arylated pyrazole urea as an off 
white solid (138 mg, 0.35 mmol, 35%); mp: 130 oC (decomposes); νmax (ATR) 2947, 1738 (C=O), 1676 
(C=O), 1558, 1510, 1469, 1274, 1246, 1103, cm-1; δH (700 MHz, CDCl3,) 8.09 (2H, d, J = 8.6 Hz, 3-H), 
7.49 (2H, d, J = 8.6 Hz, 2-H), 7.22 (2H, d, J = 8.7 Hz, 2’’-H), 6.95 (2H, d, J = 8.7 Hz, 3’’-H), 6.77 (2H, s 
br, NH, 4’-H), 3.92 (3H, s, CH3O2C) 3.83 (s, 4’’-OCH3, 3 H), 3.70 (3H, s, 1’-CH3), 3.28 (3H, s, 1’’-NCH3); 
δC (176 MHz, CDCl3) 166.6 (CO2), 159.3 (C-4’’), 154.2 (NCO), 147.5 (C-3’), 143.5 (C-5’), 135.0 (C-1’’), 
134.8 (C-4) 130.1 (C-1), 130.0 (C-3), 129.0 (C-2’’), 128.6 (C-2), 115.7 (C-3’’), 97.0 (C-4’), 55.7 (4’’-
OCH3), 52.4 (CH3O2C), 37.6 (1’’-NCH3), 37.2 (5’-NCH3); HRMS (ASAP) m/z found [M+H]+ 395.1705, 
C21H23N4O4 requires M, 395.1719. 
1-(4’-methoxyphenyl)-3-[1’’-(oxan-2’’’-yl)-4-(4’’’’,4’’’’,5’’’’,5’’’’-tetramethyl-1’’’’,3’’’’,2’’’’-
dioxaborolan-2’’’’-yl)-1H-pyrazol-3’’-yl]urea (421) 
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Synthesised from 1-(4-methoxyphenyl)-3-[1-(oxan-2-yl)-1H-pyrazol-3-yl]urea 420 (20 mg, 0.06 mmol, 
0.20 M, 1.00 equiv.) according to General Procedure A using HBpin (4.00 equiv.) instead of B2pin2. 
SiO2 gel column chromatography (20 → 50% EtOAc in PhMe) afforded the boronate ester as a 
colourless oil (9 mg, 0.02 mmol, 32%); δH (600 MHz, CDCl3) 10.18 (1H, s br, NH) 7.77 (1H, s, 5’’-H), 
7.53 (1H, s br, NH) 7.46 (2H, d, J = 9.1 Hz, 2’-H) , 6.88 (2H, d, J = 9.1 Hz, 3’-H) 5.29-5.27 (1H, dd, J = 
8.8, 2.8 Hz, 2’’’-H), 4.06-4.02 (1H, m, 6’’’-H), 3.80 (3H, s, OCH3), 3.71-3.67 (1H, m, 6’’’-H), 2.15-2.03 
(3H, m, 3’’’-H, 4’’’-H) 1.73-1.62 (3H, m, 4’’’-H, 5’’’-H), 1.31 (12H, s, 4’’’’-CH3); δC (151 MHz, CDCl3) 155.9 
(C-4’), 154.2 (C-3’’), 152.6 (C=O), 135.8 (C-5’’), 132.1 (C-1’), 122.1 (C-2’), 114.3 (C-3’), 87.2 (C-2’’’), 
84.0 (C-4’’’’), 67.6 (C-6’’’), 55.7 (OCH3), 30.2 (C-3’’’), 25.1 (C-5’’’), 24.9 (4’’’’-CH3), 24.9 (4’’’’-CH3), 22.3 
(C-4’’’); HRMS (ESI) m/z found [M]+ 442.2507, C22H32BN4O5 requires M, 442.2502.  
1-(4’-methoxyphenyl)-3-[1’’-(oxan-2’’’-yl)-5-(quinolin-6’’’’-yl)-1H-pyrazol-3’’-yl]urea (423) 
 
Synthesised from 1-(4-methoxyphenyl)-3-[1-(oxan-2-yl)-1H-pyrazol-3-yl]urea 420 (50 mg, 0.16 mmol, 
1.00 equiv.) according to General Procedure A followed by General Procedure B in a one-pot 
borylation/cross-coupling procedure using 6-bromoquinoline. After 16 h, removal of the volatiles 
followed by SiO2 gel flash chromatography (0 → 20% EtOAc in CH2Cl2) afforded the arylated 
aminopyrazole urea as a white solid (7 mg, 0.02 mmol, 10%); mp: 166-168 oC; νmax (ATR) 3277 (NH), 
2946, 1687 (C=O), 1607, 1564, 1510, 1314, 1244, 1181, 1038 cm-1; δH (700 MHz, CDCl3) 9.01 (1H, d, 
J = 4.0 Hz, 2’’’’-H)  8.24-8.23 (2H, m, 4’’’’-H, 8’’’’-H), 8.04 (1H, d, J = 1.6 Hz, 5’’’’-H) 7.89 (1H, dd, J = 
8.6, 1.6 Hz, 7’’’’-H), 7.51 (1H, dd, J = 8.2, 4.0 Hz, 3’’’’-H)  7.44 (2H, d, 8.7 Hz, 2’-H), 6.90 (2H, d, J = 8.7 
Hz, 3’-H), 6.27 (1H, s, 4’’-H), 5.18 (1H, dd, J = 10.1, 2.0 Hz, 2’’’-H), 4.16 (1H, d, J = 11.7 Hz, 6’’’-H), 
3.80 (3H, s, OCH3), 3.61 (1H, t, J = 11.7 Hz, 6’’’-H), 2.52-2.47 (1H, m, 3’’’-H), 2.08-2.06 (1H, m, 4’’’-H), 
1.93 (1H, d, J = 13.1 Hz, 4’’’-H), 1.74 (1H, m, 5’’’-H), 1.60-1.53 (2H, m, 4’’’-H, 5’’’-H); δC (176 MHz, 
CDCl3) 156.3 (C-4’), 153.2 (C=O), 151.4 (C-2’’’’), 148.6 (C-3’’), 148.0 (C-8a’’’’), 144.9 (5’’-H), 136.9 (C-
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4’’’’), 131.7 (C-1’), 130.2 (C-7’’’’), 130.1 (C-8’’’’), 128.6 (C-5’’’’), 128.3 (4’’’’-C-5’’’’), 128.0 (C-6’’’’), 122.5 
(C-2’), 122.1 (C-3’’’’), 114.4 (C-4a’’’) 96.8 (C-4’’), 84.5 (C-2’’’), 68.0 (C6’’’), 55.7 (OCH3), 30.0 (C-3’’’), 
24.9 (C-5’’’), 23.1 (C-4’’’); HRMS (ASAP) m/z found [M]+ 443.1930, C25H25N5O3 requires M, 443.1957. 
5-(4’,4’,5’,5’-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-{[2’’-(trimethylsilyl)ethoxy]methyl}-1H-
pyrazol-3-amine (451) 
 
Synthesised from tert-butyl N-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)carbamate 450 (426 
mg, 2.00 mmol, 0.50 M, 1.00 equiv.) according to General Procedure A. SiO2 gel column 
chromatography (0 → 100 % EtOAc in Hexanes) afforded the borylated pyrazole as a colourless oil 
(292 mg, 0.86 mmol, 43%); νmax (ATR) 3342 (NH2), 3268 (NH2), 2978, 1618, 1485, 1296, 1248, 1143, 
1088, 1066 cm-1; δH (700 MHz, CDCl3) 6.09 (1H, s, 4-H), 5.47 (2H, s, OCH2), 3.79 (2H, s br, NH2), 3.54-
3.51 (2H, m, 1’’-H), 1.31 (12H, s, 4’-CH3), 0.90-0.87 (2H, m, 2’’-H), -0.05 (9H, s, SiCH3); δC (176 MHz, 
CDCl3) 154.6 (C-3), 104.1 (C-4), 84.4 (C-4’), 79.0 (OCH2), 66.0 (C-1’’), 24.9 (4’-CH3), 18.0 (C-2’’), -1.3 
(SiCH3); δB (128 MHz, CDCl3) 27.5; HRMS (ESI) m/z found [M+H]+ 339.2281, C15H30BN3O3Si requires 
M, 339.2264. 
Tert‐butyl N‐[5‐(4’‐methylphenyl)‐1‐{[2’’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐
yl]carbamate (454a) 
 
Synthesised from tert-butyl N-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)carbamate 452 (157 
mg, 0.50 mmol, 1.00 M, 1.00 equiv) according to General Procedure A followed by General Procedure 
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B in a one-pot borylation/cross-coupling procedure using 1-bromo-4-methylbenzene. After 3 h, the 
volatiles were removed and SiO2 gel flash chromatography (5 → 15 % EtOAc in hexanes) afforded the 
cross-coupled pyrazole as an oily orange solid (113 mg, 0.28 mmol, 56%); νmax (ATR) 3225 (NH), 2948, 
1718 (C=O), 1587, 1543, 1483, 1367, 1260, 1242, 1153, 1079, 1025 cm -1; δH (CDCl3, 700 MHz) 7.82 
(1H, s br, NH), 7.52 (2H, d, J = 8.0 Hz, 2’-H), 7.24 (2H, d, J = 8.0 Hz, 3’-H) 6.69 (1H, s br, 4-H), 5.32 
(2H, s, NCH2), 3.69-3.67 (2H, m, 2’-H), 2.39 (3H, s, 4’-CH3) 1.51 (9H, s, CCH3), 0.93-0.91 (2H, m, 2’’-
H), -0.04 (9H, s, SiCH3); δC (176 MHz, CDCl3) 152.9 (C=O), 147.5 (C-3), 145.7 (C-5), 138.8 (C-4’), 
129.5 (C-3’), 128.9 (C-2’), 127.4 (C-1’), 97.2 (C-4), 80.7 (OCCH3) 77.5 (OCH2), 66.7 (C-1’’), 28.5 
(OCCH3), 21.4 (4’-CH3), 18.1 (C-2’’), -1.3 (SiCH3);  δSi (139 MHz, CDCl3) -0.10; HRMS (ASAP) m/z 
found [M+H]+ 404.2361, C21H34N3O3Si requires M, 404.2374. 
Tert‐butyl N‐[5‐(4’‐fluorophenyl)‐1‐{[2’’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐yl]carbamate 
(454b) 
 
Synthesised from tert-butyl N-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)carbamate 452 (313 
mg, 1.00 mmol, 1.00 M, 1.00 equiv) according to General Procedure A followed by General Procedure 
B in a one-pot procedure using 1-bromo-4-fluorobenzene.  After 16 h, the volatiles were removed and 
SiO2 gel flash chromatography (0 → 20 % EtOAc in hexanes) afforded the arylated pyrazole as a white 
solid (191 mg, 0.47 mmol, 47%); mp: 129-130 oC; νmax (ATR) 3254 (NH), 2960, 1718 (C=O), 1608, 
1564, 1511, 1234, 1154 cm-1; δH (CDCl3, 700 MHz) 7.94 (1H, s br, NH), 7.62-7.61 (2H, m, 2’-H), 7.13 
(2H, t, J = 8.5 Hz, 3’-H), 6.71 (1H, s br, 4-H), 5.31 (2H, s, NCH2), 3.72-3.69 (2H, m, 2’’-H), 1.53 (9H, s, 
CCH3), 0.94-0.91 (2H, m, 1’’-H), -0.04 (9H, s, SiCH3); δC (151 MHz, CDCl3) 163.2 (d, J = 250 Hz, C-4’), 
152.9 (C=O), 147.5 (C-3), 144.5 (C-5), 130.9 (d, J = 8 Hz, C-2’), 126.3 (d, J = 3 Hz, C-1’), 115.9 (d, J = 
22 Hz, C-3’), 97.6 (C-4), 80.9 (CCH3), 77.5 (OCH2), 66.8 (C-1’’), 28.5 (CCH3), 18.1 (C-2’’), -1.3 (SiCH3); 
δF (376 MHz, CDCl3) -112.8; HRMS (ASAP) m/z found [M+H]+ 408.2119, C20H31FN3O3Si requires M, 
408.2119. 
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Tert‐butyl N‐[5‐(4’‐nitrophenyl)‐1‐{[2’’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐yl]carbamate 
(454c) 
 
Synthesised from tert-butyl N-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)carbamate 452 (313 
mg, 1.00 mmol, 1.00 M, 1.00 equiv) according to General Procedure A followed by General Procedure 
B in a one-pot borylation/cross-coupling procedure using 1-bromo-4-nitrobenzene. After 16 h, the 
volatiles were removed and SiO2 gel column chromatography (0 → 10 % Et2O in PhMe) afforded the 
cross-coupled pyrazole as a bright yellow solid (169 mg, 0.39 mmol, 39%); mp: 139-141 oC; νmax (ATR) 
3254 (NH) 2960, 1722 (C=O), 1613, 1566, 1514, 1478, 1343, 1238, 1156, 1112  cm-1; δH (CDCl3, 700 
MHz) 8.29 (2H, d, J = 8.7 Hz, 3’-H), 7.89 (1H, s br, NH), 7.87 (2H, d, J = 8.7 Hz, 2’-H), 6.88 (1H, s, 4-
H), 5.36 (2H, s, OCH2), 3.76-3.74 (2H, m, 2’’-H), 1.53 (9H, s, CCH3), 0.96-0.94 (2H, m, 1’’-H), -0.03 (9H, 
s, SiCH3); δC (176 MHz, CDCl3) 152.8 (C=O), 147.9 (C-4’), 147.7 (C-3), 143.0 (C-5), 136.2 (C-1’), 129.6 
(C-2’), 124.2 (C-3’), 98.8 (C-4), 81.2 (OCCH3), 77.9 (NCH2), 67.1 (C-1’’), 28.5 (OCCH3), 18.1 (C-2’’), -
1.3 (SiCH3); HRMS (ESI) m/z found [M+H]+ 435.2065, C20H31N4O5Si requires M, 435.2064. 
3,4-dimethyl-1-[5’-(4’’-methylphenyl)-1’-{[2’’’-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3’-yl]-
2,5-dihydro-1H-pyrrole-2,5-dione (479) 
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Synthesised from 1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-amine 450 (213 mg, 1.00 mmol, 
0.50 M, 1.00 equiv) according to General Procedure A followed by General Procedure B in a one-pot 
borylation/cross-coupling procedure using 1-bromo-4-methylbenzene. After 16 h, the volatiles were 
removed and the crude arylated aminopyrazole 485 was suspended in H2O (5 mL). Dimethyl-2,5-
dihydrofuran-2,5-dione (304 mg, 1.00 mmol, 1.00 equiv) was added and the reaction was stirred at 80 
oC for 1 h, cooled, and diluted with CH2Cl2 (10 mL). The aqueous layer was extracted with CH2Cl2 (3 x 
5 mL), and the combined organic fractions were dried over MgSO4, filtered, an evaporated.  SiO2 gel 
column chromatography (60 → 100% CH2Cl2 in hexanes) followed by recrystallisation from hexanes 
afforded the corresponding arylated pyrazole as a white solid (289 mg, 0.70 mmol, 70%); mp: 81-83 oC 
(hexanes); νmax (ATR) 2957, 1728 (C=O), 1713 (C=O), 1516, 1487, 1346, 1250, 1087, cm-1; δH (600 
MHz, CDCl3) 7.53 (2H, d, J = 8.0 Hz, 2’’-H) 7.26-7.25 (2H, m, 3’’-H), 6.40 (1H, s, 4’-H), 5.41 (2H, s, 
OCH2), 3.79- 3.76 (2H, m, 1’’’-H), 2.40 (3H, s, 4’’-CH3) 2.05 (6H, s, 3-CH3), 0.95-0.92 (2H, m, 2’’’-H), -
0.01 (9H, s, SiCH3); δC (151 MHz, CDCl3) 170.3 (C-2), 146.1 (C-5’), 140.2 (C-3’), 139.1 (C-4’’), 138.1 
(C-3), 129.6 (C-3’’), 129.1 (C-2’’), 126.8 (C-1’’), 103.1 (C-4’), 78.3 (OCH2), 67.2 (C-1’’’), 21.4 (4’’-CH3), 
18.1 (C-2’’’), 9.1 (3-CH3), -1.3 (SiCH3); HRMS (ESI) m/z found [M+H]+ 412.2048, C22H30N3O3Si requires 
M, 412.2056. 
3,3-dimethyl-1-[5’-(4’’-methylphenyl)-1’-(oxan-2’’-yl)-1H-pyrazol-3’-yl]pyrrolidine-2,5-dione 
(488a) 
 
Synthesised from 3,3-dimethyl-1-[1-(oxan-2-yl)-1H-pyrazol-3-yl]pyrrolidine-2,5-dione 485 (146 mg, 
0.36 mmol, 1.00 equiv.) according to General Procedure A followed by General Procedure B in a one-
pot borylation/cross-coupling procedure using 4-methylbromobenzene. After 2 h, the volatiles were 
removed and SiO2 gel column chromatography (20 → 50% acetone in hexanes) afforded the arylated 
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aminopyrazole as a colourless oil (product contains 15% constitutional isomer 3,3-dimethyl-1-[4-(4-
methylphenyl)-1-(oxan-2-yl)-1H-pyrazol-3-yl]pyrrolidine-2,5-dione 499ai) (14 mg, 0.04 mmol, 11%); 
vmax (ATR) 2933, 1789 (C=O), 1722 (C=O), 1509, 1477, 1209, 1152, 1084, 1042 cm -1; δH (700 MHz, 
CDCl3) 7.43 (2H, d, J = 8.0 Hz, 2’’-H) 7.27-7.26 (2H, m, 3’’-H), 6.34 (1H, s, 4’-H), 5.22 (1H, dd, J = 10.1, 
2.5 Hz, 2’’’-H) 4.13, 4.13-4.10 (1H, m, 6’’’-H), 3.59-3.55 (1H, td, J = 11.6, 2.4 Hz, 6’’’-H)  2.71 (2H, m, 
4-H) 2.54-2.48 (1H, m, 3’’’-H) 2.42 (3H, s, 4’’-CH3), 2.05-2.02 (1H, m, 4’’’-H) 1.87-1.84 (1H, m, 3’’’-H) 
1.77-1.70 (1H, m, 5’’’-H), 1.55-1.51 (2H, m, 4’’’-H, 5’’’-H), 1.43 (3H, s, 3-CH3), 1.41 (3H, s, 3-CH3); δC 
(176 MHz, CDCl3) 181.5 (C-2), 174.2 (C-5), 145.8 (C-5’), 140.5 (C-3’), 139.2 (C-4’’), 129.5 (C-3’’), 129.2 
(C-2’’), 126.9 (C-1’’), 103.2 (C-4’), 84.6 (C-2’’’), 67.8 (C-6’’’), 44.0 (C-4), 40.4 (C-3), 29.8 (C-3’’’), 26.0 
(3-CH3), 25.9 (3-CH3), 24.9 (C-5’’’), 22.9 (C-4’’’), 21.5 (4’’-CH3); HRMS (ESI) m/z found [M+H]+ 
368.1959, C21H26N3O3 requires M, 368.1974. 
Methyl 4-[3’-(3’’,3’’-dimethyl-2’’,5’’-dioxopyrrolidin-1’’-yl)-1’-(oxan-2’’’-yl)-1H-pyrazol-5’-
yl]benzoate (488b) 
 
Synthesised from 3,3-dimethyl-1-[1-(oxan-2-yl)-1H-pyrazol-3-yl]pyrrolidine-2,5-dione 485 (50 mg, 0.18 
mmol, 1.00 equiv.) in a one-pot procedure according to General Procedure A followed by Suzuki-
Miyaura according to a modified procedure of Mclaughlin et al.[2]. To an oven-dried vial was added 
Pd(dba)2 (2 mg, 2.5 mol%), PCy3HBF4 (2 mg, 4 mol%), K3PO4 (115 mg, 0.54 mmol, 3.00 equiv.), and 
methyl 4-bromobenzoate (39 mg, 0.18 mmol, 1.00 equiv.). The vial was sealed and subjected to three 
N2 purge/refill cycles. A solution of crude pyrazole boronate ester in degassed dioxane (0.54 mL) was 
added, and the reaction mixture was stirred at 80 oC for 16 h, before filtration over Celite® with EtOAc 
(5 mL). SiO2 gel column chromatography (0 → 40% EtOAc in PhMe (1% Et3N)) afforded the arylated 
aminopyrazole as a colourless oil (13 mg, 0.03 mmol, 18%); vmax (ATR) 2950, 1791 (C=O), 1724 (C=O), 
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1617, 1557, 1507, 1481, 1444, 1338, 1284, 1111, 1048 cm-1; δH (700 MHz, CDCl3) 8.13 (2H, d, J = 8.6 
Hz, 3-H) 7.64 (2H, d, J = 8.6 Hz, 2-H), 6.45 (1H, s, 4’-H), 5.20 (1H, dd, J = 10.0 Hz, 2.6 Hz, 2’’’-H), 4.14-
4.11 (1H, m, 6’’’-H), 3.95 (3H, s, OCH3) 3.57 (1H, td, J = 11.6, 2.3 Hz, 6’’’-H), 2.72 (2H, d, J = 1.5 Hz, 
4’’-H) 2.54-2.48 (1H, m, 3’’’-H) 2.07-2.04 (1H, m, 4’’’-H), 1.89-1.86 (1H, m, 3’’’-H), 1.76-1.70 (1H, m, 5’’’-
H), 1.57-1.51 (2H, m, 4’’’-H, 5’’’-H), 1.43 (3H, s, 3’’-CH3), 1.42 (3H, s, 3’’-CH3); δC (176 MHz, CDCl3) 
181.5 (C-2’’), 174.1 (C-5’’), 166.7 (C=O), 144.6 (C-5’), 140.6 (C-3’), 134.1 (C-1), 130.7 (C-4), 130.1 (C-
3), 129.2 (C-2), 104.0 (C-4’), 85.0 (C-2’’’), 67.8 (C-6’’’), 52.5 (OCH3), 44.0 (C-4’’), 40.5 (C-3’’), 29.7 (C-
3’’’), 25.9 (3’’-CH3), 25.87 (3’’-CH3), 24.8 (C-5’’’), 22.8 (C-4’’’); HRMS (ESI) m/z found [M+H]+ 412.1880, 
C22H26N3O5 requires M, 412.1872. 
3,3-Dimethyl-1-[1’-(oxan-2’’-yl)-5’-(thiophen-2’’’-yl)-1H-pyrazol-3’-yl]pyrrolidine-2,5-dione (488c) 
 
Synthesised from 3,3-dimethyl-1-[1-(oxan-2-yl)-1H-pyrazol-3-yl]pyrrolidine-2,5-dione 485 (50 mg, 0.18 
mmol, 1.00 equiv.) in a one-pot procedure according to General Procedure A followed by Suzuki-
Miyaura cross-coupling according to a modified procedure of Clapham et al.[3]. To an oven-dried vial 
was added Pd(dppf)Cl2•CH2Cl2 (13 mg, 10 mol%), K3PO4 (102 mg, 0.48 mmol, 3.00 equiv.), and 
KOCHO (7 mg, 0.08 mmol, 0.50 equiv.). The vial was sealed and subject to three N2 purge/refill cycles. 
The crude boronate ester (1.1 equiv.) in degassed dioxane (1.1 mL) followed by 2-bromothiophene 
(0.02 mL, 0.16 mmol, 1.00 equiv.) were added and the reaction was stirred at 80 oC for 16 h. Filtration 
over Celite® with EtOAc (10 mL) followed by SiO2 gel column chromatography (0 → 40% EtOAc in 
PhMe) afforded the heteroarylated aminopyrazole as a colourless oil (9 mg, 0.03 mmol 16%); vmax 
(ATR) 2967, 1788 (C=O), 1726 (C=O), 1518, 1481, 1457, 1321, 1234, 1208, 1154, 1088, 1038 cm-1; 
δH (700 MHz, CDCl3) 7.45 (1H, dd, J = 5.1, 1.1 Hz, 1’’’-H) 7.31 (1H, dd, J = 3.5, 1.1 Hz, 3’’’-H) 7.14-7.12 
(1H, m, 4’’’-H), 6.46 (1H, s, 4’’-H), 5.38 (1H, dd, J = 9.8, 2.5 Hz, 2’’-H) 4.12-4.08 (1H, m, 6’’-H), 3.65 
(1H, td, J = 11.4, 2.7 Hz, 6’’-H), 2.71 (2H, d, J = 1.5 Hz, 4-H), 2.54-2.48 (1H, m, 3’’-H) 2.11-2.08 (1H, 
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m, 4’’-H), 1.96-1.94 (1H, m, 3’’-H), 1.75-1.72 (1H, m, 5’’-H) 1.63-1.55 (2H, m, 5’’-H, 4’’-H) 1.43 (3H, s, 
3-CH3), 1.42 (3H, s, 2-CH3); δC (176 MHz, CDCl3) 181.5 (C-2), 174.1 (C-5), 140.3 (C-3’), 138.8 (C-5’), 
129.9 (C-2’’’), 128.6 (C-3’’’), 127.83 (C-1’’’), 127.81 (C-4’’’), 104.4 (C-4’), 84.8 (C-2’’), 67.5 (C-6’’), 44.0 
(C-4), 40.5 (C-3), 29.3 (C-3’’), 26.0 (3-CH3), 25.9 (3-CH3), 24.9 (C-5’’), 22.8 (C-4’’); HRMS (ESI) m/z 
found [M+H]+ 360.1374, C18H22N3O3S requires M, 360.1382. 
Tert‐butyl 3‐methyl‐4‐(4’‐methylphenyl)‐1H‐pyrazole‐1‐carboxylate (494) 
 
Synthesised from a 9:1 mixture of tert-butyl 3-methyl-1H-pyrazole-1-carboxylate and tert-butyl 5-
methyl-1H-pyrazole-1-carboxylate 493a and 493b (182 mg, 1.00 mmol, 1.00 M, 1.00 equiv) according 
to General Procedure A using 1.50 equiv. B2pin2 followed by General Procedure B in a one-pot 
borylation/cross-coupling procedure using 4-bromotoluene. After 1 h, the volatiles were removed and 
SiO2 gel flash chromatography (10 → 20 % EtOAc in hexanes) afforded the cross-coupled pyrazole as 
a yellow/orange oil (272 mg, 78%). Product contains ca. 6% of isomer tert-butyl 5-methyl-4-(4-
methylphenyl)-1H-pyrazole-1-carboxylate 494b; δH (600 MHz, CDCl3) 8.05 (1H, s, 5-H), 7.30 (2H, d, J 
= 7.9 Hz, 2’-H), 7.21 (2H, d, J = 7.9 Hz, 3’-H), 2.43 (3H, s, 3-CH3), 2.38 (3H, s, 4’-CH3), 1.66 (9H, s, 
OCCH3); δC (151 MHz, CDCl3) 151.7 (C-3), 147.8 (C=O), 137.2 (C-4’), 129.5 (C-3’), 129.0 (C-1’), 128.3 
(C-5), 127.8 (C-2’), 124.7 (C-4), 85.1 (OCCH3) 28.1 (OCCH3), 21.3 (4’-CH3), 13.8 (3-CH3); HRMS (ESI) 
m/z found [M+H]+ 273.1630, C16H21N2O2 requires M, 273.1603.  
tert-butyl 3-(3’,3’-dimethyl-2’,5’-dioxopyrrolidin-1’-yl)-4-(4’’,4’’,5’’,5’’-tetramethyl-1’’,3’’,2’’-
dioxaborolan-2’’-yl)-1H-pyrazole-1-carboxylate (500) 
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Synthesised from tert-butyl 3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)-1H-pyrazole-1-carboxylate 498 (35 
mg, 0.12 mmol, 1.00 equiv.) according to General Procedure A using 1.00 equiv. B2pin2. SiO2 gel 
column chromatography (0 → 100% EtOAc in hexanes) afforded the the borylated pyrazole as a white 
solid (38 mg, 0.10 mmol, 76%); mp: 158-159 oC; vmax (ATR) 2984, 1781 (C=O), 1764 (C=O), 1731 
(C=O), 1574, 1498, 1377, 1314, 1231, 1148, 1088 cm-1; δH (700 MHz, CDCl3) 8.40 (1H, s, 5-H), 2.69 
(2H, s, 4’-H), 1.62 (9H, s, C(CH3)3), 1.43 (6H, s, 3’-CH3), 1.25 (12H, s, 4’’-CH3);  δC (176 MHz, CDCl3) 
181.3 (C-2’), 174.5 (C-5’), 149.0 (C-3), 146.5 (C=O), 139.4 (C-5), 86.5 (C(CH3)3), 84.1 (C-4’), 44.3 (C-
4’), 40.6 (C-3’), 28.0 (C(CH3)3), 25.7 (3’-CH3), 24.9 (4’’-CH3); HRMS (ESI) m/z found [M]+ 419.2326, 
C20H30BN3O6 requires M, 419.2342. 
Tert-butyl 3-(3’,3’-dimethyl-2’,5’-dioxopyrrolidin-1’-yl)-4’’-phenyl-1H-pyrazole-1-carboxylate 
(501a) 
 
Synthesised from tert-butyl 3-(3,3-dimethyl-2’,5’-dioxopyrrolidin-1’-yl)-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate 500 (30 mg, 0.07 mmol, 1.00 equiv.) according to 
General Procedure C with iodobenzene. SiO2 gel column chromatography (20 → 40 % EtOAc in 
hexanes) afforded the arylated aminopyrazole as a colourless oil (13 mg, 0.04 mmol, 49%); vmax (ATR) 
2981, 1781 (C=O), 1760 (C=O), 1727 (C=O), 1507, 1483, 1450, 1402, 1372, 1308, 1292, 1251, 1235, 
1215, 1150 cm-1; δH (600 MHz, CDCl3) 8.22 (1H, s, 5-H), 7.37-7.31 (3H, m, Ph H) 7.28-7.26 (2H, m, Ph 
H), 2.67 (2H, s, 4’-H), 1.66 (9H, s, C(CH3)3), 1.33 (6H, s, 3’-CH3); δC (151 MHz, CDCl3) 181.7 (C-2’), 
174.5 (C-5’), 146.8 (CO2), 142.4 (C-3), 130.0 (C-5), 129.5 (C-1’’), 129.0 (Ph C), 128.4 (Ph C), 127.9 
(Ph C), 123.4 (C-4), 86.7 (C(CH3)3), 44.2 (C-4’), 40.9 (C-3’), 28.1 (C(CH3)3), 25.7 (3’-CH3); HRMS (ESI) 
m/z found [M+H]+ 370.1779, C20H24N3O4 requires M, 370.1767. 
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Tert-butyl 3-(3’,3’-dimethyl-2’,5’-dioxopyrrolidin-1’-yl)-4-(4’’-fluorophenyl)-1H-pyrazole-1-
carboxylate (501b) 
 
Synthesised from tert-butyl 3-(3,3’-dimethyl-2’,5’-dioxopyrrolidin-1’-yl)-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate 500 (62 mg, 0.15 mmol, 1.00 equiv.) according to 
General Procedure C with 1-bromo-4-fluorobenzene. SiO2 gel column chromatography (20 → 40 % 
EtOAc in hexanes) afforded the arylated aminopyrazole as a white solid (38 mg, 0.10 mmol, 66%); mp: 
148-150 oC; vmax (ATR) 2984, 1779 (C=O), 1761 (C=O), 1726 (C=O), 1579, 1514, 1488, 1420, 1396, 
1371, 1306, 1291, 1252, 1230, 1149, cm-1; δH (600 MHz, CDCl3) 8.19 (1H, s, 5-H), 7.25-7.22 (2H, m, 
2’’-H), 7.04 (2H, t, J = 8.7 Hz, 3’’-H) 2.67 (2H, s, 4’-H), 1.65 (9H, s, C(CH3)3), 1.32 (6H, s, 3’-CH3); δC 
(151 MHz, CDCl3) 181.7 (C-2’), 174.4 (C-5’), 162.8 (d, J = 248 Hz, C-4’’) 146.7 (CO2), 142.3 (C-5), 
130.0 (C-5), 129.8 (d, J = 8 Hz, C-2’’) 125.5 (d, J = 3 Hz, C-1’’) 122.4 (C-4), 116.0 (d, J = 22 Hz, 3’’-H), 
86.7 (C(CH3)3), 44.1 (C-4’), 40.9 (C-3’), 28.0 (C(CH3)3), 25.6 (3’-CH3); HRMS (ESI) m/z found [M+H]+ 
388.1671, C20H23N3O4F requires M, 388.1673. 
Tert-butyl 3-(3’,3’-dimethyl-2’,5’-dioxopyrrolidin-1’-yl)-4-(4’’-methylphenyl)-1H-pyrazole-1-
carboxylate (501c) 
 
Synthesised from tert-butyl 3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate 500 (62 mg, 0.15 mmol, 1.00 equiv.) according to 
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General Procedure C with 1-bromo-4-methylbenzene. SiO2 gel column chromatography (25 → 35 % 
EtOAc in hexanes) afforded the arylated aminopyrazole as a colourless oil (20 mg, 0.05 mmol, 35%); 
vmax (ATR) 2981, 1779 (C=O), 1758 (C=O), 1727 (C=O), 1587, 1518, 1488, 1399, 1371, 1306, 1293, 
1253, 1235, 1212, 1150 cm-1; δH (600 MHz, CDCl3) 8.19 (1H, s, 5-H), 7.15 (4H, s, 2’’-H, 3’’-H) 2.67 (2H, 
s, 4’-H), 2.34 (3H, s, 4’’-CH3), 1.65 (9H, s, C(CH3)3), 1.34 (6H, s, 3’-CH3); δC (151 MHz, CDCl3) 181.7 
(C-2’), 174.5 (C-5’), 146.8 (CO2), 142.4 (C-3), 138.2 (C-4’’), 129.8 (C-5), 129.7 (C-2’’), 127.6 (C-3’’), 
126.5 (C-1’’), 123.3 (C-4), 44.2 (C-4’), 40.9 (C-3’), 28.0 (C(CH3)3), 25.7 (3’-CH3), 21.3 (4’’-CH3); HRMS 
(ESI) m/z found [M+H]+ 384.1923, C21H26N3O4 requires M, 384.1923. 
Methyl 4‐(3’‐nitro‐1’‐{[2’’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐5’‐yl)benzoate (513) 
 
Synthesised from 3-nitro-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazole 449 (61 mg, 0.25 mmol, 0.50 
M, 1.00 equiv) according to General Procedure A using 1.50 equiv. B2pin2. The crude pyrazole boronate 
ester was cross-coupled according to the following procedure. To an oven-dried vial was added 
Pd(dppf)Cl2 (18 mg, 10 mol%) and K3PO4 (106 mg, 0.50 mmol, 2.00 equiv.). The vial was subjected to 
three N2 purge/refill cycles. Methyl 4-iodobenzoate (72 mg, 0.28 mmol, 1.10 equiv.) followed by a 
solution of crude pyrazole boronate ester in degassed 2-MeTHF (0.5 mL) were added. The reaction 
mixture was stirred at 80 oC for 16 h before removal of the volatiles. SiO2 gel column chromatography 
(5 → 20 % EtOAc in Hexanes) afforded the corresponding arylated pyrazole as a colourless oil (19 mg, 
0.05 mmol, 20%); νmax (ATR) 2971, 1739 (C=O), 1608, 1510, 1447, 1343, 1235, 1154, cm-1; δH (600 
MHz, CDCl3) 8.17 (2H, d, J = 8.4 Hz, 3-H), 7.76 (2H, d, J = 8.4 Hz, 2-H), 7.08 (1H, s, 4’-H), 5.49 (2H, 
s, OCH2), 3.96 (3H, s, OCH3), 3.84-3.81 (2H, m, 2’’-H), 0.98-0.95 (2H, m, 1’’-H), -0.01 (9H, s, SiCH3); 
δC (151 MHz, CDCl3) 166.3 (C=O), 155.6 (C-3’), 146.5 (C-5’), 132.2 (C-1), 131.6 (C-4), 130.4 (C-3), 
129.1 (C-2), 103.3 (C-4’), 79.7 (OCH2), 68.2 (C-2’’), 52.6 (OCH3), 18.1 (C-1’’), -1.3 (SiCH3); HRMS 
(ASAP) m/z found [M-H]+ 376.1327, C17H22N3O5Si requires M, 376.1329. 
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N-[3-(4’-fluorophenyl)-1-(oxan-2’’-yl)-1H-pyrazol-5-yl]acetamide (540) 
 
Synthesised from N-[1-(oxan-2-yl)-1H-pyrazol-5-yl]acetamide 538 (77 mg, 0.37 mmol, 1.00 equiv.) in a 
one-pot procedure according to General Procedure A with modifications. The borylation was stirred for 
3 h. Suzuki-Miyaura cross-coupling according to a modified procedure of Chai et al. of the crude 
pyrazole boronate ester was performed as follows.[4] To an oven-dried vial was added Pd(dppf)Cl2 (16 
mg, 10 mol%) and tetrabutylammonium bromide (7 mg, 0.02 mmol, 0.10 equiv. The vial was sealed 
and subject to three N2 purge/refill cycles. The crude boronate ester (1.0 equiv.) in degassed PhMe (1.1 
mL) followed by 1-bromo-4-fluorobenzene (0.02 mL, 0.22 mmol, 1.00 equiv.) were added and the 
mixture was cooled to 0 oC. 2M Na2CO3 (0.22 mL, 0.44 mmol, 2.00 equiv.) was added and the reaction 
was stirred at 110 oC for 1 h. EtOAc (5 mL) and H2O (5 mL) were added the aqueous layer was extracted 
with EtOAc (3 x 5mL). The combined organic layers were dried over MgSO4, filtered, and evaporated. 
SiO2 gel column chromatography (0 → 100% iPrOH in hexanes (1%Et3N)) afforded the arylated 
aminopyrazole as a white solid (48 mg, 0.16 mmol 43%); mp: 150-151 oC; vmax (ATR) 3275 (NH), 2943, 
1674 (C=O), 1608, 1551, 1523, 1442, 1334, 1252, 1206, 1155, 1082, 1040 cm-1; δH (600 MHz, CDCl3) 
8.45 (1H, s br, NH), 7.77-7.75 (2H, m, 2’-H), 7.05 (2H, t, J = 8.7 Hz, 3’-H) 6.88 (1H, s, 4-H), 5.52 (1H, 
dd, J = 7.5, 2.9 Hz, 2’’-H), 4.00-3.97 (1H, m, 6’’-H), 3.74-3.70 (1H, m, 6’’-H), 2.31-2.25 (1H, m, 3’’-H), 
2.20 (3H, s, CH3) 2.14-2.08 (2H, m, 3’’-H, 4’’-H), 1.75-1.63 (3H, m, 4’’-H, 5’’-H); δC (151 MHz, CDCl3) 
166.6 (C=O), 162.7 (d, J = 246 Hz, C-4’), 149.5 (C-3), 138.2 (C-5), 129.8 (d, J = 3 Hz, C-4’) 127.4 (d, J 
= 8 Hz, C-2’), 115.5 (d, J = 21 Hz, C-3’) 95.2 (C-4), 86.9 (C-2’’), 66.8 (C-6’’), 29.2 (C-3’’), 25.2 (C-5’’), 
24.2 (CH3), 21.2 (C-4’’); HRMS (ESI) m/z found [M+H]+ 304.1478, C16H19N3O2F requires M, 304.1461.  
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1-({4'’-fluoro-5’-methoxy-[1’,1'’-biphenyl]-2’-yl}methyl)-4-(4’’’-fluorophenyl)-1H-pyrazol-5-amine 
(550) 
 
Synthesised from 1-[(4-methoxyphenyl)methyl]-1H-pyrazol-5-amine 548 (102 mg, 0.50 mmol, 1.00 
equiv.) in a one-pot procedure according to General Procedure A with modifications. The borylation 
was left for 3.5 h. Suzuki-Miyaura cross-coupling of half of the material was conducted as follows.[162] 
To an oven-dried vial was added Pd(dppf)Cl2 (25 mg, 10 mol%) and tetrabutylammonium bromide (8 
mg, 0.03 mmol, 0.10 equiv). The vial was sealed and subject to three N2 purge/refill cycles. The crude 
boronate ester (1.0 equiv.) in degassed PhMe (1.3 mL) followed by 1-bromo-4-fluorobenzene (0.03 mL, 
0.25 mmol, 1.00 equiv.) were added and the mixture was cooled to 0 oC. 2M Na2CO3 (0.25 mL, 0.50 
mmol, 2.00 equiv.) was added and the reaction as stirred at 110 oC for 1 h. The reaction was filtered 
over Celite® before removal of the volatiles. SiO2 gel column chromatography (0 → 100% EtOAc in 
hexanes) afforded the arylated aminopyrazole as a colourless oil; νmax (ATR) 3431 (NH2), 3325 (NH2), 
2964, 1607, 1574, 1494, 1373, 1297, 1220, 1158, 1094, 1034 cm-1; δH (700 MHz, CDCl3) 7.43 (1H, s, 
3-H), 7.31-7.29 (2H, m, 2’’-H), 7.28- 7.26 (2H, m, 2’’’-H), 7.14 (2H, t, J = 8.9 Hz, 3’’-H), 7.11 (1H, d, J = 
8.6 Hz, 3’-H), 7.06 (2H, t, J = 8.8 Hz, 3’’’-H) 6.89 (1H, dd, J = 2.7, 8.6 Hz, 4’-H) 6.79, (1H, d, J = 2.7 Hz, 
6’-H) 5.07 (2H, s, NCH2), 3.80 (3H, s, OCH3); δC (176 MHz, CDCl3) 162.5 (d, J = 247 Hz, 4’’-H), 161.2 
(d, J = 245 Hz, 4’’’-H) 159.1 (C-5’), 141.5 (C-1’), 140.9 (C-5), 137.5 (C-3), 136.4 (d, J = 3 Hz, C-1’’), 
130.8 (d, J = 8 Hz, C-2’’), 129.8  (C-4’), 129.7 (d, J = 3 Hz C-1’’’) 128.1 (d, J = 8 Hz, C-2’’’), 125.9 (C-
3’), 116.0 (d, J = 21 Hz, C-3’’), 115.9 (C-2’), 115.8 (d, J = 21 Hz, C-3’’’), 113.9 (C-3’’), 106.1 (C-4), 55.5 
(OCH3), 49.2 (NCH2); HRMS (ESI) m/z found [M+H]+ 392.1585, C23H20N3OF2 requires M, 392.1574.  
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4.2.2 Synthesis of Pyrazole Derivatives 
Tert-butyl N-(1-methyl-1H-pyrazol-3-yl)carbamate (376)[5] 
 
1-Methyl-1H-pyrazol-3-amine 373 (0.16 mL, 2.00 mmol, 1.00 equiv.) and Boc2O (480 mg, 2.20 mmol, 
1.10 equiv.) were stirred at 50 oC for 5 min. The resulting precipitate was dissolved in CH2Cl2 (15 mL) 
and washed with H2O (2 x 10 mL), saturated NaHCO3(aq) (10 mL) and brine (10 mL). The organic layer 
was dried over MgSO4, filtered, and evaporated. Recrystallisation from iPrOH afforded the Boc pyrazole 
as a white solid (351 mg, 1.78 mmol, 89%); mp: 112-113 oC; vmax (ATR) 3187 (NH), 2983, 1743 (C=O), 
1553, 1370, 1286, 1147 cm-1; δH (700 MHz, CDCl3) 8.29-8.46 (1H, m br, NH), 7.19 (1H, s, 5-H), 6.45 
(1H, s, 4-H), 3.80 (3H, s, 1-CH3) 1.50 (9H, s, CCH3); δC (176 MHz, CDCl3) 153.0 (C-3), 148.0 (C=O), 
130.8 (C-5), 96.0 (C-4), 80.3 (CCH3), 38.8 (CH3N), 28.5 (CCH3); m/z (ESI) [M+H]+ 198.1. Data for 376 
was consistent with a previous report. 
Tert‐butyl N‐methyl‐N‐(1‐methyl‐1H‐pyrazol‐3‐yl)carbamate (376b) 
 
At 0 oC under N2, a solution of tert-butyl N-(1-methyl-1H-pyrazol-3-yl)carbamate 376 (280 mg, 1.36 
mmol, 1.0 equiv.) in anhydrous THF (2 mL) was treated dropwise with 1M LiHMDS in THF (2.15 mL, 
2.15 mmol, 1.50 equiv.). After stirring for 30 min, MeI (0.45 mL, 7.2 mmol, 5.00 equiv.) was added and 
the mixture was warmed to rt. After stirring for 30 min, the reaction was poured into saturated NH4Cl 
(10 mL) and the crude mixture was concentrated to ca. half volume. H2O (20 mL) was added and 
aqueous phase was extracted with EtOAc (3 x 30 mL). The combined organic fractions were dried over 
MgSO4, filtered and evaporated. SiO2 gel column chromatography (30% → 40% EtOAc in hexanes) 
afforded the methylated pyrazole as a colourless oil (342 mg, 0.73 mmol, 54%); vmax (ATR) 2981, 1700 
(C=O), 1535, 1495, 1387, 1253, 1148 cm-1; δH (600 MHz, CDCl3) 7.16 (1H, d, J = 2.1 Hz, 5-H) 6.33 
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(1H, s br, 4-H), 3.74 (3H, s, 1-CH3), 3.28 (3H, s, 3-NCH3), 1.47 (9H, s, CCH3); δC (151 MHz, CDCl3) 
153.7 (C=O), 151.1 (C-3), 130.5 (C-5), 98.8 (C-4), 80.6 (CCH3), 38.8 (1-CH3), 34.3 (3-NCH3), 28.4 
(CCH3); HRMS (ASAP) m/z found [M+H]+ 212.1405, C10H18N3O2 requires M, 212.1399.  
tert-butyl N-(1’-methyl-1H-pyrazol-5’-yl)carbamate (383) 
 
At 0 oC, a solution of 1-methyl-1H-pyrazol-5-amine 380 (1.94 g, 20.0 mmol, 1 equiv.), trimethylamine 
(4.20 mL, 30.0 mmol, 1.50 equiv.), and DMAP (244 mg, 2.00 mmol, 0.10 equiv.) in CH2Cl2 (20 mL) was 
charged portionwise with Boc2O (4.80 g, 22.0 mmol, 1.10 equiv.). The reaction was stirred for 16 h 
before addition of saturated saturated NaHCO3(aq) (10 mL). The organic layer was washed with 
saturated NaHCO3(aq) (3 x 20 mL) and the combined aqueous fractions were back-extracted with CH2Cl2 
(3 x 20 mL). The combined organic fractions were dried over MgSO4, filtered, and evaporated. 
Recrystallisation from tert-butyl methyl ether afforded the Boc pyrazole as a white solid (3.26 g, 16.5 
mmol, 83%); mp: 93-94 oC (mtbe); vmax (ATR) 3182 (NH), 2977, 1733 (C=O), 1573, 1395, 1367, 1274, 
1249, 1160, 1002 cm-1; δH (700 MHz, CDCl3) 7.34 (1H, d, J = 2.0 Hz, 3’-H), 6.87 (1H, s br, NH), 6.09 
(1H, s br, 4’-H), 3.70 (3H, s, 1’-CH3), 1.47 (9H, s, CCH3); δC (176 MHz, CDCl3) 153.0 (C=O), 138.2 (C-
3’), 136.2 (C-5’), 99.4 (C-4’), 81.6 (CCH3), 35.4 (1’-CH3), 28.3 (CCH3); HRMS (ESI) m/z found [M+H]+ 
198.1243, C9H16N3O2 requires M, 198.1243.  
1-[(3’,5’-dimethylphenyl)methyl]-1H-pyrazol-3-amine (402) 
 
To a solution of 1-[(3,5-dimethylphenyl)methyl]-3-nitro-1H-pyrazole 403 (384 mg, 1.66 mmol, 1.00 
equiv.) in EtOH (17 mL) and NH4Cl (2.3 mL) was added Fe (1.39 g, 24.9 mmol, 15 equiv.). The reaction 
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was refluxed for 3 h, cooled, and filtered over Celite®. Removal of the volatiles followed by filtration 
over SiO2 with CH2Cl2 (50 mL) afforded the aminopyrazole as a white solid (254 mg, 1.26 mmol, 76%); 
mp: 91-92 oC; δH (700 MHz, CDCl3) 7.13 (1H, d, J = 2.3 Hz, 5-H) 6.91 (1H, s br, 4’-H), 6.82 (2H, s br, 
2’-H), 5.61 (1H, d, J = 2.3 Hz 4-H), 5.01 (2H, s, CH2), 3.44 (2H, s br, NH2), 2.28 (6H, s, CH3); δC (176 
MHz, CDCl3) 154.6 (C-3), 138.4 (C-3’), 136.9 (C-1’), 130.9 (C-5), 129.6 (C-4’), 125.5 (C-2’), 93.3 (C-4), 
55.6 (CH2), 21.4 (CH3); HRMS (ESI) m/z found [M+H]+ 202.1344, C12H16N3 requires M, 202.1344. 
1-[(3’,5’-dimethylphenyl)methyl]-3-nitro-1H-pyrazole (403) 
 
To a solution of 3-nitro-1H-pyrazole 404 (565 g, 5.00 mmol, 1.00 equiv.) in THF (5 mL) under N2 at - 20 
oC was added portionwise 60% NaH dispersion in mineral oil (220 mg, 5.50 mmol, 1.1 equiv.). The 
reaction was allowed to stir for 30 min before the addition of 1-(bromomethyl)-3,5-dimethylbenzene 
(1.10 g, 5.50 mmol, 1.10 equiv.). The cooling bath was removed and after 2 h, the reaction was 
quenched with NH4Cl (10 mL) and approximately one third of the volatiles were removed. EtOAc (20 
mL) and H2O (10 mL) were added and the aqueous layer was extracted with EtOAc (3 x 10 mL). The 
combined organic layers were dried over MgSO4, filtered and evaporated. Recrystallisation of the 
residue from tert-butyl methyl ether afforded the benzylated pyrazole as a white solid (2.03 g, 4.2 mmol, 
84%); mp: 91-92 oC; vmax (ATR) 2923, 1611, 1544, 1505, 1382, 1303, 1193, 1055, cm-1; δH (700 MHz, 
CDCl3) 7.39 (1H, d, J = 2.6 Hz, 5-H) 6.99 (1H, s br, 4’-H), 6.90 (2H, s br, 2’-H), 6.88 (1H, d, J = 2.6 Hz, 
3-H), 5.28 (2H, s, CH2), 2.30 (6H, s, CH3); δC (176 MHz, CDCl3) 155.8 (C-3), 139.0 (C-3’), 134.0 (C-1’), 
131.8 (C-5), 130.7 (C-4’), 126.2 (C-2’), 103.4 (C-4), 57.8 (CH2), 21.3 (CH3); HRMS (ESI) m/z found 
[M+H]+ 232.1075, C12H14N3O2 requires M, 232.1086. 
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1-(4-methoxyphenyl)-1H-pyrazol-3-amine (410) [6] 
 
A flame-dried vial was charged with 1H-pyrazol-3-amine 369 (416 mg, 5.00 mmol, 1.00 equiv.), Cu2O 
(72 mg, 0.50 mmol, 10 mol%), and KOH (561 mg, 10.0 mmol, 2.00 equiv.). The vial was sealed and 
purged/refilled x3 with N2, followed by addition of 1-iodo-4-methoxybenzene (1.76 g, 7.50 mmol, 1.50 
equiv.) and DMSO (10 mL). The reaction was stirred at 120 oC for 16 h, cooled, and diluted with EtOAc 
(20 mL) and H2O (50 mL). The organic phase was washed with H2O (3 x 40 mL) and brine (40 mL), 
and the organic phase was dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (65 → 75% EtOAc in hexanes) afforded the aminopyrazoles as a brown solid (316 mg, 
1.67 mmol, 33%); mp: 146-150 oC; δH (600 MHz, DMSO) 7.99 (1H, d, J = 2.1 Hz, 5-H) 7.55 (2H, d, J = 
8.8 Hz, 2’-H) 6.96 (2H, d, J = 8.8 Hz, 3’-H) 5.67 (1H, d, J = 2.1 Hz, 4-H) 4.92 (2H, s br, NH2), 3.75 (CH3); 
δC (151 MHz, DMSO) 157.1, 156.5, 134.3, 127.9, 118.3, 114.8, 95.8, 55.8; m/z (EI) [M]+ 189.1, 174.1, 
77.1. Data for 410 was consistent with a previous report. 
3-nitro-1-(oxan-2’-yl)-1H-pyrazole (413)[7] 
 
To a solution of 3-nitro-1H-pyrazole 404 (117 mg, 1.04 mmol, 1.00 equiv.) and 3,4-dihydro-2H-pyran 
(0.28 mL, 3.10 mmol, 3.00 equiv.) in CH2Cl2 (8.5 mL) was added p-TsOH (20 mg, 0.10 mmol, 10 mol%). 
The reaction was stirred for 1 h, poured into saturated NaHCO3(aq) (10 mL), and the aqueous layer was 
extracted with CH2Cl2 (3 x 5 mL). SiO2 gel column chromatography (0 → 100% EtOAc in hexanes) 
afforded the THP pyrazole as a colourless oil; (203 mg, 1.03 mmol, 99%); vmax (ATR) 2946, 1541, 1510, 
1457, 1381, 1314, 1184, 1084, cm-1; δH (600 MHz, CDCl3) 7.70 (1H, d, J = 2.6 Hz, 5-H), 6.92 (1H, d, J 
= 2.6 Hz, 4-H), 5.44 (1H, dd, J = 9.0, 2.8 Hz, 2’-H), 4.06-4.03 (1H, m, 6’-H) 3.72-3.68 (1H, m, 6’-H), 
2.17-2.13 (1H, m, 3’-H), 2.05-1.98 (2H, m, 4’-H, 3’-H), 1.73-1.60 (3H, m, 4’-H, 5’-H); δC (151 MHz, 
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CDCl3) 155.8 (C-3), 130.2 (C-5), 103.0 (C-4), 88.8 (C-2’), 67.9 (C-6’), 30.7 (C-3’), 24.8 (C-5’), 21.7 (C-
4’). m/z (ESI) [M]+ 197.3. Data for 415 was consistent with a previous report. 
5-nitro-1-(oxan-2’-yl)-1H-pyrazole (414) 
 
To a solution of 3-nitro-1H-pyrazole 404 (500 mg, 4.42 mmol, 1.00 equiv.) and 3,4-dihydro-2H-pyran 
(1.20 mL, 13.3 mmol, 3.00 equiv.) in CH2Cl2 (36 mL) was added PPTS (111 mg, 0.44 mmol, 10 mol%). 
The reaction was stirred for 16 h, poured into saturated NaHCO3(aq) (15 mL), and the aqueous layer 
was extracted with CH2Cl2 (3 x 15 mL). SiO2 gel column chromatography (0 → 50% EtOAc in hexanes) 
afforded the THP pyrazole as a crude colourless oil, (1.47 g, 1.47 mmol, 33%); vmax (ATR) 2950, 1552, 
1511, 1442, 1351, 1242, 1209, 1182, 1130, 1089, 1047 cm-1; δH (600 MHz, CDCl3) 7.56 (1H, d, J = 1.9 
Hz, 3-H), 7.07 (1H, d, J = 1.9 Hz, 4-H), 6.17 (1H, dd, J = 9.5, 2.6 Hz, 2’-H), 3.98 (1H, d, J = 11.6 Hz, 2’-
H), 3.72 (1H, td, J = 11.6 Hz, 2.6 Hz, 6’-H), 2.43-2.37 (1H, m, 3’-H), 2.13-2.10 (1H, m, 4’-H), 2.05-2.03 
(1H, m, 3’-H), 1.76-1.59 (3H, m, 4’-H, 5’-H); δC (151 MHz, CDCl3) 146.1 (C-5), 138.4 (C-3), 107.7 (C-
4), 85.9 (C-2’), 68.0 (C-6’), 29.0 (C-3’), 24.9 (C-5’), 22.4 (C-4’); HRMS (ASAP) m/z found [M]+ 197.0793, 
C8H11N3O3 requires M, 197.0800. 416 was found to isomerise slowly in untreated CDCl3 catalysed by 
the presence of trace HCl.  
1-(oxan-2’-yl)-1H-pyrazol-3-amine (418) 
 
Under N2, a solution of 3-nitro-1-(oxan-2-yl)-1H-pyrazole 413 (167 mg, 0.85 mmol, 1.00 equiv.) in EtOAc 
(1 mL) was charged with 10% dry Pd/C (45 mg, 5 mol%) followed by MeOH (5 mL). The reaction was 
allowed to stir under H2 for 1 h at rt. The reaction mixture was filtered over Celite® and the volatiles 
were removed. Filtration through a SiO2 plug with EtOAc (1% Et3N) (50 mL) afforded the aminopyrazole 
as an orange oil (129 mg, 0.77 mmol, 91%); vmax (ATR) 3426 (NH2), 3340 (NH2), 2950, 1621, 1554, 
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1498, 1438, 1388, 1208, 1084, 1041 cm-1; δH (600 MHz, CDCl3) 7.32 (1H, d, J = 2.5 Hz, H-5) 5.64 (1H, 
d, J = 2.5 Hz, H-4), 5.10 (1H, dd, J = 10.3, 2.4 Hz, 2’-H),  4.06-4.03 (1H, m, 6’-H), 3.66-3.62 (1H, m, 6’-
H), 3.54 (2H, s br, NH2), 2.11-2.05 (1H, m, 3’-H), 2.02-1.94 (2H, m, 3’-H, 5’-H), 1.69-1.60 (2H, m, 5’-H, 
4’-H), 1.57-1.52 (1H, m, 5’-H); δC (151 MHz, CDCl3) 154.8 (C-3), 129.3 (C-5), 94.2 (C-4), 87.2 (C-2’), 
67.9 (C-6’), 30.2 (C-3’), 25.1 (C-5’), 22.9 (C-4’); HRMS (ESI) m/z found [M+H]+ 168.1153, C8H14N3O 
requires M, 168.1137. 
3‐Nitro‐1‐{[2’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazole (449)[8] 
 
Method A: To a solution of 3-nitro-1H-pyrazole 404 (1.13 g, 10.0 mmol, 1.00 equiv.) in THF (20 mL) 
under N2 at - 20 oC was added portionwise 60% NaH dispersion in mineral oil (440 mg, 11.0 mmol, 1.10 
equiv.). The reaction was allowed to stir for 5 min before the addition of SEMCl (1.93 mL, 11.0 mmol, 
1.10 equiv.). The cooling bath was removed and after 2 h, the reaction was quenched with NH4Cl (20 
mL) and ca. one third of the volatiles were removed. EtOAc (30 mL) and H2O (20 mL) were added and 
the aqueous layer was extracted with EtOAc (3 x 20 mL). The combined organic layers were dried over 
MgSO4, filtered and evaporated. SiO2 gel column chromatography (10 → 40% Et2O in hexanes) afforded 
the SEM pyrazole as a white solid (2.03 g, 8.40 mmol, 84%). Alternatively, the crude solid could be 
recrystallised from hexanes to afford lustrous white crystals in identical yield.  
 
Method B: To a solution of 3-nitro-1H-pyrazole (1.13 g, 10.0 mmol, 1.00 equiv.) in THF (20 mL) under 
N2 at rt was rapidly added LiHMDS in THF (11 mL, 11 mmol, 1.0 M, 1.1 equiv.). SEMCl (1.93 mL, 11.0 
mmol, 1.10 equiv.) was added immediately thereafter and the solution was allowed to stir for 16 h. The 
reaction was quenched with NH4Cl (20 mL) and ca. one third of the volatiles were removed. EtOAc (30 
mL) and H2O (20 mL) were added and the aqueous layer was extracted with EtOAc (3 x 20 mL). The 
combined organic layers were dried over MgSO4, filtered and evaporated. SiO2 gel column 
chromatography (5 → 20% EtOAc in hexanes) afforded the protected pyrazole as a white solid (550 
mg, 2.13 mmol, 23%); mp: 60–62 oC (hexanes); vmax (ATR) 2925, 1545, 1503, 1374, 1296, 1247, 1176, 
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1093, cm-1; δH (700 MHz, CDCl3) 7.66 (1H, d, J = 2.5 Hz, 5-H) 6.97 (1H, d, J = 2.5 Hz, 4-H), 5.49, (2H, 
s, NCH2) 3.61-3.59 (2H, m, 1’-H), 0.92-0.90 (2H, m, 2’-H), -0.03 (9H, s, SiCH3); δC (176 MHz, CDCl3) 
156.1 (C-4), 131.8 (C-5), 103.9 (C-4), 81.9 (NCH2), 68.0 (C-1’), 17.9 (C-2’), -1.3 (SiCH3); m/z (EI) [M – 
C2H5]+ 214.1, 188.0, 170.1. Data for 449 was consistent with a previous report.  
1‐{[2’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐amine (450)[9] 
 
Under N2, a solution of 3-nitro-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazole 457 (2.03 g, 8.40 mmol, 
1.00 equiv.) in EtOAc (10 mL) was charged with 10% dry Pd/C (445 mg, 5 mol%) followed by MeOH 
(40 mL). The reaction was allowed to stir under H2 for 1 h at 35 oC. The reaction mixture was filtered 
over Celite® and the volatiles were removed. SiO2 gel column chromatography (0 → 100% Et2O in 
hexanes) afforded the aminopyrazole as a white solid (1.47 g, 6.89 mmol, 82%); mp: 62-64 oC; vmax 
(ATR) 3330 (NH2), 3261 (NH2), 2952, 1616, 1551, 1250, 1086 cm-1; δH (700 MHz, CDCl3) 7.28, (1H, d, 
J = 2.5 Hz, 5-H) 5.68 (1H, d, J = 2.5 Hz, 4-H), 5.20 (2H, s, NCH2), 3.76 (2H, s br, NH2), 3.55-3.52 (2H, 
m, 1’-H), 0.90-0.88 (2H, m, 2’-H), -0.03 (9H, s, SiCH3); δC (176 MHz, CDCl3) 155.2 (C-3), 131.9 (C-5), 
95.3 (C-4), 80.2 (NCH2), 67.0 (C-1’), 18.4 (C-2’), -0.9 (SiCH3); m/z (EI) [M]+ 213.2, 140.2, 96.1. 
Alternatively, the crude solid can be recrystallised from hexanes to afford lustrous, white crystals in 
identical yield. Data for 450 was consistent with a previous report. 
Tert‐butyl N‐(1‐{[2’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐yl)carbamate (452) 
 
1‐{[2’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐amine 450 (213 mg, 1.00 mmol, 1.00 equiv.) and 
Boc2O (240 mg, 1.10 mmol, 1.10 equiv.), were stirred neat at 50 oC for 3 h. The cooled reaction was 
dissolved in CH2Cl2 (10 mL), washed with saturated NaHCO3(aq) (3 x 5 mL). The aqueous layer was 
extracted with CH2Cl2 (3 x 5 mL), and the combined organic fractions were dried over MgSO4, filtered 
and evaporated. SiO2 gel column chromatography (20 → 30% EtOAc in hexanes) afforded the Boc 
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pyrazole as a colourless oil (197 mg, 0.63 mmol, 63%); vmax (ATR) 3195 (NH), 2954, 1727 (C=O), 1583, 
1356, 1246, 1163, 1092 cm-1; δH (400 MHz, CDCl3) 7.49 (1H, s br, NH), 7.40 (1H, d, J = 2.5 Hz, 5-H), 
6.56 (1H, s br, 4-H), 5.29 (2H, s, NCH2), 3.54-3.50 (2H, m, 1’-H), 1.50 (9H, s, CCH3), 0.91-0.87 (2H, m, 
2’-H) 0.05 (9H, s, SiCH3); δC (176 MHz, CDCl3) 152.8 (C=O), 148.3 (C-3), 130.8 (C-5), 97.35 (C-4), 
80.8 (CCH3) 80.0 (NCH2), 66.7 (C-1’), 28.5 (CCH3), 17.9 (C-2’), -1.3 (SiCH3); HRMS (ASAP) [M+H]+ 
m/z found 314.1909, C14H28N3O3Si requires M, 314.1900.  
N‐(1‐{[2’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐yl)acetamide (458) 
 
1‐{[2‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐amine 450 (213 mg, 1.00 mmol, 1.00 equiv.) and Ac2O 
(0.11 mL, 1.10 mmol, 1.10 equiv.) were stirred neat for 0.5 h. The reaction mixture was diluted in EtOAc 
(20 mL), washed with saturated NaHCO3(aq) (10 mL), H2O (10 mL) and brine (10 mL). The organic layer 
was dried over MgSO4, filtered, and evaporated. Filtration through an SiO2 plug CH2Cl2 (3 x 20 mL) 
afforded the acetylated pyrazole as a colourless oil (212 mg, 0.83 mmol, 83%); vmax (ATR) 3241 (NH), 
2952, 1673 (C=O), 1580, 1539, 1425, 1372, 1250, 1208, 1094 cm-1; δH (700 MHz, CDCl3) 8.19 (1H, s 
br, NH), 7.44 (1H, d J = 2.6 Hz, 5-H), 6.77 (1H, d, J = 2.6 Hz, 4-H), 5.28 (2H, s, NCH2), 3.53-3.50 (2H, 
m, 1’-H), 2.15 (3H, s, Ac CH3), 0.90-0.88 (2H, m, 2’-H), -0.03 (9H, s, SiCH3); δC (176 MHz, CDCl3) 167.8 
(C=O), 147.7 (C-3), 131.0 (C-5), 98.9 (C-4), 80.1 (NCH2), 66.9 (C-1’), 24.0 (CH3CO), 17.9 (C-2’), -1.3 
(SiCH3); HRMS (ESI) m/z found [M+H]+ 256.1496, C11H22N3O2Si requires M, 212.1481.  
3‐phenyl‐1‐{[2’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazole (466a)[10] 
5-phenyl-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazole (466b) 
  
At 0 oC under N2, 60% NaH dispersion in mineral oil (110 mg, 2.80 mmol, 1.10 equiv.) was added to a 
solution of 3‐phenyl‐1H‐pyrazole (360 mg, 2.50 mmol, 1.00 equiv.) in THF (7.5 mL). After 5 min, SEMCl 
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(0.88 ml, 5.00 mmol, 2.00 equiv.) was added before removal of the cooling bath. After 0.5 h, the reaction 
was quenched with NH4Cl (10 mL) and the reaction was concentrated to ca. half volume. H2O (10 mL) 
was added and the aqueous layer was extracted with EtOAc (3 x 20 mL). The organic layer was dried 
over MgSO4, filtered, and the volatiles were removed to obtain the crude alkylated pyrazole. NMR 
analysis indicated a 3:2 isomeric ratio 466a:466b. SiO2 gel column chromatography (5 → 15% EtOAc 
in hexanes) afforded the SEM pyrazole as a colourless oil (25 mg, 0.09 mmol, 4%); δH (700 MHz, 
CDCl3) 7.83 (2H, d, J = 7.6 Hz, 2’’-H), 7.59 (1H, d, J = 2.3 Hz, 5-H), 7.40 (2H, t, J = 7.6 Hz, 3’’-H), 7.31 
(1H, t, J = 7.6 Hz, 4’’-H), 6.63 (1H, d, J = 2.3 Hz, 4-H), 5.47 (2H, s, NCH2), 3.63 (2H, m, 1’-H), 0.93 (2H, 
m, 2’-H), -0.02 (9H, s, SiCH3); δC (176 MHz, CDCl3) 152.2, 133.5, 130.9, 128.7, 127.9, 125.9, 104.2, 
80.4, 66.8, 17.9, -1.3; m/z (ESI) [M+H]+ 275.2, 216.1, 158.1. Data for 466a was consistent with a 
previous report. 
3‐phenyl‐1H‐pyrazole (467)[11] 
 
Method A: To a solution of (2E)-3-amino-1-phenylprop-2-en-1-one (350 mg, 2.00 mmol, 1.00 equiv.) in 
EtOH (4 mL) was added 50% hydrazine hydrate (0.18 mL, 3.8 mmol, 1.90 equiv.). The reaction was 
refluxed for 2 h, before removal of the volatiles. SiO2 gel column chromatography (30% EtOAc in 
hexanes) afforded the phenyl pyrazole as a brown solid (285 mg, 1.98 mmol, 99%).  
 
Method B: To a crude mixture of 3‐phenyl‐1‐{[2‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazole (466a) and 
5-phenyl-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazole (466b) (25 mg, 0.09 mmol, 1 equiv.) in EtOH 
(4 mL) was added 3M HCl (1 mL). The resulting solution was refluxed for 3 h, and the reaction was 
neutralized with saturated NaHCO3(aq) (10 mL). Approximately one third of the volatiles were removed, 
and saturated NaHCO3(aq) (10 mL) followed by EtOAc (20 mL) were added. The organic layer was 
washed with saturated NaHCO3(aq) (3 x 10 mL) and the aqueous layer was back-extracted with EtOAc 
(3 x 10 mL). The combined organic fractions were dried over MgSO4, filtered, and evaporated. SiO2 gel 
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column chromatography (0 → 20% EtOAc in hexanes) afforded the phenyl pyrazole as a brown solid (8 
mg, 62%) mp: 76-77 oC; δH (700 MHz, CDCl3) 7.76 (2H, d, J = 7.7 Hz, 2’-H), 7.62 (1H, s br, 5-H), 7.42 
(2H, t, J = 7.7 Hz, 3’-H), 7.34 (1H, t, J = 7.7 Hz, 4’-H), 6.62 (1H, s br, 4-H); δC (176 MHz, CDCl3) 132.2, 
128.9, 128.2, 125.9, 102.9; m/z (ESI) [M+H+MeCN]+ 186.3, 145.3. Data for 467 was consistent with a 
previous report. 
3,4-dimethyl-1-(1’-{[2’’-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3’-yl)-2,5-dihydro-1H-pyrrole-
2,5-dione (470) 
 
To a solution of 1‐{[2’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐amine 450 (126 mg, 1.00 mmol, 1.00 
equiv.) in water (5 mL) was added dimethyl-2,5-dihydrofuran-2,5-dione (126 mg, 1.00 mmol, 1.00 eq). 
The reaction was stirred at 80 oC for 1 h, cooled, and diluted with CH2Cl2 (5 mL). The aqueous layer 
was extracted with CH2Cl2 (3 x 10 mL), dried over MgSO4, and evaporated. SiO2 gel column 
chromatography (40 → 60 → 100% CH2Cl2 in hexanes) afforded the maleimide as a white solid (306 
mg, 0.95 mmol, 95%); mp: 81-83 oC (hexanes); vmax (ATR) 2953, 1729 (C=O), 1705 (C=O), 1525, 1497, 
1425, 1349, 1249, 1211, 1095 cm-1;  δH (700 MHz, CDCl3) 7.59 (1H, d, J = 2.5 Hz, 5’-H), 6.37 (1H, d, J 
= 2.5 Hz, 4’-H), 5.41 (2H, s, NCH2), 3.60-3.57 (2H, m, 1’’-H), 2.02 (6H, s, 3-CH3), 0.90-0.88 (2H, m, 2’’-
H), -0.04 (SiCH3); δC (176 MHz, CDCl3) 170.1 (C=O), 140.9 (C-3’), 138.0 (C-3), 130.7 (C-5’), 103.6 (C-
4’), 80.8 (NCH2), 67.1 (C-1’’), 17.9 (C-2’’), 9.0 (3-CH3), -1.3 (SiCH3); HRMS (ASAP) m/z found [M+H]+ 
322.1588, C15H24N3O3 requires M, 322.1587.  
3,4-dimethyl-1-(1-methyl-1H-pyrazol-5-yl)-2,5-dihydro-1H-pyrrole-2,5-dione (471) 
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To a solution of 1-methyl-1H-pyrazol-5-amine 380 (194 mg, 2.00 mmol, 1.00 eq) in H2O (10 mL) was 
added dimethyl-2,5-dihydrofuran-2,5-dione (252 mg, 2.00 mmol, 1.00 eq.). The reaction was stirred at 
rt for 16 h, cooled, and diluted with CH2Cl2 (10 mL). The organic layer was washed with saturated 
NaHCO3(aq) (10 mL), dried over MgSO4, and filtered over a SiO2 plug with CH2Cl2 (20 mL). Removal of 
the volatiles afforded the maleimide as a white solid (401 mg, 1.95 mmol, 98%); mp: 136-137 oC; vmax 
(ATR) 2960, 1731 (C=O), 1708 (C=O), 1554, 1421, 1388, 1311, 1278, 1078 cm-1; δH (700 MHz, CDCl3) 
7.54 (1H, d, J = 2.0 Hz, 3’-H), 6.19 (1H, d, J = 2.0 Hz, 4’-H), 3.71 (3H, s, 1’-CH3), 2.08 (6H, s, 3-CH3); 
δC (176 MHz, CDCl3) 169.8 (C=O), 138.9 (C-3), 138.8 (C-3’), 129.8 (C-5’), 104.2 (C-4’), 36.4 (1’-CH3), 
9.2 (3-CH3); HRMS (ESI) m/z found [M+H]+ 206.0943, C10H11N3O2 requires M, 206.0930. 
3,4-dimethyl-1-(1’-methyl-1H-pyrazol-3’-yl)-2,5-dihydro-1H-pyrrole-2,5-dione (471b) 
 
To a solution of 1-methyl-1H-pyrazol-3-amine 373 (0.43 mL, 5.00 mmol, 1.00 eq) in H2O (5 mL) was 
added dimethyl-2,5-dihydrofuran-2,5-dione (631 mg, 5.00 mmol, 1.00 eq). The reaction was refluxed 
for 1 h, cooled, and diluted with CH2Cl2 (15 mL). The organic layer was washed with saturated 
NaHCO3(aq) (10 mL), dried over MgSO4, and filtered over a SiO2 plug with CH2Cl2 (50 mL). Removal of 
the volatiles afforded the maleimide as a white solid (984 mg, 4.80 mmol, 96%); mp = 146-148 oC; vmax 
(ATR) 2925, 1759 (C=O), 1722 (C=O), 1505, 1435, 1414, 1386, 1343, 1302, 1224, 1090 cm-1; δH (700 
MHz, CDCl3) 7.37 (1H, d, J = 2.4 Hz, 5’-H), 6.26 (1H, d, J = 2.4 Hz, 4’-H), 3.90 (3H, s, CH3N), 2.02 (6H, 
s, 3’-CH3); δC (176 MHz, CDCl3) 170.4 (C=O), 140.2 (C-3’), 137.9 (C-3), 131.4 (C-5’), 102.5 (C-4’), 39.6 
(1’-CH3), 9.0 (3-CH3); HRMS (ESI) m/z found [M+H]+ 206.0936, C10H11N3O2 requires M, 206.0930.  
3-[(1’-{[2’’-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)carbamoyl]propanoic acid (474) 
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To a solution of 1‐{[2’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐amine 450 (213 mg, 1.00 mmol, 1.00 
equiv.) and Et3N (0.28 mL, 2.00 mmol, 2.00 equiv.) in THF (2 mL) was added succinic anhydride (220 
mg, 2.20 mmol, 2.20 equiv.). The reaction was refluxed for 1 h, cooled, and diluted with EtOAc (10 mL) 
and H2O (10 mL). The aqueous layer was extracted with EtOAc (3 x 10 mL), dried over MgSO4, filtered 
and evaporated. Purification via SiO2 gel column chromatography (0 → 10%, 10 → 100% Et2O in PhMe 
(2% Et3N)) afforded the amic acid as a white solid (112 mg, 0.35 mmol, 35%); mp: 80-83 oC; vmax (ATR) 
3296 (OH), 3249 (NH), 2953, 1708 (C=O), 1697 (C=O), 1614, 1584, 1502, 1428, 1403, 1378, 1342, 
1246, 1209, 1169, 1013 cm-1; δH (700 MHz, CDCl3) 10.41 (1H, s br, NH), 7.44 (1H, d, J = 1.7 Hz, 5’-H), 
6.85 (1H, d, 1.7 Hz, 4’-H), 5.26 (2H, s, NCH2), 3.52-3.50 (2H, m, 1’-H), 2.83-2.77 (4H, m, 1-H, 2-H), 
0.91-0.88 (2H, m, 2’-H), -0.02 (9H, s, SiCH3); δC (176 MHz, CDCl3) 177.3 (C-3), 170.0 (1-CO), 148.6 
(C-3’), 131.4 (C-5’), 98.9 (C-4’), 79.8 (NCH2), 67.2 (C-1’), 31.3 (C-1), 29.3 (C-2), 17.8 (C-2’), -1.3 
(SiCH3); HRMS (ESI) m/z found [M+H]+ 314.1534 C13H24N3O4Si requires M, 314.1536.  
3-[(1-methyl-1H-pyrazol-5-yl)carbamoyl]propanoic acid (475) 
 
To a solution of 1-methyl-1H-pyrazol-5-amine 380 (485 mg, 5.00 mmol, 5.00 equiv.) in PhMe (5 mL) 
was added succinic anhydride (505 mg 1.05 mmol, 1.05 equiv.). The reaction was refluxed for 1h, 
cooled, and diluted with H2O (10 mL). The aqueous layer was extracted with EtOAc (3 x 10 mL), dried 
over MgSO4, filtered and evaporated. Recrystallisation from EtOH afforded the amic acid as a white 
solid (486 mg, 2.47 mmol, 49%); mp: 155-156 oC; vmax (ATR) 3274 (OH), 3149 (NH), 2495, 1702 (C=O), 
1671 (C=O), 1545, 1428, 1399, 1321, 1291, 1179, 1071 cm-1; δH (600 MHz, DMSO) 12.14 (1H, s br, 
OH), 9.93 (1H, s br, NH), 7.30 (1H, d, J = 1.7 Hz, 3’-H), 6.14 (1H, d, J = 1.7 Hz, 4’-H) 3.63 (3H, s, CH3), 
2.60-2.58 (2H, m, CH2), 2.53-2.51 (2H, m, CH2); δC (151 MHz, DMSO) 173.7 (C=O), 170.2 (C=O), 137.3 
(C-5’), 136.4 (C-3’), 98.6 (C-4’), 35.5 (CH3), 30.1 (CH2), 28.7 (CH2); HRMS (ASAP) m/z found [M+H]+ 
198.0843 C8H12N3O3 requires M, 198.0879.  
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1-(1’-methyl-1H-pyrazol-3’-yl)pyrrolidine-2,5-dione (476) 
 
Oxalyl dichloride (1 mL), followed by DMF (0.1 mL) were added to 3-[(1-methyl-1H-pyrazol-5-
yl)carbamoyl]propanoic acid 475 (197 mg, 1.00 mmol, 1.00 equiv.) and stirred for 1 h. The volatiles 
were removed and the residue was recrystallised from EtOH to afford the succinimide as a yellow solid 
(23 mg, 0.13 mmol, 13%); mp: 197-198 oC;  vmax (ATR) 2946, 1777 (C=O), 1714 (C=O), 1554, 1488, 
1427, 1397, 1381, 1301, 1302, 1184, 1161, 1054 cm-1; δH (600 MHz, DMSO) 7.49, (1H, d, J = 2.0 Hz, 
3’-H) 6.20 (1H, d, J = 2.0 Hz, 4’-H), 3.60 (3H, s, 1’-H), 2.82 (4H, s, 3-H) δC (151 MHz, DMSO) 176.6 
(C=O), 138.5 (C-3’), 131.0 (C-5’), 104.4 (C-4’), 36.2 (CH3), 29.2 (C-3); HRMS (ESI) m/z found [M+H]+ 
180.0774, C8H10N3O2 requires M, 180.0773. 
3,3-dimethyl-1-[1’-(oxan-2’’-yl)-1H-pyrazol-3’-yl]pyrrolidine-2,5-dione (485) 
 
Method A: To a solution of 1-(oxan-2-yl)-1H-pyrazol-3-amine 418 (42 mg, 0.25 mmol, 1.00 equiv.) in 
DMF (1.3 mL) was added 3,3-dimethyloxolane-2,5-dione (35 mg, 0.28 mmol, 1.1 equiv.). The reaction 
was refluxed overnight, cooled, and diluted with EtOAc (10 mL) and H2O (10 mL). The organic phase 
was washed with H2O (4 x 10 mL), dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (0 → 100% acetone in hexanes) afforded the maleimide as an orange oil (60 mg, 0.22 
mmol, 86%).  
Method B: To a solution of 3,3-dimethyl-1-(1H-pyrazol-3-yl)pyrrolidine-2,5-dione 486 (21 mg, 0.19 
mmol, 1.00 equiv.) and 3,4-dihydro-2H-pyran (0.03 mL, 0.33 mmol, 3.00 equiv.) in CH2Cl2 (0.89 mL) 
was added p-TsOH (2.1 mg, 0.01 mmol, 10 mol%). The reaction was stirred for 1 h, poured into 
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saturated NaHCO3(aq) (10 mL), and the organic layer was collected. The aqueous layer was extracted 
with CH2Cl2 (3 x 5 mL). SiO2 gel column chromatography (0 → 100% acetone in hexanes) afforded the 
THP pyrazole as an orange oil; (24 mg, 0.09 mmol, 80%); vmax (ATR) 2934, 1790 (C=O), 1715 (C=O), 
1519, 1492, 1425, 1376, 1335, 1233, 1203, 1146, 1084, 1042 cm-1; δH (700 MHz, CDCl3) 7.65 (1H, d, 
J = 2.6 Hz, 5’-H) 6.34 (1H, d, J = 2.6 Hz, 4’-H), 5.40 (1H, dd, J = 9.3, 2.7 Hz, 2’’-H) , 4.04-4.01 (1H, m, 
6’’-H) 3.66 (1H, td, J = 11.2, 2.8 Hz, 6’’-H), 2.68 (2H, s, 4-H), 2.10-1.95 (3H, m, 3’’-H, 4’’-H), 1.69-1.61 
(2H, m, 5’’-H, 4’’-H), 1.60-1.55 (1H, m, 5’’-H), 1.39 (6H, s, CH3); δC (176 MHz, CDCl3) 181.4 (C-2), 174.1 
(C-5), 140.6 (C-3’), 128.7 (C-5’), 103.1 (C-4’), 88.0 (C-2’’), 67.7 (C-6’’), 43.9 (C-4), 40.3 (C-3), 30.6 (C-
3’’), 25.8 (CH3), 24.9 (C-5’’), 22.2 (C-4’’); HRMS (ESI) m/z found [M+H]+ 278.1524, C14H20N3O3 requires 
M, 278.1505.  
3,3-dimethyl-1-(1H-pyrazol-3’-yl)pyrrolidine-2,5-dione (486) 
 
To a solution of 1H-pyrazol-3-amine 369 (83 mg, 1.00 mmol, 1.00 equiv.) in DMF (5 mL) was added 
3,3-dimethyloxolane-2,5-dione (141 mg, 1.10 mmol, 1.10 equiv.). The reaction was stirred at 150 oC for 
16 h, cooled, and diluted with PhMe (30 mL). The volatiles were azeotropically removed, and SiO2 gel 
column chromatography (70 → 100% EtOAc in hexanes (1% Et3N)) afforded the succinimide as a white 
solid (120 mg, 0.62 mmol, 62%); mp: 145-148 oC; vmax (ATR) 3300 (NH), 2981, 1791 (C=O), 1711 
(C=O), 1531, 1347, 1264, 1208, 1145, 1091 cm-1; δH (700 MHz, CDCl3) 12.22 (1H, s br, NH), 7.65 (1H, 
d, J = 2.4 Hz, 5’-H), 6.45 (1H, d, J = 2.4 Hz, 5’-H), 2.71 (2H, s, 4-H), 1.39 (6H, s, CH3); δC (176 MHz, 
CDCl3) 181.6 (C-2), 174.2 (C-5), 140.6 (C-3’), 131.0 (C-5’), 100.9 (C-4’), 43.8 (C-4), 40.3 (C-3) 25.8 
(CH3); HRMS (ESI) m/z found [M+H]+ 194.0938, C9H12N3O2 requires M, 194.0930. 
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Tert‐butyl 3‐methyl‐1H‐pyrazole‐1‐carboxylate (493a)[12] 
Tert‐butyl 5‐methyl‐1H‐pyrazole‐1‐carboxylate (493b) 
 
 
At 0 oC under N2, Boc2O (2.62 g, 12.0 mmol, 1.20 equiv.) followed by DMAP (122 mg, 1.00 mmol, 0.10 
equiv.) were added to a solution of 3-methyl-1H-pyrazole (820 mg, 10.0 mmol, 1.00 equiv.) in MeCN 
(10 mL). The reaction was warmed to rt, stirred for 2 h, and diluted with EtOAc (30 mL). The organic 
phase was washed with 1M HCl (10 mL), saturated NaHCO3(aq) (10 mL), and brine (10 mL). The 
aqueous fractions were back-extracted with EtOAc (3 x 20 mL) and the combined organic fractions 
were dried over MgSO4, filtered, and evaporated. SiO2 gel column chromatography (60 → 100% CH2Cl2 
in hexanes) afforded the Boc pyrazoles 493a and 493b in a 9:1 ratio as a colourless oil; vmax (ATR) 
2984, 1714 (C=O), 1553, 1412, 1351, 1204, 1147 cm-1; m/z (ESI) [M+H]+ 182.1; δH 493a (700 MHz, 
CDCl3) 7.95 (1H, d, J = 2.7 Hz, 5-H), 6.16 (1H, s, 4-H), 2.32 (3H, s, 3-CH3), 1.62 (9H, s, CCH3); δC 493a 
(176 MHz, CDCl3) 153.9 (C=O), 147.8 (C-3), 131.4 (C-5), 109.3 (C-4), 85.1 (CCH3), 28.1 (CCH3), 14.1 
(3-CH3); δH 493b (700 MHz, CDCl3) 7.54 (1H, s, 3’-H), 6.10 (1H, s, 4’-H), 2.52 (3H, s, 5’-CH3), 1.64 (9H, 
s, CCH3); δC 493b (176 MHz, CDCl3) 153.8 (C=O) 143.7 (C-3’), 142.5 (C-5’), 109.7 (C-4’), 85.0 (CCH3), 
29.80 (CCH3) 14.55 (5-CH3); Data for 493a was consistent with a previous report. 
tert-butyl 3-nitro-1H-pyrazole-1-carboxylate (495)  
 
At 0 oC under N2, a solution of 3-nitro-1H-pyrazole 404 (565 mg, 5.00 mmol, 1.00 equiv.) in THF (5.00 
mL) was treated with 1M LiHMDS in THF (5.50 mL, 5.50 mmol, 1.10 equiv.) and stirred for 0.5 h. Boc2O 
was added and the reaction was allowed to warm to rt and stirred for 1 h.  The reaction was quenched 
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with NH4Cl (10 mL) and diluted with EtOAc (10 mL). The organic layer was washed with saturated 
NaHCO3(aq) (2 x 10 mL), and the combined aqueous layers were back-extracted with EtOAc (3 x 5 mL). 
The combined organic fractions were dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (5% Et2O in PhMe) followed by recrystallisation from iPrOH afforded the Boc pyrazole 
as a white solid (400 mg, 1.88 mmol, 38%); mp: 104-105 oC (iPrOH); vmax (ATR) 2997, 1774 (C=O), 
1551, 1521, 1401, 1430, 1374, 1321, 1291, 1054 cm-1; δH (600 MHz, CDCl3) 8.18 (1H, d, J = 2.9 Hz, 
H-5), 6.98 (1H, d, J = 2.9 Hz, H-4) 1.68 (9H, s, CH3); δC (151 MHz, CDCl3) 158.1 (C=O), 146.2 (C-3), 
133.3 (C-5), 104.4 (C-4), 88.5 (OCCH3), 27.9 (CH3); HRMS (ESI) m/z found [M-H]- 212.0671, 
C8H10N3O4 requires M, 212.0671. 
tert-butyl 3-amino-1H-pyrazole-1-carboxylate (496) [13] 
 
Under N2, a solution of tert-butyl 3-nitro-1H-pyrazole-1-carboxylate 495 (350 mg, 1.64 mmol, 1.00 
equiv.) in EtOAc (2 mL) was charged with 10% dry Pd/C (87 mg, 5 mol%) followed by MeOH (10 mL). 
The reaction was allowed to stir under H2 for 4 h at rt. The reaction mixture was cooled and filtered over 
Celite®, followed by removal of the volatiles. SiO2 gel column chromatography (0 → 100% acetone in 
hexanes) afforded the aminopyrazole as a white solid (227 mg, 1.24 mmol, 76%); mp: 107-109 oC; vmax 
(ATR) 3460 (NH2), 3316 (NH2), 2990, 1734 (C=O), 1624, 1584, 1488, 1388, 1308, 1244, 1141 cm-1 δH 
(700 MHz, CDCl3) 7.82, (1H, s br, 5-H) 5.81 (1H, d, J = 2.9 Hz) , 5.80, 3.89 (2H, s br, NH2), 1.60 (9H, 
s, CH3); δC (176 MHz, CDCl3) 157.3 (C-3), 147.8 (C=O), 132.1 (C-5), 99.2 (C-4), 84.3 (CCH3), 28.0 
(CH3); m/z (ESI) [M-H]- 182.1. Data for 495 was consistent with a previous report.  
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Tert-butyl 3-(3’,3’-dimethyl-2’,5’-dioxopyrrolidin-1-yl)-1H-pyrazole-1-carboxylate (498) 
 
At 0 oC under N2, Boc2O (408 mg, 1.83 mmol, 1.20 equiv.) followed by DMAP (19 mg, 0.16 mmol, 0.10 
equiv.) were added to a solution of 3,3-dimethyl-1-(1H-pyrazol-3’-yl)pyrrolidine-2,5-dione 486 (300 mg, 
1.55 mmol, 1.00 equiv.) in MeCN (1.6 mL). The reaction was warmed to rt, stirred for 16 h, and diluted 
with EtOAc (5 mL). The organic phase was washed with 1M HCl (5 mL), saturated NaHCO3(aq) (5 mL) 
and brine (5 mL). The aqueous fractions were back-extracted with EtOAc (3 x 5 mL) and the combined 
organic fractions were dried over MgSO4, filtered, and evaporated. SiO2 gel column chromatography 
(20 → 35% acetone in hexanes) afforded the Boc pyrazole as a white solid (411 mg, 1.40 mmol, 90%); 
vmax (ATR) 2981, 1791 (C=O), 1758 (C=O), 1720 (C=O), 1542, 1480, 1412, 1366, 1305, 1236, 1147, 
1058, cm-1; δH (700 MHz, CDCl3) 8.12 (1H, d, J = 2.8 Hz, 5-H), 6.48 (1H, d, J = 2.8 Hz, 4-H), 2.70 (2H, 
s, 4’-H), 1.63 (9H, s, OCH3), 1.40 (6H, s, 3’-CH3); δC (176 MHz, CDCl3) 181.0 (C-2’), 173.6 (C-5’), 146.9 
(CO2), 144.6 (C-3), 132.1 (C-5), 106.0 (C-4), 86.4 (OCCH3), 44.0 (C-4’), 40.5 (C-3’), 27.9 (OCCH3), 
25.8 (3’-CH3); HRMS (ESI) m/z found [M+H]+ 294.1464, C14H20N3O4 requires M, 294.1454.  
Methyl 3-(3’,3’-dimethyl-2’,5’-dioxopyrrolidin-1’-yl)-1H-pyrazole-1-carboxylate (503) 
 
At 0 oC under N2, methyl chlorofomate (0.05 mL, 0.62 mmol, 1.20 equiv.) was added to a solution of 
3,3-dimethyl-1-(1H-pyrazol-3’-yl)pyrrolidine-2,5-dione 486 (300 mg, 1.55 mmol, 1.00 equiv.) and 
pyridine (0.05 mL, 0.62 mmol, 1.20 equiv.) in CH2Cl2 (0.5 mL). The reaction was warmed to rt, stirred 
for 16 h, and diluted with CH2Cl2 (5 mL). The organic phase was washed with 1M HCl (5 mL), saturated 
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NaHCO3(aq) (5 mL) and brine (5 mL). The aqueous fractions were back-extracted with CH2Cl2 (3 x 5 mL) 
and the combined organic fractions were dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (0 → 100% EtOAc in hexanes) afforded the acylated pyrazole as a white solid (83 mg, 
0.44 mmol, 64%); mp: 131-132 oC; vmax (ATR) 2976, 1785 (C=O), 1720 (C=O), 1541, 1481, 1444, 1373, 
1305, 1282, 1232, 1141 cm-1; δH (700 MHz, CDCl3) 8.20 (1H, d, J = 2.9 Hz, 5-H) 6.55 (1H, d, J = 2.9 
Hz, 4-H), 4.05 (3H, s, OCH3), 2.70 (2H, s, 4’-H), 1.39 (6H, s, 3’-CH3); δC (176 MHz, CDCl3) 180.7 (C-
2’), 173.3 (C-4’), 149.4 (CO2), 145.2 (C-3), 132.4 (C-5), 106.5 (C-4), 55.4 (OCH3), 43.9 (C-4’), 40.5 (C-
3’), 25.8 (3’-CH3); HRMS (ESI) m/z found [M+H]+ 252.0989, C11H14N3O4 requires M, 252.0984. 
1-(1-acetyl-1H-pyrazol-3-yl)-3,3-dimethylpyrrolidine-2,5-dione (505) 
 
At 0 oC under N2, acetyl chloride (0.04 mL, 0.62 mmol, 1.20 equiv.) was added to a solution of 3,3-
dimethyl-1-(1H-pyrazol-3’-yl)pyrrolidine-2,5-dione 486 (300 mg, 1.55 mmol, 1.00 equiv.) and pyridine 
(0.05 mL, 0.62 mmol, 1.20 equiv.) in CH2Cl2 (0.5 mL). The reaction was warmed to rt, stirred for 1 h, 
and diluted with CH2Cl2 (5 mL). The organic phase was washed with 1M HCl (5 mL), saturated 
NaHCO3(aq) (5 mL) and brine (5 mL). The aqueous fractions were back-extracted with CH2Cl2 (3 x 5 mL) 
and the combined organic fractions were dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (0 → 100% acetone in hexanes) afforded the acetyl pyrazole as a white solid (103 mg, 
0.44 mmol, 85%); mp: 97- 98oC; vmax (ATR) 2976, 1797 (C=O), 1720 (C=O), 1544, 1476, 1411, 1371, 
1353, 1269, 1223, 1147, 1042 cm-1; δH (700 MHz, CDCl3) 8.29 (1H, d, J = 2.9 Hz, 5-H), 6.57 (1H, d, J 
= 2.9 Hz, 4-H), 2.74 (2H, s, 4’-H), 2.70 (3H, s, Ac CH3), 1.43 (6H, s, 3’-CH3); δH (176 MHz, CDCl3) 181.0 
(C-2’), 173.5 (C-5’), 169.1 (Ac C=O), 144.7 (C-3), 129.4 (C-5), 106.9 (C-4), 43.9 (C-4’), 40.6 (C-3’), 25.8 
(3’-CH3), 21.7 (Ac CH3); HRMS (ESI) m/z found [M+H]+ 236.1059, C11H14N3O3 requires M, 236.1035. 
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(3’-Amino-1H-pyrazol-1-yl)methyl 2,2-dimethylpropanoate (514) 
 
Under N2, a solution of (3-nitro-1H-pyrazol-1-yl)methyl 2,2-dimethylpropanoate 514b (2.17 g, 9.56 
mmol, 1.00 equiv.) in EtOAc (10 mL) was charged with 10% dry Pd/C (507 mg, 5 mol%), NH4OCOH 
(6.0 g, 96 mmol, 10 equiv.) followed by MeOH (30 mL). The reaction was allowed to stir under N2 for 
0.5 h at 40 oC. The reaction mixture was filtered over Celite® with Et2O (100 mL) and the volatiles were 
removed. Purification with SiO2 column chromatography (0 → 100% EtOAc in hexanes) afforded the 
aminopyrazole as a yellow oil (0.80g, 4.01 mmol, 42%); vmax (ATR) 3446 (NH2), 3346 (NH2), 2981, 1731 
(C=O), 1621, 1560, 1488, 1438, 1281, 1131, 1031 cm-1 δH (700 MHz, CDCl3) 7.34 (1H, s br, 5’-H), 5.77 
(NCH2), 5.63 (1H, s br, 4’-H) 3.59 (2H, s br, NH2), 1.13 (9H, s, CH3); δC (176 MHz, CDCl3) 178.2 (C=O), 
155.5 (C-3’), 133.0 (C-5’), 95.5 (C-4’), 72.1 (OCH2), 38.8 (C-2), 26.9 (CH3); HRMS (ESI) m/z found 
[M+H]+ 198.1252, C9H16N3O2 requires M, 198.1243.  
(3’-Nitro-1H-pyrazol-1-yl)methyl 2,2-dimethylpropanoate (514b) 
 
At -20 oC under N2, a solution of 3-nitro-1H-pyrazole 405 (1.13 g, 10.0 mmol, 1.00 equiv.) in THF (20 
mL) was treated with 60% NaH dispersion in mineral oil (440 mg, 11.0 mmol, 1.10 equiv.) portionwise. 
After stirring at 0 oC for 30 min, chloromethyl 2,2-dimethylpropanoate (2.90 mL, 20.0 mmol, 2.00 equiv.) 
was added and the reaction was allowed to warm to rt over 30 min. The reaction was reverse quenched 
with NH4Cl (10 mL) and ca. one third of the volatiles were removed. EtOAc (30 mL) was added and the 
aqueous layer was extracted with EtOAc (3 x 20 mL) and dried over MgSO4, filtered, and evaporated. 
Filtration over an SiO2 plug with Et2O (50 mL) afforded the pivalate as a colourless oil (2.21 g, 9.74 
mmol, 97%); vmax (ATR) 2981, 1744 (C=O), 1554, 1518, 1383, 1115, 1038 cm-1; δH (600 MHz, CDCl3) 
7.75 (1H, d, J = 2.7 Hz, 5’-H), 6.91 (1H, d, J = 2.7 Hz), 6.04 (2H, s, NCH2), 1.17 (CH3); δC (151 MHz, 
CDCl3) 177.9 (C=O), 156.7 (C-3’), 134.2 (C-5’), 103.6 (C-4’), 72.8 (NCH2), 38.8 (C-2), 26.8 (CH3); 
HRMS (ESI) m/z found [M+H]+ 228.0984, C9H14N3O4 requires M, 228.0984.  
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(3-Amino-1H-pyrazol-1-yl)methyl acetate (515) 
 
Under N2, a solution of (3-nitro-1H-pyrazol-1-yl)methyl acetate 515b (47.0 mg, 0.25 mmol, 1.00 equiv.) 
in EtOAc (0.5 mL) was charged with 10% dry Pd/C (13.0 mg, 5 mol%) followed by MeOH (1 mL). The 
reaction was allowed to stir under H2 for 1 h at 35 oC. The reaction mixture was filtered over Celite® 
and the volatiles were removed. SiO2 gel column chromatography (50% EtOAc in hexanes) afforded 
the aminopyrazole as an off-white solid (16 mg, 0.10 mmol, 41%); mp: 115-116 oC; vmax (ATR) 3418 
(NH2), 3308 (NH2), 2975, 1712 (C=O), 1633, 1567, 1484, 1428, 1369, 1334, 1276, 1250, 1227, 1205, 
1129, 1029 cm-1; δH (700 MHz, CDCl3) 7.37 (1H, d, J = 2.4 Hz, 5-H), 5.79 (2H, s, NCH2) 5.66 (1H, d, J 
= 2.4 Hz, 4-H), 3.73 (2H, s br, NH2), 2.06 (3H, s, CH3); δC (176 MHz, CDCl3) 170.7 (C=O), 156.0 (C-3), 
133.3 (C-5), 95.7 (C-4), 72.3 (NCH2), 21.0 (CH3); HRMS (ESI) m/z found [M+Na]+ 178.0594, 
C6H9N3O2Na requires M, 178.0592.  
(3-Nitro-1H-pyrazol-1-yl)methyl acetate (515b) 
 
At 0 oC under N2, a solution of 3-nitro-1H-pyrazole 404 (219 mg, 1.94 mmol, 1.00 equiv.) in THF (4 mL) 
was treated with 60% NaH dispersion in mineral oil (85 mg, 2.13 mmol, 1.1 equiv.) portionwise. After 
stirring at 0 oC for 5 min, bromomethylacetate (0.38 mL, 3.87 mmol, 2.00 equiv.) was added and the 
reaction was allowed to warm to rt over 10 min. The reaction was reverse quenched with NH4Cl (10 
mL) and ca. one third of the volatiles were removed. EtOAc (10 mL) was added and the aqueous layer 
was extracted with EtOAc (3 x 5 mL), dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (40 → 60% EtOAc in hexanes) afforded the pyrazole acetate as a white solid (244 mg, 
1.32 mmol, 68%); mp: 82-84 oC; vmax (ATR) 2984, 1738 (C=O), 1552, 1507, 1463, 1370, 1310, 1236, 
1222, 1070, 1033, cm-1; δH (700 MHz, CDCl3) 7.77 (1H, d, J = 2.7 Hz, 5-H), 6.91 (1H, d, J = 2.7 Hz, 4-
H) 6.03 (2H, s, NCH2), 2.12 (3H, s, CH3); δC (176 MHz, CDCl3) 170.3 (C=O), 157.0 (C-3), 134.6 (C-5), 
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103.8 (C-4), 72.8 (NCH2), 20.7 (CH3); HRMS (ASAP) m/z found [M+H]+ 186.0521, C6H8N3O4 requires 
M, 186.0515.  
[3-(3,4-Dimethyl-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-1H-pyrazol-1’-yl]methyl 2,2-
dimethylpropanoate (515c) 
 
To a solution of (3’-amino-1H-pyrazol-1-yl)methyl 2,2-dimethylpropanoate 515 (394 mg, 2.00 mmol, 
1.00 equiv.) and Et3N (0.28 mL, 2.00 mmol, 2.00 equiv.) in THF (4 mL) was added dimethyl-2,5-
dihydrofuran-2,5-dione (277 mg, 2.20 mmol, 1.10 equiv.). The reaction was refluxed for 2 h, cooled, 
followed by removal of the volatiles. CH2Cl2 (10 mL) and saturated NaHCO3(aq) (10 mL) were added and 
the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The organic fractions were dried over MgSO4, 
filtered, and evaporated. SiO2 gel column chromatography (0 → 100% EtOAc in hexanes) afforded the 
maleimide as a white solid (263 mg, 0.86 mmol, 43%); mp: 101-103 oC; vmax (ATR) 2984, 1738 (C=O), 
1724 (C=O), 1708 (C=O), 1531, 1498, 1430, 1355, 1281, 1124, 1095 cm-1; δH (700 MHz, CDCl3) 7.66 
(1H, d, J = 2.6 Hz, 5’’-H), 6.37 (1H, d, J = 2.6 Hz, 4’’-H), 5.99 (2H, s, NCH2), 2.02 (6H, s, 3’-CH3), 1.16 
(9H, s, 2-CH3); δC (176 MHz, CDCl3) 178.1 (CO2), 169.8 (C-2’), 142.0 (C-3’’), 138.0 (C-3’), 132.6 (C-
5’’), 103.2 (C-4’’), 72.5 (NCH2), 38.8 (C-2), 26.8 (2-CH3), 8.9 (3’-CH3); HRMS (ESI) m/z found [M+H]+ 
306.1464, C15H20N3O4 requires M, 306.1454.  
(3-acetamido-1H-pyrazol-1-yl)methyl acetate (515d) 
 
(3-amino-1H-pyrazol-1-yl)methyl acetate (34 mg, 0.22 mmol, 1.00 equiv.) and Ac2O (25 mg, 0.24 mmol, 
1.10 equiv.) were stirred neat for 0.5 h. SiO2 gel column chromatography (0 → 100% EtOAc in hexanes) 
afforded the acetylated pyrazole as a colourless oil (42 mg, 0.21 mmol, 98%); δH (700 MHz, CDCl3) 
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8.22 (1H, s br, NH), 7.53 (1H, d, J = 2.5 Hz, 5-H), 6.78 (1H, d, J = 2.5 Hz, 4-H) 5.87 (2H, s, NCH2), 2.15 
(3H, s, NAc CH3), 2.07 (3H, s, OAc CH3); δC (176 MHz, CDCl3) 170.4 (CO2), 167.9 (CONH), 148.8 (C-
3), 132.8 (C-5), 99.7 (C-4), 72.1 (NCH2), 24.0 (NAc CH3), 20.9 (OAc CH3); HRMS (ESI) m/z found 
[M+H]+ 198.0882, C8H12N3O3 requires M, 198.0879.  
5-nitro-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazole (525) 
 
To a solution of 3-nitro-1H-pyrazole 404 (1.13 g, 10.0 mmol, 1.00 equiv.) in THF (20 mL) under N2 at 0 
oC was rapidly added LiHMDS in THF (11 mL, 11 mmol, 1.0 M, 1.1 equiv.). After 5 min, SEMCl (1.93 
mL, 11.0 mmol, 1.10 equiv.) was added and the reaction was allowed to warm to rt. After 3 h, the 
reaction was quenched with NH4Cl (20 mL) and ca. one third of the volatiles were removed. EtOAc (30 
mL) and H2O (20 mL) were added and the aqueous layer was extracted with EtOAc (3 x 20 mL). The 
combined organic layers were dried over MgSO4, filtered and evaporated. SiO2 chromatography (5 → 
20% EtOAc in hexanes) afforded the SEM pyrazole as a colourless oil (846 mg, 3.50 mmol, 35%); vmax 
(ATR) 2952, 1549, 1510, 1460, 1350, 1250, 1094 cm-1; δH (700 MHz, CDCl3) 7.57 (1H, d, J = 2.1 Hz, 
3-H), 7.11 (1H, d, J = 2.1 Hz, 4-H), 5.88 (2H, s, NCH2), 3.61-3.58 (2H, m, 1’-H), 0.90-0.88 (2H, m, 2’-
H), -0.04 (9H, s, SiCH3); δC (176 MHz, CDCl3) 146.0 (C-5), 138.6 (C-3), 107.8 (C-4), 80.7 (NCH2), 67.6 
(C-1’), 17.9 (C-2’), -1.4 (SiCH3); HRMS (ASAP) [M]+ m/z found 243.1040, C9H17N3O3Si, requires M, 
243.1039. 
5-Amino-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazole (526) 
 
Under N2, a solution of 5-nitro-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazole 531 (772 mg, 3.10 mmol, 
1.00 equiv.) in EtOAc (2 mL) was charged with 10% dry Pd/C (164 mg, 5 mol%) followed by MeOH (15 
mL). The reaction was allowed to stir under H2 for 4 h at 40 oC. The reaction mixture was filtered over 
Celite® and the volatiles were removed. SiO2 gel column chromatography (0 → 100% EtOAc in 
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hexanes) afforded the aminopyrazole as an off-white solid (560 mg, 83%); mp: 60–62 oC; vmax (ATR) 
3321 (NH2), 3259 (NH2), 2957, 1626, 1526, 1511, 1417, 1250, 1072 cm-1; δH (700 MHz, CDCl3) 7.25 
(1H, d, J = 1.9 Hz, 3-H), 5.51 (1H, d, J = 1.9 Hz, 4-H), 5.34 (2H, s, NCH2), 3.94 (2H, s br, NH2), 3.55-
3.53 (2H, m, 1’-H), 0.89-0.87 (2H, m, 2’-H), -0.04 (9H, s, SiCH3); δC (176 MHz, CDCl3); 145.7 (C-5), 
139.0 (C-3), 91.1 (C-4), 77.2 (NCH2), 66.2 (C-1’), 17.9 (C-2’), -1.3 (SiCH3); HRMS (ASAP) [M+H]+ m/z 
found 214.1365, C9H20N3OSi requires M, 214.1376.  
Tert-butyl N-[(tert-butoxy)carbonyl]-N-(1-{[2’-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-5-
yl)carbamate (526b) 
 
At 0 oC under N2, a solution of 5-amino-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazole 532 (107 mg, 
0.50 mmol, 1.00 equiv.) in THF (0.75 mL) was treated with 1M LDA in THF (0.50 mL, 1.00 mmol, 2.00 
equiv.) and stirred for 0.5 h. Boc2O was added and the reaction was allowed to warm to rt and stirred 
for 1 h.  The reaction was quenched with NH4Cl (10 mL) and diluted with EtOAc (10 mL). The organic 
layer was washed with saturated NaHCO3(aq) (2 x 10 mL), and the combined aqueous layers were back-
extracted with EtOAc (3 x 5 mL). The combined organic fractions were dried over MgSO4, filtered, and 
evaporated. SiO2 gel column chromatography (0 → 100% EtOAc in hexanes) afforded the bisBoc 
pyrazole as a yellow solid (124 mg, 0.30 mmol, 60%); mp: 61-62 oC; vmax (ATR) 2987, 1804 (C=O), 
1764 (C=O), 1564, 1474, 1368, 1278, 1251, 1151, 1095 cm-1; δH (700 MHz, CDCl3) 7.49 (2H, d, J = 1.9 
Hz, 3-H), 6.15 (2H, d, J = 1.9 Hz, 4-H), 5.30 (2H, s, NCH2), 3.56-3.53 (2H, m, 1’-H), 1.42 (18H, s, CCH3), 
0.90 (2H, m, 2’-H), -0.03 (9H, s, SiCH3); δC (176 MHz, CDCl3) 150.1 (C=O), 138.8 (C-3), 136.7 (C-5), 
104.6 (C-4), 76.9 (NCH2), 83.7 (CCH3), 66.6 (C-1’), 27.8 (CCH3), 17.7 (C-2’), -1.5 (SiCH3); HRMS (ESI) 
m/z found [M+H]+ 414.2418, C19H36N3O5Si requires M, 414.2424.  
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N-(1-{[2’-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-5-yl)acetamide (531) 
 
1‐{[2‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐5‐amine 526 (80 mg, 0.38 mmol, 1.00 equiv.) and Ac2O 
(0.04 mL, 0.41 mmol, 1.10 equiv.) were stirred neat for 0.5 h. The reaction mixture was diluted in EtOAc 
(5 mL), washed with saturated NaHCO3(aq) (5 mL), H2O (5 mL) and brine (5 mL). The organic layer was 
dried over MgSO4, filtered, and evaporated. SiO2 gel (pre-treated with Et3N) column chromatography 
(0% → 100% EtOAc in hexanes (1% Et3N)) afforded the acylated pyrazole as a white solid (99 mg, 0.32 
mmol, 84%); mp: 68-70 oC; vmax (ATR) 3288 (NH), 2954, 1678 (C=O), 1572, 1549, 1406, 1380, 1309, 
1270, 1248, 1089 cm-1; δH (700 MHz, CD3OD) 7.48 (1H, d, J = 1.9 Hz, 3-H) 6.42 (1H, d, J = 1.9 Hz, 4-
H) 5.44 (2H, s, NCH2), 3.56-3.53 (2H, m, 1’-H), 2.18 (3H, s, Ac CH3), 0.89-0.87 (2H, m, 2’-H), -0.01 (9H, 
s, SiCH3); δC (176 MHz, CD3OD) 171.4 (C=O), 140.3 (C-5), 138.5 (C-3), 101.2 (C-4), 77.9 (NCH2), 67.5 
(C-1’), 23.0 (Ac CH3), 18.6 (C-2’), -1.4 (SiCH3); HRMS (ESI) m/z found [M+H]+ 256.1496, C11H22N3O2Si 
requires M, 212.1481.  
tert-butyl 5-amino-1H-pyrazole-1-carboxylate (534) 
 
To a solution of 1H-pyrazol-3-amine 369 (500 mg, 6.02 mmol, 1.00 equiv.) and triethylamine (0.92 mL, 
6.62 mmol, 1.10 equiv.) in CH2Cl2 (6 mL) was charged portionwise with Boc2O (1.44 g, 6.62 mmol, 1.10 
equiv.). The reaction was refluxed for 16 h before addition of saturated NaHCO3(aq) (10 mL). The organic 
layer was washed with saturated NaHCO3(aq) (3 x 10 mL) and the combined aqueous fractions were 
back-extracted with CH2Cl2 (3 x 10 mL). The combined organic fractions were dried over MgSO4, 
filtered, and evaporated. SiO2 gel column chromatography (45 → 55% EtOAc in hexanes (1% Et3N)) 
afforded the Boc pyrazole as a white solid (243 mg, 1.33 mmol, 22%); vmax (ATR) 3480 (NH2), 3373 
(NH2), 2934, 1737 (C=O), 1609, 1479, 1454, 1372, 1332, 1207, 1151, 1126, 1068 cm-1; δH (700 MHz, 
CD3OD) 7.36 (1H, d, J = 1.9 Hz, 3-H)  5.41 (1H, d, J = 1.9 Hz, 4-H) 1.64 (9H, s, CH3); δC (176 MHz, 
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CD3OD) 153.0 (C-5), 151.5 (C=O), 144.8 (C-3), 88.8 (C-4), 86.4 (OCCH3), 28.2 (OCCH3); HRMS (ESI) 
m/z found [M+H]+ 184.1096, C10H14N3O2 requires M, 184.1086.  
N-[1-(oxan-2’-yl)-1H-pyrazol-5-yl]acetamide (538) 
 
Crude 1-(oxan-2-yl)-1H-pyrazol-5-amine 537 (107 mg, 0.64 mmol, 1.00 equiv.), Et3N (0.10 mL, 0.70 
mmol, 1.10 equiv.), and Ac2O (0.06 mL, 0.67 mmol, 1.05 equiv.) were stirred neat for 0.5 h. The reaction 
mixture was diluted in EtOAc (5 mL), washed with saturated NaHCO3(aq) (2 mL), H2O (2 mL) and brine 
(2 mL). The organic layer was dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (0 → 100% EtOAc in hexanes (1% Et3N)) afforded the acetylated pyrazole as a 
colourless oil (120 mg, 0.58 mmol, 90%); vmax (ATR) 3280 (NH), 2963, 1675 (C=O), 1546, 1456, 1374, 
1251, 1205, 1181, 1082, 1040 cm-1; δH (600 MHz, CDCl3) 8.45 (1H, s br, NH), 7.39 (1H, s, 3-H), 6.50 
(1H, s, 4-H), 5.42-5.40 (1H, m, 2’-H), 3.92-3.89 (1H, m, 6’-H), 3.68-3.64 (1H, m, 6’-H), 2.23-2.19 (1H, 
m, 3’-H), 2.14 (3H, s, CH3), 2.06-2.01 (2H, m, 3’-H, 4’-H), 1.69-1.60 (3H, m, 4’-H, 5’-H); δC (151 MHz, 
CDCl3) 166.9 (C=O), 139.0 (C-3), 137.0 (C-5), 98.3 (C-4), 86.1 (C-2’), 66.7 (C-6’), 29.0 (C-3’), 25.1 (C-
5’), 24.0 (CH3), 21.3 (C-4’); HRMS (ESI) m/z found [M+H]+ 210.1240, C10H16N3O2 requires M, 210.1243. 
547 was found to decompose on SiO2 gel unless pre-treated with Et3N. 
3,3-dimethyl-1-[1-(oxan-2’’-yl)-1H-pyrazol-5’-yl]pyrrolidine-2,5-dione (542) 
 
To a solution of 3,3-dimethyl-1-(1H-pyrazol-3-yl)pyrrolidine-2,5-dione 486 (100 mg, 0.52 mmol, 1.00 
equiv.) and 3,4-dihydro-2H-pyran (0.14 mL, 1.55 mmol, 3.00 equiv.) in CH2Cl2 (4.2 mL) was added 
PPTS (13.1 mg, 0.05 mmol, 10 mol%). The reaction was stirred for 0.5 h, poured into saturated 
NaHCO3(aq) (5 mL), and the aqueous layer was extracted with CH2Cl2 (3 x 5 mL). SiO2 gel column 
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chromatography (15 → 25% acetone in hexanes) afforded the THP pyrazole as a white solid; (77 mg, 
0.28 mmol, 54%); mp: 93-94 oC; vmax (ATR) 2950, 1794 (C=O), 1720 (C=O), 1568, 1468, 1407, 1291, 
1210, 1142, 1083 cm-1; δH (700 MHz, CDCl3) 7.59 (1H, d, J = 1.9 Hz, 3’-H), 6.32 (1H, d, J = 1.9 Hz, 4’-
H) 5.36-5.35 (1H, m, 2’’-H), 3.64-3.61 (1H, m, 6’’-H), 3.49-3.46 (1H, m, 6’’-H), 2.71 (2H, s, 4-H), 2.46-
2.41 (1H, m, 3’’-H), 2.08-2.00 (2H, m, 3’’-H, 4’’-H) 1.67-1.63 (1H, m, 4’’-H) 1.60-1.53 (2H, m, 5’’-H), 1.43 
(3H, s, CH3), 1.41 (3H, s, CH3); δC (176 MHz, CDCl3) 181.2 (C-2), 173.8 (C-5), 138.7 (C-3’), 130.3 (C-
5’), 106.2 (C-4’), 85.2 (C-2’’), 65.3 (C-6’’), 43.9 (C-4), 40.7 (C-3), 28.1 (C-3’’), 25.7 (CH3), 25.6 (CH3), 
24.9 (C-5’’), 20.6 (C-4’’); HRMS (ESI) m/z found [M+H]+ 278.1524, C14H20N3O3 requires M, 278.1505.  
Chloromethyl 5-amino-1H-pyrazole-1-carboxylate (556) 
 
Under N2 at 0 oC, a solution chloromethyl chloroformate (0.09 mL, 1.00 mmol, 1.00 equiv.) in CH2Cl2 
(2.5 mL) was treated with a solution of 1H-pyrazol-3-amine 369 (83 mg, 1.0 mmol, 1.0 equiv.) and Et3N 
(0.14 mL, 1.00 mmol, 1.00 equiv.) in CH2Cl2 (2.5 mL) dropwise over 5 min. The reaction was warmed 
to rt and stirred for 1.5 h before addition of H2O (5 mL). The aqueous layer was extracted with CH2Cl2 
(3 x 5 mL), dried over MgSO4, filtered, and evaporated. Purification with SiO2 gel column 
chromatography (0 → 100% EtOAc in hexanes (1% Et3N)) afforded the acylated pyrazole as a white 
solid (62 mg, 0.35 mmol, 35%); mp: 133-135 oC; vmax (ATR) 3472 (NH2), 3300 (NH2), 2975, 1756 (C=O), 
1622, 1578, 1494, 1452, 1393, 1241, 1154, 1095 cm-1; δH (700 MHz, DMSO) 7.42 (1H, d, J = 1.8 Hz, 
3-H), 6.51 (2H, s br, NH2), 6.11 (2H, s, CH2), 5.34, (1H, d, J = 1.8 Hz, 4-H); δC (176 MHz, DMSO) 152.1 
(C-5), 149.8 (C=O), 145.7 (C-3), 87.7 (C-4), 72.2 (CH2); HRMS (ESI) m/z found [M+H]+ 176.0217, 
C5H7N3O235Cl requires M, 176.0227. 
Chloromethyl 3-amino-1H-pyrazole-1-carboxylate (557)  
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Under N2 at 0 oC, a solution chloromethyl chloroformate (1.80 mL, 20.0 mmol, 1.00 equiv.) in CH2Cl2 
(50 mL) was treated with a solution of 1H-pyrazol-3-amine 369 (1.66 g, 20.0 mmol, 1.0 equiv.) and Et3N 
(2.80 mL, 20.0 mmol, 1.00 equiv.) in CH2Cl2 (50 mL) dropwise over 1 h. The reaction was warmed to rt 
and stirred for 1 h before addition of H2O (50 mL). The aqueous layer was extracted with CH2Cl2 (3 x 
25 mL), dried over MgSO4, filtered, and evaporated. Purification with SiO2 gel column chromatography 
(0 → 100% EtOAc in hexanes (1% Et3N)) afforded the acylated pyrazole as a white solid (600 mg, 3.42 
mmol, 17%); mp: 141-143 oC (MeCN); vmax (ATR) 3466 (NH2), 3297 (NH2), 2995, 1751 (C=O), 1619, 
1573, 1492, 1449, 1387, 1348, 1312, 1240, 1150, 1094 cm-1; δH (700 MHz, DMSO) 7.96 (1H d, J = 2.8 
Hz, 5-H), 6.04 (2H, s, CH2), 5.91 (1H, d, J = 2.8 Hz, 4-H), 5.67 (2H, s br, NH2); δC (176 MHz, DMSO) 
160.0 (C-3), 132.8 (C-5), 102.6 (C-4), 72.4 (CH2). HRMS (ESI) m/z found [M+H]+ 176.0231, 
C5H7N3O235Cl requires M, 176.0227. 
1-[2-(trimethylsilyl)ethyl]-1H-pyrazole (558) 
 
Under N2 at 0 oC, a solution of 2-(trimethylsilyl)ethan-1-ol (0.72 g, 5.00 mmol, 1.00 equiv.) in THF (5 
mL) was treated with 60% NaH dispersion in mineral oil (220 mg, 5.50 mmol, 1.10 equiv.) portionwise. 
After stirring for 0.5 h, MsCl was added dropwise (0.39 mL, 5.00 mmol, 1.00 equiv.) and the reaction 
was warmed to rt. After 2 h, the reaction was cooled to 0 oC and 1M sodium 1H-pyrazol-1-ide in THF 
(5.00 mL, 5.00 mmol, 5.00 equiv.) was added dropwise. After warming to rt, the reaction was stirred for 
16 h and quenched with NH4Cl (10 mL). The aqueous layer was extracted with Et2O (3 x 10 mL), and 
the combined organic fractions were dried over MgSO4 and filtered. Removal of the volatiles at 0 oC 
followed by SiO2 gel column chromatography (0 → 50% EtOAc in hexanes) afforded the pyrazole as a 
colourless oil (110 mg, 0.65 mmol, 13%); vmax (ATR) 2957, 1510, 1397, 1494, 1258, 1091, cm-1; δH (700 
MHz, CDCl3) 7.48, (1H, d, J = 1.5 Hz, 3-H) 7.39 (1H, d, J = 2.2 Hz 5-H), 6.22 (1H, t, J = 2.0 Hz, 4-H), 
4.18-4.16 (2H, m, 1’-H), 1.23-1.20 (2H, m, 2’-H, 2’-H), 0.03 (9H, s, SiCH3); δC (176 MHz, CDCl3) 138.8 
(C-3), 127.8 (C-5), 105.1 (C-4), 48.5 (C-1’), 18.66 (C-2’) , -1.86 (SiCH3); HRMS (ESI) m/z found [M+H]+ 
169.1147, C8H16N2Si requires M, 169.1161. 
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(9H-Fluoren-9’-yl)methyl 3-amino-1H-pyrazole-1-carboxylate (559) 
 
Under N2 at 0 oC, a solution of FmocCl (4.37 g, 16.9 mmol, 1.00 equiv) in CH2Cl2 (40 mL) was treated 
with a solution of 1H-pyrazol-3-amine 369 (1.40 g, 16.9 mmol, 1.00 equiv.) and Et3N (2.40 mL, 16.9 
mmol, 1.00 equiv.) in CH2Cl2 (40 mL) dropwise over 10 min. The reaction was warmed to rt and stirred 
for 2 h before addition of NH4Cl (50 mL). The aqueous layer was extracted with CH2Cl2 (3 x 25 mL), 
dried over MgSO4, filtered, and evaporated. Crude NMR analysis indicated a 3:2 isomeric ratio of 
products. SiO2 gel column chromatography (0 → 100% EtOAc in hexanes) afforded the acylated 
pyrazole as a white solid (1.51 g, 4.95 mmol, 29%); mp: 138 oC (iPrOH); vmax (ATR) 3467 (NH2), 3293 
(NH2), 2970, 1724 (C=O), 1624, 1576, 1435, 1405, 1372, 1295, 1244, 1143, 1041 cm -1; δH (700 MHz, 
DMSO) 7.89 (2H, d, J = 7.7 Hz, 4’-H), 7.81 (1H, s br, 5-H), 7.71 (2H, d, J = 7.7 Hz, 1’-H), 7.41 (2H, t, J 
= 7.4 Hz, 3’-H) 7.32 (2H, td, J = 7.5, 1.1 Hz, 2’-H), 5.85 (1H, d, J = 3.0 Hz) 5.55 (2H, s br, NH2), 4.59 
(2H, d, J = 7.1 Hz, CH2), 4.38 (1H, t, J = 7.1 Hz, 9’-H); δC (176 MHz, DMSO) 159.5 (C-3), 149.3 (C=O), 
143.8 (9’-C), 141.2 (4’-C), 132.2 (C-5), 128.3 (C-3’), 127.7 (C-2’), 125.6 (C-1’), 120.7 (C-4’), 101.4 (C-
4), 68.5 (CH2), 46.7 (C-9’); HRMS (ESI) m/z found [M+H]+ 306.1247, C18H16N3O2 requires M, 306.1243.  
(9H-fluoren-9’-yl)methyl 3-{[(chloromethoxy)carbonyl]amino}-1H-pyrazole-1-carboxylate (560) 
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Under N2 at 0 oC, a solution of (9H-Fluoren-9-yl)methyl 3-amino-1H-pyrazole-1-carboxylate 559 (960 
mg, 3.14 mmol, 1.00 equiv) in CH2Cl2 (9.5 mL) was treated with chloromethyl chloroformate (0.28 mL, 
3.14 mmol, 1.00 equiv.) and Et3N (0.44 mL, 3.14 mmol, 1.00 equiv.) dropwise simultaneously. The 
reaction was warmed to rt and stirred for 1 h before addition of NH4Cl (10 mL). The aqueous layer was 
extracted with CH2Cl2 (3 x 10 mL), dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (0 → 100% EtOAc in hexanes) afforded the acylated pyrazole as a white solid (650 
mg, 1.63 mmol, 52%); mp: 177-178 oC; vmax 3248 (NH), 2975, 1763 (C=O), 1734 (C=O), 1603, 1448, 
1383, 1364, 1315, 1223, 1207, 1157, 1097, 1004 cm-1; δH (700 MHz, CD2Cl2) 8.21 (1H, s br, NH), 8.03 
(1H, d, J = 2.7 Hz, 5-H) 7.81 (2H, d, J = 7.5 Hz, 4’-H) 7.67 (2H, dd, J = 7.5, 0.8 Hz, 1’-H), 7.43 (2H, d, 
3’-H) 7.32 (2H, td, J = 7.5, 0.8 Hz, 2’-H), 6.86 (1H, s br, 4-H), 5.82 (2H, s, CH2Cl), 4.71 (2H, d, J = 7.3 
Hz, 9’-CH2), 4.40 (1H, t, J = 7.3 Hz, 9’-H); δC (176 MHz, CD2Cl2) 151.4 (NC=O), 151.2 (C-3), 149.4 
(CO2), 143.6 (C-1a’), 141.9 (C-4a’), 132.7 (C-5), 128.6 (C-3’), 127.8 (C-2’), 125.6 (C-1’), 120.7 (C-4’), 
102.2 (C-4), 71.2 (CH2Cl), 70.3 (9’-CH2), 47.2 (C-9’); HRMS (ESI) m/z found [M+H]+ 398.0919, 
C20H17N3O435Cl requires M, 398.0908.  
3,4-dimethyl-1-(1H-pyrazol-3’-yl)-2,5-dihydro-1H-pyrrole-2,5-dione (561) 
 
To a suspension of 1H-pyrazol-3-amine 369 (2.00 g, 24.1 mmol, 1.00 equiv.) in H2O (120 mL) was 
added dimethyl-2,5-dihydrofuran-2,5-dione (3.34 g, 26.5 mmol, 1.10 equiv.). The inhomogeneous 
reaction was stirred at rt for 3 h, diluted with EtOAc (50 mL), and the aqueous fractions were extracted 
with EtOAc (3 x30 mL). The combined organic fractions were dried over MgSO4, filtered, and 
evaporated. The obtained maleimide was obtained as a yellow solid which was used without further 
purification (4.40 g, 23.0 mmol, 96%); mp: 153-154 oC; vmax (ATR) 3256 (NH), 2919, 1735 (C=O), 1704 
(C=O), 1611, 1542, 1497, 1433, 1347, 1283, 1202, 1081 cm-1 δH (700 MHz, CDCl3) 12.29 (1H, s br, 
NH), 7.67 (1H, d, J = 2.4 Hz, 5’-H), 6.42 (1H, d, J = 2.4 Hz, 4’-H), 2.03 (6H, s, CH3); δC (176 MHz, 
CDCl3) 170.1 (C=O), 140.6, (C-3’), 138.0 (C-2), 130.9 (C-5’), 99.8 (C-4’), 8.98 (CH3); HRMS (ESI) m/z 
found [M+H]+ 192.0759, C9H10N3O2 requires M, 192.0773.  
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1-{1’-[(3’’,5’’-dimethylphenyl)methyl]-1H-pyrazol-3’-yl}-3,3-dimethylpyrrolidine-2,5-dione (562) 
 
To a solution of 1-[(3,5-dimethylphenyl)methyl]-1H-pyrazol-3-amine 402 (49 mg, 0.24 mmol, 1.00 
equiv.) and Et3N (0.03 mL, 0.24 mmol, 1.00 equiv.) in PhMe (2.5 mL) was added 3,3-dimethyloxolane-
2,5-dione (37 mg, 0.29 mmol, 1.10 equiv.). The reaction was refluxed for 16 h, cooled, and diluted with 
EtOAc (5 mL) and H2O (5 mL). The aqueous phase was extracted with EtOAc (3 x 5 mL), and the 
combined organic fractions were dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (0 → 100% EtOAc in hexanes) afforded the succinimide as a white solid (39 mg, 0.13 
mmol, 51%); mp: 121-122 oC; vmax (ATR) 2987, 1798 (C=O), 1724 (C=O), 1604, 1521, 1501, 1418, 
1344, 1234, 1211, 1148 cm-1; δH (700 MHz, CDCl3) δ 7.33 (1H, d, J = 2.4 Hz, 5’-H) 6.94 (1H, s br, 4’’-
H), 6.86 (1H, s br, 2’-H), 6.30 (1H, d, J = 2.4 Hz, 4’-H), 5.24 (2H, s, 1’’-CH2), 2.70 (2H, s, 4-H), 2.28 (6H, 
s, 3’’-CH3), 1.41 (6H, s, 3-CH3); δC (176 MHz, CDCl3) 181.7 (C-2), 174.4 (C-5), 140.4 (C-3’), 138.6 (C-
3’’), 135.3 (C-1’’), 130.7 (C-5’), 130.1 (C-4’’), 126.1 (C-2’’), 103.1 (C-4’), 56.7 (1’’-CH2), 43.9 (C-4), 40.3 
(C-3), 25.9 (3-CH3), 21.3 (3’’-CH3); HRMS (ESI) m/z found [M+H]+ 312.1714, C16H22N3O2 requires M, 
312.1712. 
3,3-dimethyl-1-(1’-{[2’’-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3’-yl)pyrrolidine-2,5-dione 
(563) 
 
To a solution of 1‐{[2‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazol‐3‐amine 450 (107 mg, 0.50 mmol, 1.00 
equiv.) and Et3N (0.07 mL, 0.05 mmol, 1.00 equiv.) in PhMe (5 mL) was added 3,3-dimethyloxolane-
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2,5-dione (77 mg, 0.60 mmol, 1.20 equiv.). The reaction was stirred at 100 oC for 1 h, cooled, and 
diluted with EtOAc (5 mL) and H2O (5 mL). The aqueous phase was extracted with EtOAc (3 x 5 mL), 
and the combined organic fractions were dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (0 → 100% EtOAc in hexanes) afforded the succinimide as a colourless oil (73 mg, 
0.23 mmol, 45%); vmax (ATR) 2957, 1794 (C=O), 1720 (C=O), 1524, 1498, 1424, 1350, 1255, 1208, 
1195, 1148, 1098 cm-1; δH (700 MHz, CDCl3) 7.63 (1H, d, J = 2.5 Hz, 5’-H) 6.40 (1H, d, J = 2.5 Hz, 4’-
H) 5.44 (2H, s, OCH2) , 3.60-3.58 (2H, m, 1’’-H), 2.71 (2H, s, 4-H), 1.42 (6H, s, CH3), 0.91-0.89 (2H, m, 
2’’-H), -0.02 (9H, s, SiCH3); δC (176 MHz, CDCl3) 181.5 (C-2), 174.2 (C-5), 141.0 (C-3’), 130.9 (C-5’), 
104.2 (C-4’), 80.9 (CH2), 67.2 (C-1’’), 44.0 (C-4), 40.4 (C-3), 25.9 (3-CH3), 17.9 (C-2’’), -1.3 (SiCH3); 
HRMS (ESI) m/z found [M+H]+ 324.1749, C15H26N3O3Si requires M, 312.1743. 
N-[1-(oxan-2’-yl)-1H-pyrazol-3-yl]acetamide (564) 
 
1-(oxan-2-yl)-1H-pyrazol-3-amine 418 (107 mg, 0.64 mmol, 1.00 equiv.), Et3N (0.10 mL, 0.70 mmol, 
1.10 equiv.), and Ac2O (0.06 mL, 0.67 mmol, 1.05 equiv.) were stirred neat for 0.5 h. The reaction 
mixture was diluted in EtOAc (5 mL), washed with saturated NaHCO3(aq) (2 mL), H2O (2 mL) and brine 
(2 mL). The organic layer was dried over MgSO4, filtered, and evaporated. SiO2 gel column 
chromatography (50 → 100% EtOAc in hexanes (1% Et3N)) afforded the acetylated pyrazole as a 
colourless oil (90 mg, 0.43 mmol, 67%); vmax (ATR) 3290 (NH) 2944, 1668 (C=O), 1574, 1487, 1428, 
1376, 1250, 1202, 1083, 1000 cm-1; δH (600 MHz, CDCl3) 8.21 (1H, s br, NH), 7.47 (1H, d, J = 2.1 Hz, 
5-H), 6.73 (1H, d, J = 2.1 Hz, 4-H), 5.20 (1H, dd, J = 9.7, 2.1 Hz, 2’-H) 4.03 (1H, d, J = 11.6 Hz, 6’-H), 
3.65 (1H, td, J = 11.6, 2.3 Hz, 6’-H) 2.11 (3H, s, CH3), 2.08-1.93 (3H, m, 3’-H, 4’-H), 1.67-1.64 (2H, m, 
5’-H, 4’-H) 1.61-1.56 (1H, m, 5’-H); δC (151 MHz, CDCl3) 167.8 (C=O), 147.6 (C-3), 128.9 (C-5), 98.3 
(C-4), 87.4 (C-2’), 67.9 (C-6’), 30.3 (C-3’), 25.0 (C-5’), 23.9 (CH3), 22.6 (C-4’); HRMS (ESI) m/z found 
[M+H]+ 210.1245, C10H16N3O2 requires M, 210.1243  
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Tert-butyl N-{1-[(4’-methoxyphenyl)methyl]-1H-pyrazol-5-yl}carbamate (565) 
 
1-[(4-methoxyphenyl)methyl]-1H-pyrazol-5-amine 548 (300 mg, 1.48 mmol, 1.00 equiv.) and Boc2O 
(1.61 g, 7.38 mmol, 5.00 equiv.), were stirred neat at 50 oC for 16 h. The reaction was dissolved in 
CH2Cl2 (20 mL) and washed with NaHCO3 (3 x 5 mL). The aqueous layer was extracted with CH2Cl2 (3 
x 10 mL), and the combined organic fractions were dried over MgSO4, filtered and evaporated. SiO2 gel 
column chromatography (0 → 100% EtOAc in hexanes) afforded the Boc pyrazole as a white solid (350 
mg, 1.15 mmol, 78%); mp: 81-83 oC; vmax (ATR) 3196 (NH), 2977, 1722 (C=O), 1613, 1565, 1513, 1457, 
1367, 1304, 1243, 1156, 1117, 1033 cm-1; δH (600 MHz, CDCl3) 7.43 (1H, s, 3-H), 7.09 (2H, d, J = 8.5 
Hz, 2’-H), 6.84 (2H, d, J = 8.5 Hz, 3’-H), 6.26 (1H, s br, NH), 6.19 (1H, s br, 4-H), 5.17 (2H, s, CH2), 
3.77 (3H, s, OCH3), 1.46 (9H, s, CCH3); δC (151 MHz, CDCl3) 159.4 (4’-H), 152.6 (C=O), 138.8 (C-3), 
135.9 (C-5), 128.6 (C-2’), 128.3 (C-1’), 114.4 (C-3’), 99.8 (C-4), 81.7 (CCH3), 55.4 (OCH3), 52.0 (CH2), 
28.3 (CCH3); HRMS (ESI) m/z found [M+H]+ 304.1668 C16H22N3O3 requires M, 304.1661. 
3,4-Dimethyl-1-{1’-[(2’’,4’’,6’’-trimethylphenyl)methyl]-1H-pyrazol-3’-yl}-2,5-dihydro-1H-pyrrole-
2,5-dione (566) 
 
Under N2, a suspension of 3,4-dimethyl-1-(1H-pyrazol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione 561 (500 
mg, 2.61 mmol, 1.00 equiv.) and Cs2CO3 (1.28 g, 3.92 mmol, 1.50 mmol) in MeCN (20 mL) was treated 
with 2-(chloromethyl)-1,3,5-trimethylbenzene (529 mg, 3.14 mmol, 1.20 equiv.). The reaction was 
refluxed for 16 h, cooled, and poured into H2O (20 mL). The aqueous phase was extracted with EtOAc 
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(3 x 10 mL), and the combined organic fractions were dried over MgSO4, filtered, and evaporated. SiO2 
gel column chromatography (20 → 50% EtOAc in hexanes) afforded the benzylated pyrazole  as a white 
solid (196 mg, 0.61 mmol, 23%); mp: 164-165 oC; vmax (ATR) 2923, 1728 (C=O), 1705 (C=O), 1521, 
1500, 1424, 1386, 1343, 1206, 1092, 1058 cm-1; δH (700 MHz, CDCl3) 6.96 (1H, d, J = 2.4 Hz, 5’-H), 
6.91 (2H, s, 3’’-H), 6.21 (1H, d, J = 2.4 Hz, 4’-H) 5.34 (2H, s, CH2), 2.29 (3H, s, 4’’-CH3), 2.28 (6H, s, 
2’’-CH3), 2.03 (6H, s, 3-CH3); δC (176 MHz, CDCl3) 170.4 (C=O), 140.2 (C-3’), 138.7 (C-4’’), 138.4 (C-
1’’), 137.9 (C-3), 129.5 (C-3’’), 129.0 (C-5’), 128.1 (C-2’’), 101.8 (C-4’), 50.6 (CH2), 21.1 (4’’-CH3), 19.8 
(2’’-CH3), 9.0 (3-CH3); HRMS (ESI) m/z found [M+H]+ 324.1731, C19H22N3O2 requires M, 324.1712. 
3,4-Dimethyl-1-{1’-[(2’’,4’’,6’’-trimethylphenyl)methyl]-1H-pyrazol-5’-yl}-2,5-dihydro-1H-pyrrole-
2,5-dione (567) 
 
Synthesised alongside 3,4-dimethyl-1-{1-[(2,4,6-trimethylphenyl)methyl]-1H-pyrazol-3-yl}-2,5-dihydro-
1H-pyrrole-2,5-dione 561 using an identical procedure for the synthesis of 564 (vide supra). Obtained 
as a white solid (229 mg, 0.71 mmol, 27%); mp: 98-99 oC; vmax (ATR) 2927, 1739 (C=O), 1715 (C=O), 
1563, 1481, 1463, 1388, 1343, 1295, 1084, 1037 cm-1; δH (700 MHz, CDCl3) 7.55 (1H, d, J = 1.9 Hz, 
3’-H), 6.78 (2H, s, 3’’-H), 6.19 (1H, d, J = 1.9 Hz, 4’-H), 5.24 (2H, s, CH2), 2.22 (3H, s, 4’’-CH3), 2.10 
(6H, s, 2’’-CH3), 1.93 (6H, s, 3-CH3); δC (176 MHz, CDCl3) 169.4 (C=O), 138.7 (C-3’), 138.3 (C-3), 138.0 
(C-1’’), 137.7 (C-4’’), 129.5 (C-3’’), 129.3 (C-5’), 127.9 (C-2’’), 105.3 (C-4’), 49.0 (CH2), 21.0 (4’’-CH3), 
19.8 (2’’-CH3), 8.9 (3-CH3); HRMS (ESI) m/z found [M+H]+ 324.1731, C19H22N3O2 requires M, 324.1712. 
4.2.3 Synthesis of Heterocyclic Ureas 
General Procedure E for the Synthesis of Heteroaryl Ureas: To a solution of an aminoheterocycle 
(5.00 mmol, 1.00 equiv.) in anhydrous MeCN (15 mL) was added an isocyanate (10.0 mmol, 2.00 
equiv.). After stirring the reaction for 16 h, the volatiles were removed and the resulting solid was 
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suspended in Et2O (20 mL) and filtered. After washing with Et2O (3 x 10 mL), the urea product was 
purified by SiO2 gel chromatography or recrystallisation where necessary.  
1‐(4’‐Methoxyphenyl)‐3‐(1’’‐methyl‐1H‐pyrazol‐3’’‐yl)urea (391) 
 
To a solution of 1-methyl-1H-pyrazol-3-amine 373 (0.40 ml, 5.00 mmol, 2.00 equiv.) in MeCN (15 mL) 
was added 1-isocyanato-4-methoxybenzene (0.32 mL, 2.50 mmol, 1.00 equiv.). After stirring at rt for 
16 h, the volatiles were removed and purification by SiO2 gel column chromatography (1:1 
Hexanes:EtOAc) afforded the pyrazole urea as a yellow solid (425 mg, 1.75 mmol, 70%); mp: 124-125 
oC; vmax (ATR) 3333 (NH), 2984, 1674 (C=O), 1539, 1510, 1417, 1353, 1292, 1169, 1029 cm-1; δH (600 
MHz, CDCl3) 9.58 (1H, s br, NH), 8.51 (1H, s br, NH) 7.42 (2H, d, J = 8.9 Hz, 2’-H) 7.20 (1H, d, J = 2.2 
Hz, 5’’-H), 6.86 (2H, d, J = 8.9 Hz, 3’-H), 5.93 (1H, s br, 4’’-H), 3.80 (3H, s, 1’’-CH3), 3.79 (3H, s, OCH3); 
δC (151 MHz, CDCl3) 156.0 (C-4’), 153.8 (C=O), 148.7 (C-3’’), 131.9 (C-1’), 131.1 (C-5’’), 122.3 (C-2’), 
114.2 (C-3’), 94.5 (C-4’’), 55.6 (OCH3), 38.9 (1’’-CH3); HRMS (ASAP) m/z found [M+H]+ 247.1183 
C12H15N4O2 requires M, 247.1195. 
 
1‐(4’‐Methoxyphenyl)‐3‐methyl‐3‐(1’’‐methyl‐1H‐pyrrol‐3’’‐yl)urea (395) 
 
At 0 oC under N2, a solution of lithium bis(trimethylsilyl)amide in THF (6 mL, 6.0 mmol, 1.2 equiv.) was 
added dropwise at 0 oC to a solution of 1‐(4‐methoxyphenyl)‐3‐(1‐methyl‐1H‐pyrazol‐3‐yl)urea 391 
(1.23 g, 5.00 mmol, 1.00 equiv.) in anhydrous THF (15 mL). The ice bath was removed and the resulting 
mixture was stirred at rt for 30 min before the addition of methyl iodide (0.65 mL, 5.00 mmol, 1.00 
equiv.). The resulting solution was stirred for 30 min, quenched with NH4Cl (10 mL) and approximately 
one third of the volatiles were removed. EtOAc (35 mL) and H2O (25 mL) were added and the solution 
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was extracted with EtOAc (3 x 20 mL). The combined organic fractions were dried over MgSO4, filtered 
and evaporated. SiO2 gel column chromatography (50 → 60% EtOAc in hexanes) afforded the 
methylated urea as a white solid; (600 mg, 2.30 mmol, 46%); mp = 99 - 100 oC; vmax (ATR) 3254 (NH), 
2950, 1658 (C=O), 1510, 1498, 1412, 1348, 1243, 1148, 1030 cm-1; δH (700 MHz, CDCl3) 10.50 (1H, 
br s, NH); 7.43 (2H, d, J = 8.5 Hz, 2’-H), 7.29 (1H, s br, 5’’-H), 6.85 (2H, d, J = 8.5 Hz, 3’-H) 5.88 (1H, s 
br, 4’’-H), 3.85 (3H, s, 1’’-CH3), 3.78 (3H, s, OCH3) 3.34 (3H, s, 3-CH3); δC (176 MHz, CDCl3) 155.7 (C-
4’), 153.5 (C=O), 152.5 (C-3’’), 132.7 (C-1’), 131.1 (C-5’’), 122.0 (C-4’’), 114.1 (C-3’), 95.0 (C-4’’), 55.6 
(O CH3), 39.2 (1’’-CH3), 33.3 (3-CH3); HRMS (ASAP) m/z found [M+H]+  261.1351, C13H17N4O2 requires 
M, 261.1352.  
1‐(4’‐Methoxyphenyl)‐1,3‐dimethyl‐3‐(1’’‐methyl‐1H‐pyrrol‐3’’‐yl)urea (396) 
 
At 0 oC under N2, a solution of lithium bis(trimethylsilyl)amide in THF (4.80 mL, 4.80 mmol, 2.40 equiv.) 
was added dropwise to a solution of 1‐(4‐methoxyphenyl)‐3‐(1‐methyl‐1H‐pyrazol‐3‐yl)urea 391 (492 
mg, 4.80 mmol, 1.00 equiv.) in THF (3.5 mL). The ice bath was removed and the resulting mixture was 
stirred at rt for 30 min before the addition of methyl iodide (1.25 mL, 20.0 mmol, 10.0 equiv.). The 
resulting solution was stirred for 30 min, quenched with NH4Cl (10 mL) and approximately one third of 
the volatiles were removed. EtOAc (35 mL) and H2O (25 mL) were added and the solution was extracted 
with EtOAc (3 x 20 mL). The combined organic fractions were dried over MgSO4, filtered and 
evaporated. SiO2 gel column chromatography (EtOAc) afforded the bismethylated urea as a yellow oil 
(359 mg, 3.12 mmol, 65%); vmax (ATR) 2930, 1652 (C=O), 1510, 1412, 1358, 1148, 1243, 1028 cm -1;  
δH (700 MHz, CDCl3) 7.00 (1H, s br, 5’’-H), 6.88 (2H, d, J = 8.9 Hz, Ph H), 6.70 (2H, d, J = 8.9 Hz, Ph 
H), 5.91 (1H, s br, 4’’-H), 3.72 (3H, s, OCH3), 3.64 (3H, s, 1’’-CH3), 3.18 (3H, s, 1-CH3), 3.05 (3H, s, 3-
CH3); δC (176 MHz, CDCl3) 160.4 (C=O), 157.0 (C-4’), 152.5 (C-3’’), 138.8 (C-1’), 130.4 (C-5’’) 126.7 
(Ar CH), 114.1 (Ar CH), 99.8 (C-4’’), 55.5 (OCH3), 40.0 (1-CH3), 38.9 (1’’-CH3), 37.8 (3-CH3); HRMS 
(ASAP) m/z found [M+H]+ 275.1510, C14H19N4O2 requires M, 275.1508 m/z. 
1-(4’-methoxyphenyl)-1-methyl-3-(1’’-methyl-1H-pyrazol-3’’-yl)urea (398) 
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To a solution of 4-methoxy-N-methylaniline 397 (685 mg, 5.00 mmol, 1.00 equiv.) and Et3N (2.10 mL, 
15.0 mmol, 3.00 equiv.) in THF (65 mL) under N2 was added triphosgene (743 mg, 2.5 mmol, 0.5 equiv.) 
in one portion. After allowing the mixture to stir for 30 min at rt, 1-methyl-1H-pyrazol-3-amine 373 (0.21 
mL, 2.40 mmol, 3.00 equiv.) was added. The resulting solution was stirred at reflux for 16 h before 
cooling and addition of NH4Cl (100 mL). EtOAc (100 mL) was added and the aqueous layer was 
extracted with EtOAc (3 x 50 mL). The organics were dried over MgSO4, filtered, and evaporated. SiO2 
gel column chromatography (step gradient, 30 → 45%, 90 → 100% EtOAc in hexanes) afforded the 
methylated urea as a white solid (416 mg, 1.32 mmol, 32%); mp = 117-120 oC; vmax (ATR) 3236 (NH), 
2940, 1658 (C=O), 1549, 1498, 1352, 1246, 1149, 1029 cm-1; δH (700 MHz, CDCl3) 7.20 (2H, d, J = 8.4 
Hz, 2’-H), 7.16 (1H, s br, 5’’-H), 6.93 (2H, d, J = 8.4 Hz, 3’-H), 6.73 (1H, s br, NH), 6.56 (1H, s br, 4’’-
H), 3.81 (3H, s, OCH3), 3.68 (3H, s, 1’’-CH3), 3.27 (3H, s, 1-CH3); δC (176 MHz, CDCl3) 159.3 (C-4’), 
154.3 (C=O), 148.3 (C-3’’), 135.1 (C-1’), 131.0 (C-5’’), 129.0 (C-2’), 115.7 (C-3’), 96.1 (C-4’’), 55.7 
(OCH3), 38.6, (1’’-CH3), 37.5 (1-CH3); HRMS (ASAP) m/z found [M+H]+  261.1332, C13H16N4O2 requires 
M, 261.1327; Anal. Calc. for C13H16N4O2: C 59.99, H 6.20, N 21.52, found C 59.42, H 6.19, N 21.51. 
3-{1’-[(3’’,5’’-dimethylphenyl)methyl]-1H-pyrazol-3’-yl}-1-(4’’’-methoxyphenyl)urea (401) 
 
Synthesised according to General Procedure E from 1-[(3,5-dimethylphenyl)methyl]-1H-pyrazol-3-
amine 403 (254 mg, 1.26 mmol, 1.00 equiv.) and 1-isocyanato-4-methoxybenzene (0.33 mL, 2.52 
mmol, 2.00 equiv.). Obtained as a white solid (395 mg, 1.13 mmol, 89%); mp = 173 oC; vmax (ATR) 3340 
(NH), 2964, 1653 (C=O), 1468, 1377, 1305, 1161, 1128 cm-1; δH (700 MHz, CDCl3) 7.34 (2H, d, J = 8.7 
Hz, 2’’’-H), 7.26 (1H, s br, 5’-H), 6.97 (1H, s, 4’’-H), 6.87 (2H, s, 2’’-H), 6.85 (2H, d, J = 8.7 Hz, 3’’’-H) , 
5.88 (1H, s br, 4’-H), 5.11 (2H, s, CH2), 3.79 (3H, s, OCH3), 2.30 (6H, s, 3’’-CH3); δC (176 MHz, CDCl3) 
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156.1 (C-4’’’), 153.1 (C=O), 148.5 (C-3’), 138.7 (C-3’’), 135.8 (C-1’’), 130.7 (C-5’), 130.1 (C-4’’), 125.9 
(C-2’’), 122.3 (C-2’’’), 114.3 (C-3’’’), 94.6 (C-4’), 56.1 (CH2), 55.7 (OCH3), 21.4 (3’’-CH3); HRMS (ESI) 
m/z found [M+H]+ 351.1839, C20H23N4O2 requires M, 351.1821 m/z. 
1-(4’-methoxyphenyl)-3’’-[1-(oxan-2’’’-yl)-1H-pyrazol-3’’-yl]urea (420) 
 
Synthesised according to General Procedure E from 1-(oxan-2-yl)-1H-pyrazol-3-amine 418 (334 mg, 
2.00 mmol, 1.00 equiv.) and 1-isocyanato-4-methoxybenzene (0.52 mL, 4.00 mmol, 2.00 equiv.). 
Obtained as a white solid (275 mg, 0.87 mmol, 44%); mp = 161-162 oC; vmax (ATR) 3373 (NH), 2954, 
1691 (C=O), 1584, 1554, 1415, 1244, 1198, 1062 cm-1; δH (700 MHz, DMSO) 8.92 (1H, s br, NH), 8.84 
(1H, s br, NH), 7.72 (1H, d, J = 2.5 Hz, 5’’-H), 7.35 (2H, d, J = 9.1 Hz, 2’-H), 6.87 (2H, d, J = 9.1 Hz, 3’-
H), 6.27 (1H, s, 4’’-H), 5.26, (1H, dd, J = 10.0, 2.4 Hz, 2’’’-H) 3.91-3.90 (1H, m, 6’’’-H), 3.71 (3H, s, 
OCH3) 3.61-3.58 (1H, m, 6’’’-H), 2.07-2.02 (1H, m, 3’’’-H) 1.94-1.92 (1H, m, 4’’’-H), 1.89-1.87 (1H, m, 
3’’’-H), 1.66-1.62 (1H, m, 4’’’-H), 1.53-1.50 (2H, m, 5’’’-H); δC (176 MHz, DMSO) 154.5 (C-4’), 152.1 
(C=O), 147.9 (C-3’’), 132.5 (C-1’), 129.7 (C-5’’), 120.0 (C-2’), 114.0 (C-3’), 95.8 (C-4’’), 86.3 (C-2’’’), 
66.7 (C-6’’’), 55.2 (OCH3), 29.5 (C-3’’’), 24.6 (C-5’’’), 22.1 (C-4’’’); HRMS (ESI) m/z found [M+H]+  
317.1621, C16H21N4O3 requires M, 317.1614. 
3‐(6’‐Chloropyridin‐2’‐yl)‐1‐phenylurea (429a) 
 
Synthesised according to General Procedure E from 6-chloropyridin-2-amine 424c (643 mg, 5.00 mmol, 
1.00 equiv.) and isocyanatobenzene (1.09 mL, 10.0 mmol, 2.00 equiv.). Obtained as a white solid and 
used without further purification (805 mg, 3.25 mmol, 65%); mp: 193-194 oC; vmax (ATR) 3371 (NH), 
2964, 1687 (C=O), 1561, 1498, 1450, 1394, 1304, 1253, 1162, 1022 cm-1; δH (600 MHz, DMSO) 9.54 
(1H, s br, NH), 9.33 (1H, s br, NH), 7.79 (1H, t, J = 7.5 Hz, 4’-H), 7.76 (1H, d, J = 7.8 Hz, 3’-H), 7.46 
(2H, d, J = 7.8 Hz, 2’’-H), 7.31 (2H, t, J = 7.8 Hz, 3’’-H) 7.10 (1H, d, J = 7.5 Hz, 5’-H), 7.02 (1H, t, J = 
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7.5 Hz, 4’’-H); δC (151 MHz, DMSO) 152.8 (C-2’), 151.6 (C=O), 147.5 (C-6’), 141.6 (C-4’), 138.8 (C-1’’), 
128.9 (C-3’’), 122.6 (C-4’’), 118.6 (C-2’’), 117.2 (C-5’), 110.3 (C-3’); HRMS (ASAP) m/z found [M+H]+ 
248.0589 C12H1135ClN3O requires M, 248.0591.  
3‐(6’‐Methylpyridin‐2’‐yl)‐1‐phenylurea (429b) 
 
Synthesised according to General Procedure E from 6-methylpyridin-2-amine 424e (541 mg, 5.00 
mmol, 1.00 equiv.) and isocyanatobenzene (1.09 mL, 10.0 mmol, 2.00 equiv.). Obtained as a white 
solid and used without further purification (1.05 g, 4.65 mmol, 93%); mp: 183-184 oC; vmax (ATR) 3373 
(NH), 2984, 1687 (C=O), 1592, 1562, 1445, 1315, 1273, 1159 cm-1; δH (700 MHz, DMSO) 10.89 (1H, 
s br, NH), 9.47 (1H, s br, NH), 7.63 (1H, t, J = 8.0 Hz, 4’-H), 7.52 (2H, d, J = 7.6 Hz, 2’’-H), 7.31 (2H, t, 
J = 7.6 Hz, 3’’-H), 7.20 (1H, d, J = 8.0 Hz, 3’-H), 7.02 (1H, t, J = 7.6 Hz, 4’’-H), 6.87 (1H, d, J = 8.0 Hz,  
5’-H), 2.45 (3H, s, CH3); δC (176 MHz, DMSO) 155.3 (C-6’), 152.3 (C-2’), 152.2 (C=O), 139.1 (C-1’’), 
138.9 (C-4’), 128.9 (C-3’’), 122.4 (C-4’’), 118.6 (C-2’’), 116.5 (C-5’), 108.7 (C-3’) 23.6 (CH3); HRMS 
(ASAP) m/z found [M+H]+  228.1140 C13H14N3O requires M, 228.1137.  
3‐(6‐Ethylpyridin‐2‐yl)‐1‐phenylurea (429c) 
 
Synthesised according to General Procedure E from 6-ethylpyridin-2-amine 424f (610 mg, 5.00 mmol, 
1.00 equiv.) and isocyanatobenzene (1.09 mL, 10.0 mmol, 2.00 equiv.). Recrystallisation from EtOAc 
afforded the urea as a white crystalline solid (1.16 g, 4.80 mmol, 96%); mp: 179-181 oC;  vmax (ATR) 
3373 (NH), 2977, 1686 (C=O), 1594, 1559, 1499, 1446, 1316, 1275, 1179, 1162, 1030 cm -1; δH (600 
MHz, DMSO) 11.00 (1H, s br, NH), 9.50 (1H, s br, NH), 7.65 (1H, t, J = 8.0 Hz, 4’-H), 7.51 (2H, d, J = 
7.8 Hz, 2’’-H), 7.32 (2H, t, J = 7.8 Hz, 3’’-H) 7.18 (1H, d, J = 8.0 Hz, 3’-H), 7.02 (1H, t, J = 7.8 Hz, 4’’-
H), 6.89 (1H, d, J = 8.0 Hz, 5’-H) 2.75 (2H, q, J = 7.6 Hz, CH2), 1.27 (3H, t, J = 7.6 Hz, CH3); δC (151 
MHz, DMSO) 160.1 (C-6’), 152.4 (C-2’), 152.2 (C=O), 139.0 (C-1’’), 139.0 (C-4’), 128.9 (C-3’’), 122.5 
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(C-4’’), 118.7 (C-2’’), 115.3 (C-5’), 109.0 (C-3’), 30.1 (CH2), 13.5 (CH3); m/z (ASAP) [M+H]+  242.1; CHN 
calculated for C14H15N3O: C 69.49%, H 6.27%, N 17.43%, found: 69.69%, H 6.27%, N 17.41%; 
1-(4’-Methoxyphenyl)-3-(6’’-methylpyridin-2’’-yl)urea (429d) 
 
Synthesised according to General Procedure E from 6-methylpyridin-2-amine 425e (541 mg, 5.00 
mmol, 1.00 equiv.) and 1-isocyanato-4-methoxybenzene (1.30 mL, 10.0 mmol, 2.00 equiv.). Obtained 
as a white solid and used without further purification (1.28 g, 4.95 mmol, 99%); mp: 189-190 oC; vmax 
(ATR) 3359 (NH), 2981, 2843, 1685 (C=O), 1588, 1505, 1456, 1297, 1225, 1108, 1035 cm-1;  δH (600 
MHz, DMSO) 10.73 (1H, s br, NH), 9.39 (1H, s br, NH), 7.61 (1H, t, J = 8.0 Hz, 4’’-H), 7.42 (2H, d, J = 
8.0 Hz, 2’-H), 7.16 (1H, d, J = 9.0 Hz, 3’’-H), 6.90 (2H, d, J = 9.0 Hz, 3’-H), 6.85 (1H, d, J = 9.0 Hz, 5’’-
H), 3.72 (3H, s, CH3O), 2.44 (3H, s, 6’’-CH3); δC (151 MHz, DMSO) 155.2 (C-6’’), 154.8 (C-4’), 152.5 
(C-2’’), 152.3 (C=O), 138.8 (C-4’’), 132.1 (C-1’), 120.3 (C-2’), 116.3 (C-5’’), 114.1 (C-3’), 108.6 (C-3’’), 
55.2 (OCH3), 23.6 (6’’-CH3); HRMS (ASAP) m/z found [M+H]+ 258.1250, C14H16N3O2 requires M, 
258.1243; CHN calculated for C14H15N3O2: C 65.35%, H 5.88%, N 16.33%, found: 65.06%, H 5.78%, 
N 16.27%.  
1‐(4’‐Methoxyphenyl)‐3‐(5’’‐methylpyridin‐2’’‐yl)urea (429e) 
 
To a solution of 5-methylpyridin-2-amine 427a (1.08 g, 10.0 mmol, 2.00 equiv.) in MeCN (20 mL) was 
added 1-isocyanato-4-methoxybenzene (0.65 mL, 5.00 mmol, 1.00 equiv.). After stirring at rt for 16 h, 
the volatiles were removed before filtration in Et2O (3 x 10 mL). The pyridyl urea was obtained as a 
white solid and used without further purification (1.17 g, 4.55 mmol, 91%); mp: 153-154 oC; vmax (ATR) 
3360 (NH), 2987, 1683 (C=O), 1593, 1559, 1491, 1375, 1316, 1299, 1234, 1170, 1026 cm -1; δH (600 
MHz, DMSO) 10.32 (1H, s br, NH), 9.25 (1H, s br, NH), 8.09 (1H, s, 6’’-H), 7.56 (1H, d, J = 8.3 Hz, 4’’-
H) 7.41 (2H, d, J = 8.0 Hz, 2’-H), 7.36 (1H, d, J = 8.3 Hz, 3’’-H), 6.88 (2H, d, J = 8.0 Hz, 3’-H), 3.72 (3H, 
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s, OCH3), 2.22 (3H, s, 5’’-CH3); δC (151 MHz, DMSO) 154.8 (C-4’), 152.3 (C=O), 150.9 (C-2’’), 146.3 
(C-6’’), 139.1 (C-4’’), 132.1 (C-1’), 126.0 (C-5’’), 120.5 (C-2’), 114.0 (C-3’), 111.4 (C-3’’), 55.2 (OCH3), 
17.1 (5’’-CH3); HRMS (ASAP) m/z found [M+H]+ 258.1226, C14H16N3O2 requires M, 258.1243; CHN 
calculated for C14H15N3O2: C 65.35%, H 5.88%, N 16.33%, found: 65.23%, H 5.86%, N 16.24%. 
3‐(5’,6’‐Dimethylpyridin‐2’‐yl)‐1‐(4’’‐methoxyphenyl)urea (429f) 
 
To a solution of 5,6-dimethylpyridin-2-amine 427d (793 mg, 6.50 mmol, 2.00 equiv.) in MeCN (10 mL) 
was added 1-isocyanato-4-methoxybenzene (0.42 mL, 3.25 mmol, 1.00 equiv.). After stirring at rt for 
16 h, the volatiles were removed before filtration in Et2O (3 x 10 mL). The pyridyl urea was obtained as 
a white solid and used without further purification (1.10 g, 4.06 mmol, 81%); mp: 194-195 oC; vmax (ATR) 
3357 (NH), 2987, 1680 (C=O), 1598, 1566, 1512, 1466, 1397, 1323, 1228, 1159 cm -1;  δH (700 MHz, 
DMSO) 10.76 (1H, s br, NH), 9.28 (1H, s br, NH), 7.44 (1H, d, J = 8.3 Hz, 4’-H), 7.42 (2H, d, J = 9.0 Hz, 
2’’-H), 7.10 (1H, d, J = 8.3 Hz, 3’-H), 6.89 (2H, d, J = 9.0 Hz, 3’’-H), 3.72 (3H, s, OCH3), 2.39 (3H, s, 5’-
CH3), 2.16 (3H, s, 6’-CH3); δC (176 MHz, DMSO) 154.7 (C-4’’), 153.2 (C-6’), 152.4 (C=O), 150.4 (C-2’), 
139.7 (C-4’), 132.3 (C-1’’), 123.9 (C-5’), 120.2 (C-2’’), 114.1 (C-3’’), 108.9 (C-3’), 55.2 (OCH3), 21.9 (6’-
CH3), 17.6 (5’-CH3); m/z (ASAP) [M+H]+ 272.1; CHN calculated for C15H17N3O2: C 66.40%, H 6.32%, N 
15.49%, found: 66.51%, H 6.38%, N 15.55%. 
3‐(1’,2’‐Oxazol‐3’‐yl)‐1‐phenylurea (433a) 
 
Synthesised according to General Procedure E from 1,2-oxazol-3-amine 432a (0.38 mL, 5.00 mmol, 
1.00 equiv.) and isocyanatobenzene (1.09 mL, 10.0 mmol, 2.00 equiv.). Obtained as a white solid and 
used without further purification (1.01 g, 4.95 mmol, 99%); mp: 187-189 oC; vmax (ATR) 3279 (NH), 1673 
(C=O), 1599, 1565, 1534, 1495, 1444, 1315, 1283, 1230, 1131, 1027 cm-1; δH (600 MHz, DMSO) 9.57 
(1H, s br, NH), 8.81 (1H, s br, NH), 8.74 (1H, d, J = 1.6 Hz, 5’-H), 7.45 (2H, d, J = 7.4 Hz, 2’’-H), 7.30 
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(2H, t, J = 7.4 Hz, 3’’-H), 7.02 (1H, t, J = 7.4 Hz, 4’’-H), 6.84 (1H, d, J = 1.6 Hz, 4’-H); δC (151 MHz, 
DMSO) 159.8 (C-5’) 158.1 (C-3’), 151.3 (C=O), 138.8 (C-1’’), 128.9 (C-3’’), 122.6 (C-4’’), 118.5 (C-2’’), 
98.3 (C-4’); HRMS (ASAP) m/z found [M+H]+ 204.0770, C10H10N3O2 requires M, 204.0773; CHN 
calculated for C10H9N3O2: C 59.11%, H 4.46%, N 20.68%, found: C 59.06%, H 4.47%, N 20.86%.  
1‐(4’‐Methoxyphenyl)‐3‐(1’’,2’’‐oxazol‐3’’‐yl)urea (433b) 
 
Synthesised according to General Procedure E from 1,2-oxazol-3-amine 432 (0.38 mL, 5.00 mmol, 1.00 
equiv.) and 1-isocyanato-4-methoxybenzene (1.30 mL, 10.0 mmol, 2.00 equiv.). Obtained as a white 
solid following an additional filtration with MeOH (10 mL) (1.26 g, 4.75 mmol, 95%); mp: 198-199 oC; 
vmax (ATR) 3398 (NH), 1675 (C=O), 1607, 1560, 1508, 1233, 1026 cm-1; δH (700 MHz, DMSO) 9.50 
(1H, s br, NH), 8.72 (1H, d, J = 1.6 Hz, 5’’-H), 8.64 (1H, s br, NH), 7.35 (2H, d, J = 9.0 Hz, 2’-H), 6.88 
(2H, d, J = 9.0 Hz, 3’-H), 6.82 (1H, d, J = 1.6 Hz, 4’’-H), 3.72 (3H, s, CH3); δC (176 MHz, DMSO) 159.7 
(C-5’’), 158.2 (C-3’’), 155.0 (C-4’), 151.5 (C=O), 131.8 (C-1’), 120.5 (C-2’), 114.0 (C-3’), 98.3 (C-4’’), 
55.2 (CH3); HRMS (ASAP) m/z found [M+H]+ 234.0879, C11H12N3O3 requires M, 234.0879.  
3‐(1’‐Methyl‐1H‐indazol‐3’‐yl)‐1‐phenylurea (433c) 
 
Synthesised according to General Procedure E from 1-methyl-1H-indazol-3-amine 432b (735 mg, 5 
mmol, 1 equiv.) and isocyanatobenzene (1.09 mL, 10.0 mmol, 2.00 equiv.). Obtained as a white solid 
and used without further purification (1.26 g, 4.75 mmol, 95%); mp: 219-220 oC; vmax (ATR) 3340 (NH), 
2979, 1664 (C=O), 1598, 1495, 1449, 1343, 1326, 1235, 1159 cm-1; δH (700 MHz, DMSO) 9.80 (1H, s 
br, NH), 9.56 (1H, s br, NH), 8.00 (1H, d, J = 8.0 Hz, 4’-H), 7.56 (2H, d, J = 7.5 Hz, 2’’-H), 7.53 (1H, d, 
J = 8.0 Hz, 7’-H), 7.41 (1H, t, J = 8.0 Hz, 6’-H), 7.32 (2H, t, J = 7.5 Hz, 3’’-H), 7.08 (1H, t, J = 8.0 Hz, 5’-
H), 7.02 (1H, t, J = 7.5 Hz, 4’’-H), 3.97 (3H, s, CH3); δC (176 MHz, DMSO) 152.3 (C=O), 140.5 (1’-C-
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7’), 140.3 (C-3’), 139.3 (C-1’’), 128.8 (C-3’’), 127.1 (C-6’), 122.4 (C-4’’), 121.4 (C-4’), 119.3 (C-5’), 118.8 
(C-2’’), 114.8 (3’-C-4’), 109.3 (C-7’), 35.0 (CH3); HRMS (ASAP) m/z found [M]+ 266.1251, C15H14N4O 
requires M, 266.1246. 
4.2.4 Borylation of Aminopyridyl Derivatives 
General Procedure A – C-H Borylation of Pyridyl Derivatives: An oven-dried Schlenk tube was 
charged with [Ir(cod)(OMe)]2 (10 mg, 1.5 mol%), dtbpy (8 mg, 3.0 mol%), and B2pin2 (381 mg, 1.50 
mmol, 1.50 equiv.), sealed and subject to three N2 purge/refill cycles. Anhydrous, Ar degassed mtbe 
was added (molarity vide infra), and the dark active catalyst solution was transferred to a sealed vial 
containing the pyridyl substrate (1.00 equiv.). The reaction mixture was stirred at for the allotted time at 
the allotted temperature, followed by complete removal of the volatiles and subsequent purification.  
4‐(4’,4’,5’,5’‐Tetramethyl‐1’,3’,2’‐dioxaborolan‐2’‐yl)‐6‐(trifluoromethyl)pyridin‐2‐amine (425a)[14] 
 
Synthesised according to General Procedure A from 2-amino-6-trifluoromethylpyridine 424a (162 mg, 
1.00 mmol, 1.0 M, 1.00 equiv.). After 16 h at rt, the reaction was cooled and diluted with EtOAc (10 mL) 
before filtration over SiO2. Removal of the volatiles followed by recrystallisation from MeOH/H2O 
afforded the borylated pyridine as an off-white solid (207 mg, 0.72 mmol, 72%); vmax (ATR) 3333, 3218, 
1639, 1438, 1316, 1275, 1191, 1139 cm -1; δH (700 MHz; CDCl3) 7.33 (1H, s, 5-H), 7.03 (1H, s, 3-H), 
4.70 (2H, s br, NH2), 1.34 (12H, s, CH3); δC (176 MHz, CDCl3) 158.1 (C-2), 146.0 (q, J = 34 Hz, C-6), 
121.9 (q, J = 277 Hz, CF3), 117.9 (C-3), 114.7 (q, J = 3.1 Hz, C-5), 84.9 (C-4’), 25.0 (CH3); δF (376 MHz, 
CDCl3) -68.3; δB (128 MHz, CDCl3) 30.0; HRMS (ASAP) m/z found [M+H]+ 288.1390, C12H16BF3N2O2 
requires 288.1372. Data for 430a was consistent with a previous report.  
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6‐Fluoro‐4‐(4,4,5,5‐tetramethyl‐1,3,2‐dioxaborolan‐2‐yl)pyridin‐2‐amine (425b) 
6‐Fluoro‐5‐(4,4,5,5‐tetramethyl‐1,3,2‐dioxaborolan‐2‐yl)pyridin‐2‐amine (425c)[15]  
 
Synthesised as a 6:5 ratio 425b:425c mixture of regioisomers according to General Procedure A from 
2-amino-6-fluoropyridine 424b (112 mg, 1.00 mmol, 1.0 M, 1.00 equiv.). After 22 h at rt, the reaction 
was cooled and diluted with EtOAc (10 mL) before filtration over SiO2. Removal of the volatiles followed 
by recrystallisation from MeOH/H2O afforded the two borylated pyridines as an off-white solid (160 mg, 
0.67 mmol, 67%); vmax (ATR) 3325, 3185, 2980, 1627, 1545, 1436, 1384, 1358, 1212, 1143 cm -1;  δH 
425b (700 MHz, CDCl3) 6.69 (1H, d, J = 2.6 Hz, 5-H), 6.55 (1H, d, J = 2.6 Hz, 3-H), 4.75 (2H, s br, NH2), 
1.33 (12H, s, CH3); δH 425c (700 MHz, CDCl3) 7.86 (1H, t, J = 7.9 Hz, 4’-H), 6.30, (1H, dd, J = 7.9, 2.7 
Hz, 3’-H), 4.49 (2H, s br, NH2), 1.33 (12H, s, CH3); δC 425b (128 MHz, CDCl3) 163.3 (d, J = 239 Hz, C-
6), 157.5 (d, J = 16 Hz, C-2), 110.3 (d, J = 4 Hz, C-5), 101.8 (d, J = 34 Hz, C-3), 84.7 (OC), 24.9 (CH3); 
δC 430c (128 MHz, CDCl3) 167.6 (d, J = 243 Hz C-6’), 160.1 (d, J = 17 Hz, C-2’), 104.4 (d, J = 4 Hz, C-
3’), 149.3 (d, J = 9.0 Hz, C-4’), 83.8 (OC), 25.0 (CH3); δF 425b (376 MHz, CDCl3) -71.88; δF 425c (376 
MHz, CDCl3) -59.09; HRMS (ASAP) m/z found [M+H]+ 238.1380, C11H16BFN2O requires 2238.1403; 
Data for 425c was consistent with a previous report. 
6‐Chloro‐4‐(4,4,5,5‐tetramethyl‐1,3,2‐dioxaborolan‐2‐yl)pyridin‐2‐amine (425d)[14] 
 
Synthesised according to General Procedure A from 2-amino-6-chloropyridine 424c (129 mg, 1.00 
mmol, 1.0 M, 1.00 equiv.). After 1 h at 80 oC, the reaction was cooled and diluted with EtOAc (10 mL) 
before filtration over SiO2. Removal of the volatiles followed by recrystallisation from MeOH/H2O 
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afforded the borylated pyridine as an off-white solid (133 mg, 0.52 mmol, 52%); vmax (ATR) 3335, 3193, 
2980, 1630, 1536, 1435, 1350, 1142 cm-1; δH (700 MHz, CDCl3) 6.99 (1H, s, 5-H), 6.75 (1H, s, 3-H), 
4.50 (2H, s br, NH2), 1.33 (12H, s, CH3); δC (176 MHz, CDCl3) 158.2 (C-2), 149.5 (C-6), 118.0 (C-3), 
112.2 (C-5), 84.8 (C-4’), 25.0 (CH3); δB (128 MHz, CDCl3) 29.9; HRMS (ASAP) m/z found [M+H]+ 
254.1111, C11H16BClN2O2 requires 254.1108. Data for this compound was consistent with reported 
literature.  
1‐(4’‐Methoxyphenyl)‐3‐[6‐methyl‐4‐(4,4,5,5‐tetramethyl‐1,3,2‐dioxaborolan‐2‐yl)pyridin‐2‐yl]urea 
(430c) 
 
Synthesised according to General Procedure A from 1-(4-methoxyphenyl)-3-(6-methylpyridin-2-yl)urea 
429e (257 mg, 1.00 mmol, 0.2 M, 1.00 equiv.). After 2 h at 80 oC, the reaction was cooled and the 
volatiles were removed. Recrystallisation from EtOAc afforded the borylated urea as an oily white solid 
(30 mg, 0.08 mmol, 8%);  δH (600 MHz, DMSO) 10.53 (1H, s br, NH), 9.36 (1H s br, NH), 7.51 (1H, s, 
3’’-H), 7.42 (2H, d, J = 9.2 Hz, 2’-H), 7.04 (1H, s, H-5’’), 6.89 (2H, d, J = 9.2 Hz, 3’-H), 3.73 (3H, s, 
OCH3), 2.45 (3H, s, 6’’-CH3), 1.31 (12H, s, 4’’’-CH3); δC (151 MHz, DMSO) 154.9 (C-6’’) 154.8 (C-4’), 
152.2 (C-2’’), 152.2 (C=O), 139.3 (C-4’’), 132.1 (C-1’), 120.8 (C-5’’), 120.3 (C-2’), 114.1 (C-3’), 113.7 
(C-3’’), 84.3 (C-4’’’), 55.2 (OCH3), 24.6 (4’’’-CH3), 23.4 (6’’-CH3); HRMS (ASAP) m/z found [M+H]+ 
383.2103, C20H26BN3O requires 383.2131.  
4.2.5 Protecting Group Switch of Aminopyrazole Derivatives 
General Procedure F for the Alkylation Switch of Aminopyrazoles: To a solution of Me3OBF4 (1.00 
equiv.) suspended in CH2Cl2 (0.6 M) was added a pyrazole (1.00 equiv) in CH2Cl2 (0.6M). After refluxing 
for the allotted time, the volatiles were removed and the resulting solid was chromatographically 
purified. 
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3,4-dimethyl-1-[1’-methyl-3’-(4’’-methylphenyl)-1H-pyrazol-5’-yl]-2,5-dihydro-1H-pyrrole-2,5-
dione (480) 
 
Synthesised from 3,4-dimethyl-1-[5-(4-methylphenyl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-
yl]-2,5-dihydro-1H-pyrrole-2,5-dione 479 (70 mg, 0.17 mmol, 1.00 equiv.) according to General 
Procedure F. After 5 h, the volatiles were removed and SiO2 gel chromatography (10 → 20% EtOAc in 
PhMe) afforded the switched pyrazole as a white solid (37 mg, 0.13 mmol, 73%); 112-114 oC; νmax 
(ATR) 2950, 1783 (C=O), 1711 (C=O), 1558, 1531, 1365, 1348, 1083 cm -1; δH (600 MHz, CDCl3) 7.66 
(2H, d, J = 8.1 Hz, 2’’-H), 7.19 (2H d, J = 8.1 Hz, 3’’-H), 6.46 (1H, s, 4’-H), 3.75 (3H, s, NCH3), 2.36 (6H, 
s, 3-CH3), 2.08 (3H, s, 4’’-CH3); δC (151 MHz, CDCl3) 169.7 (C-2), 150.6 (C-3’), 138.9 (C-3), 137.8 (C-
4’’), 130.8 (C-5’), 130.2 (C-1’’), 129.4 (C-3’’), 125.5 (C-2’’), 101.1 (C-4’), 36.5 (NCH3), 21.4 (4’’-CH3), 9.2 
(3-CH3); HRMS (ESI) m/z found [M+H]+ 296.1402, C17H18N3O2 requires M, 296.1399. 
3,3-dimethyl-1-[1’-methyl-3’-(4’’-methylphenyl)-1H-pyrazol-5’-yl]pyrrolidine-2,5-dione (489) 
 
Synthesised from 3,3-dimethyl-1-[5-(4-methylphenyl)-1-(oxan-2-yl)-1H-pyrazol-3-yl]pyrrolidine-2,5-
dione 488a (12 mg, 0.03 mmol, 1.00 equiv.) according to General Procedure F. After 16 h, the volatiles 
were removed and SiO2 gel chromatography (15 → 25% EtOAc in PhMe) afforded the switched pyrazole 
as a colourless oil (5 mg, 0.02 mmol, 52%); νmax (ATR) 2930, 1794 (C=O), 1728 (C=O), 1559, 1534, 
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1362, 1347, 1297, 1211 1136 cm-1; δH (700 MHz, CDCl3) 7.65 (2H, d, J = 8.1 Hz, 2’’-H), 7.20 (2H, d, J 
= 8.1 Hz, 3’’-H), 6.52 (1H, s, 4’-H), 3.72 (3H, s, NCH3), 2.80 (2H, s, 4-H), 2.36 (3H, s, 4’’-CH3), 1.48 (6H, 
s, 3-CH3); δC (176 MHz, CDCl3) 181.1 (C-2), 173.5 (C-5), 150.8 (C-3’), 137.8 (C-4’’), 130.8 (C-5’), 130.3 
(C-1’’), 129.4 (C-3’’), 125.5 (C-2’’), 101.3 (C-4’), 44.0 (C-4), 40.9, (C-3), 36.4 (NCH3), 25.9 (3-CH3), 21.4 
(4’’-CH3); HRMS (ESI) m/z found [M+H]+ 298.1566, C17H20N3O2 requires M, 298.1566. 
1-[4’-(4’’-fluorophenyl)-1’-methyl-1H-pyrazol-5’-yl]-3,3-dimethylpyrrolidine-2,5-dione (502b) 
 
Synthesised from tert-butyl 3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)-4-(4-fluorophenyl)-1H-pyrazole-1-
carboxylate 501b (35 mg, 0.09 mmol, 1.00 equiv.) according to General Procedure F. After 16 h, the 
volatiles were removed and SiO2 gel chromatography (0 → 50% EtOAc in PhMe) afforded the switched 
pyrazole as a colourless oil (10 mg, 0.03 mmol, 37%); νmax (ATR) 2969, 1793 (C=O), 1725 (C=O), 1582, 
1511, 1429, 1343, 1230, 1179, 1140 cm-1; δH (700 MHz, CDCl3) 7.67 (1H, s, 3’-H), 7.21-7.19 (2H, m, 
2’’-H), 7.03 (2H, t, J = 8.7 Hz, 3’’-H), 3.71 (3H, s, NCH3), 2.79-2.70 (2H, m, 4-H) 1.46 (3H, s, 3-CH3), 
1.34 (3H, s, 3-CH3); δC (176 MHz, CDCl3) 181.4 (C-2), 173.8 (C-5), 162.3 (d, J = 247 Hz, C-4’’), 137.8 
(C-3’), 129.2 (d, J = 8 Hz, C-2’’), 127.4 (d, J = 3 Hz, C-1’’) 126.7 (C-5’), 119.8 (C-4’), 115.9 (d, J = 22 
Hz, C-3’’), 44.0 (C-4), 41.0 (C-3), 36.1 (1’-CH3), 25.9 (3-CH3), 25.7 (3-CH3); HRMS (ESI) m/z found 
[M+H]+ 302.1316, C16H17N3O2F requires M, 302.1305.  
3,3-dimethyl-1-[1’-methyl-4’-(4’’-methylphenyl)-1H-pyrazol-5’-yl]pyrrolidine-2,5-dione (502c) 
 
Synthesised from tert-butyl 3-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)-4-(4-methylphenyl)-1H-pyrazole-1-
carboxylate 501c (18 mg, 0.05 mmol, 1.00 equiv.) according to General Procedure F. After 16 h, the 
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volatiles were removed and SiO2 gel column chromatography (0 → 50% EtOAc in PhMe) afforded the 
switched pyrazole as a colourless oil (7 mg, 0.02 mmol, 50%); νmax (ATR) 2927, 1799 (C=O), 1726 
(C=O), 1586, 1514, 1397, 1344, 1347, 1232, 1205, 1140 cm-1; δH (700 MHz, CDCl3) 7.69 (1H, s, 3’-H), 
7.15-7.12 (4H, m, 2’’-H, 3’’-H), 3.71 (3H, s, 1’-CH3), 2.75 (2H, q, J = 18.4 Hz, 4-H), 2.33 (3H, s, 4’’-CH3), 
1.46 (3H, s, 3-CH3), 1.36 (3H, s, 3-CH3); δC (176 MHz, CDCl3) 181.4 (C-2), 173.8 (C-5), 137.9 (C-3’), 
137.2 (C-4’’), 129.6 (C-2’’), 128.4 (C-1’’), 127.1 (C-3’’), 126.5 (C-5’), 120.5 (C-4’), 44.0 (C-4), 41.0 (C-
3), 36.0 (NCH3), 25.9 (3-CH3), 25.8 (3-CH3), 21.3 (4’’-CH3); HRMS (ESI) m/z found [M+H]+ 298.1570, 
C17H20N3O2 requires M, 298.1556 
4.3 X-ray Crystallography Data* 
3‐Nitro‐1‐{[2’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazole (450) 
 
Single crystals of C9H19N3OSi (FW 213.36) were obtained via recrystallisation from iPrOH. A suitable 
crystal was selected and analysed on a Bruker D8Venture diffractometer (IμS microfocus sources, 
focusing mirrors, CMOS Photo100 detector) using MoKα (λ = 0.71073 Å) radiation, equipped with 
Crysostream (Oxford Cryosystems) open-flow nitrogen cryostats. The temperature was maintained at 
120 K during data collection. Using Olex2 the structure was solved with the ShelXS structure solution 
program using Intrinsic Phasing and refined with the ShelXL refinement package using Least Squares 
minimisation. 
 
                                                     
* Analyses performed by Dr Dmitry Yufit and Dr Andrei Batsanov  
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Crystallographic Data: plate, colourless, 0.36 × 0.18 × 0.05 mm3, triclinic P-1, a = 7.7755(19) Å, b = 
7.7755(19) Å, c = 7.7755(19) Å, α = 93.324(9)°, β = 102.300(9)°, γ = 91.292(9)°, V = 1267.1(5) Å3, Z = 
4, ρcalc = 1.118 g cm−3, T = 120 K,  μ(MoKα) = 0.163 mm-1, 20779 reflections measured (4.246° ≤ 2θ ≤ 
54.998°), 5719 unique (Rint = 0.0738, Rsigma = 0.0934) which were used in all calculations. The 
final R1 was 0.0980 (I > 2σ(I)) and wR2 was 0.3477 (all data). 
Tert-butyl 3-nitro-1H-pyrazole-1-carboxylate (495)  
 
Single crystals of C8H11N3O4 (FW 213.19) were obtained via recrystallisation from iPrOH. A suitable 
crystal was selected and analysed on a Bruker D8Venture diffractometer (IμS microfocus sources, 
focusing mirrors, CMOS Photo100 detector) using MoKα (λ = 0.71073 Å) radiation, equipped with 
Crysostream (Oxford Cryosystems) open-flow nitrogen cryostats. The temperature was maintained at 
120 K during data collection. Using Olex2[16] the structure was solved with the ShelXT[17] structure 
solution program using Intrinsic Phasing and refined with the ShelXL[18] refinement package using Least 
Squares minimisation. 
 
Crystallographic Data: plate, colourless, 0.337 × 0.266 × 0.102 mm3, monoclinic P21/c, a = 5.8959(5) 
Å, b = 26.572(2) Å, c = 6.4821(6) Å, α = 90.0000°, β = 101.672(4)°, γ = 90.0000°, V = 994.53(15) Å3, Z 
= 1, ρcalc = 1.424 g cm−3, T = 120 K,  μ(MoKα) = 0.116 mm-1, 3363 reflections measured (6.132° ≤ 2θ ≤ 
50.082°), 3363 unique (Rint = n/a, Rsigma = 0.0473) which were used in all calculations. The final R1 was 
0.0423 (I>2σ(I)) and wR2 was 0.1037 (all data)
   
 
 
Tert-butyl 5-amino-1H-pyrazole-1-carboxylate (534) 
 
Single crystals of C8H13N3O2 (FW 183.21) were obtained via recrystallisation from iPrOH. A suitable 
crystal was selected and analysed on a Bruker D8Venture diffractometer (IμS microfocus sources, 
focusing mirrors, CMOS Photo100 detector) using MoKα (λ = 0.71073 Å) radiation, equipped with 
Crysostream (Oxford Cryosystems) open-flow nitrogen cryostats. The temperature was maintained at 
120 K during data collection. Using Olex2 the structure was solved with the ShelXS[19] structure solution 
program using Intrinsic Phasing and refined with the ShelXL refinement package using Least Squares 
minimisation. 
 
Crystallographic Data: irregular, colourless, 0.29 × 0.17 × 0.04 mm3, monoclinic P21/c, a = 9.9588(6) 
Å, b = 9.9588(6) Å, c = 12.2360(7) Å, α = 90.0000°, β = 108.404(3)°, γ = 90.0000°, V = 967.48(10) Å3, 
Z = 4, ρcalc = 1.258 g cm−3, T = 120 K,  μ(MoKα) = 0.093 mm-1, 2318 reflections measured (6.002° ≤ 2θ 
≤ 55.986°), 2318 unique (Rint = 0.0660, Rsigma = 0.0395) which were used in all calculations. The 
final R1 was 0.0492 (I > 2σ(I)) and wR2 was 0.1249 (all data). 
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5.1 NMR Spectra 
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5.2 X-Ray Crystallography Data* 
3‐Nitro‐1‐{[2’‐(trimethylsilyl)ethoxy]methyl}‐1H‐pyrazole (450) 
 
Empirical formula  C9H19N3OSi 
Formula weight  213.36 
Temperature/K  120.0 
Crystal system  triclinic 
Space group  P-1 
a/Å  7.7755(19) 
b/Å  9.616(2) 
c/Å  17.385(4) 
α/°  93.324(9) 
β/°  102.300(9) 
γ/°  91.292(9) 
Volume/Å3  1267.1(5) 
Z  4 
ρcalcg/cm3  1.118 
μ/mm-1  0.163 
F(000)  464.0 
Crystal size/mm3  0.36 × 0.18 × 0.05 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.246 to 54.998 
Index ranges  -10 ≤ h ≤ 10, -12 ≤ k ≤ 12, -22 ≤ l ≤ 22 
Reflections collected  20779 
Independent reflections  5791 [Rint = 0.0738, Rsigma = 0.0934] 
Data/restraints/parameters  5791/0/275 
Goodness-of-fit on F2  1.151 
Final R indexes [I>=2σ (I)]  R1 = 0.0980, wR2 = 0.3227 
Final R indexes [all data]  R1 = 0.1466, wR2 = 0.3477 
Largest diff. peak/hole / e Å-3  0.82/-0.63 
                                                     
* Analyses performed by Dr Dmitry Yufit and Dr Andrei Batsanov  
5 Appendix 
327 
 
Table 1: Crystal data and structure refinement for 450 
Atom x y z U(eq) 
Si1 -244(2) 6281.5(19) 1442.7(9) 30.4(4) 
O1 -535(5) 8227(4) 3592(2) 20.1(8) 
N1 2424(6) 7631(4) 4145(2) 17.6(9) 
N2 3452(5) 8847(4) 4268(2) 15.1(9) 
N3 6269(6) 9484(5) 4075(3) 20.7(10) 
C3 4906(7) 8498(5) 4016(3) 17.7(10) 
C4 4801(7) 7092(5) 3719(3) 20.4(11) 
C5 3206(7) 6590(5) 3808(3) 20.2(11) 
C6 634(7) 7659(5) 4233(3) 19.4(11) 
C7 -970(7) 7292(6) 2895(3) 22.6(11) 
C8 102(7) 7630(6) 2284(3) 23.3(11) 
C9 -2563(10) 6239(8) 879(4) 46.6(18) 
C10 1276(11) 6718(10) 783(4) 59(2) 
C11 256(10) 4542(7) 1844(4) 43.4(17) 
Si1A 4584(2) 1341.3(18) 1396.0(9) 28.9(4) 
O1A 4093(5) 3183(4) 3534(2) 19.8(8) 
N1A 1637(6) 2639(4) 4097(2) 17.7(9) 
N2A 801(6) 3840(4) 4251(3) 19.7(9) 
N3A -2144(7) 4460(5) 4077(3) 21.1(10) 
C3A -885(7) 3501(5) 4010(3) 17.5(10) 
C4A -1173(7) 2100(5) 3684(3) 21.2(11) 
C5A 468(7) 1605(5) 3755(3) 19.7(11) 
C6A 3515(7) 2665(6) 4184(3) 20.8(11) 
C7A 3785(7) 2177(6) 2867(3) 22.5(11) 
C8A 4719(8) 2667(6) 2239(3) 24.6(12) 
C9A 5408(12) -335(7) 1786(4) 50(2) 
C10A 2257(9) 1073(8) 835(4) 45.3(17) 
C11A 5988(10) 1984(9) 727(4) 48.1(19) 
Table 2: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for 450. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor  
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Atom U11 U22 U33 U23 U13 U12 
Si1 37.7(10) 31.9(9) 21.1(8) -4.6(6) 6.3(7) 8.3(7) 
O1 22.1(18) 15.2(18) 22.3(18) -3.0(14) 4.1(14) 2.6(14) 
N1 25(2) 6.5(19) 21(2) 0.4(16) 5.3(17) 0.3(16) 
N2 21(2) 8.9(19) 15.0(19) -1.3(15) 3.6(16) 0.1(16) 
N3 21(2) 17(2) 26(2) 0.6(18) 7.2(18) 5.7(18) 
C3 20(2) 14(2) 18(2) 1.4(19) 1.2(19) 3.4(19) 
C4 26(3) 15(3) 21(2) -0.6(19) 5(2) 7(2) 
C5 28(3) 8(2) 22(2) 0.4(19) 2(2) 2(2) 
C6 26(3) 17(3) 16(2) 0.9(19) 5(2) 1(2) 
C7 22(3) 23(3) 22(3) -1(2) 5(2) 0(2) 
C8 31(3) 23(3) 18(2) 5(2) 8(2) 6(2) 
C9 49(4) 48(4) 36(4) -3(3) -5(3) 11(3) 
C10 66(5) 75(6) 37(4) -26(4) 23(4) -7(4) 
C11 57(4) 22(3) 47(4) -10(3) 3(3) 13(3) 
Si1A 36.6(9) 31.6(9) 18.7(7) -2.2(6) 6.2(6) 9.6(7) 
O1A 22.6(18) 15.1(18) 21.5(18) -2.8(14) 5.6(14) 2.5(14) 
N1A 24(2) 10(2) 19(2) 0.9(16) 4.9(17) 3.7(17) 
N2A 23(2) 13(2) 24(2) 1.9(17) 6.6(18) 3.7(17) 
N3A 20(3) 17(2) 26(2) -4.8(19) 5.2(19) 0.0(19) 
C3A 23(3) 16(2) 14(2) 3.3(18) 5.1(19) 1(2) 
C4A 25(3) 15(3) 23(3) 1(2) 5(2) -3(2) 
C5A 32(3) 7(2) 20(2) -0.1(18) 8(2) 0(2) 
C6A 23(3) 21(3) 19(2) 3(2) 4(2) 6(2) 
C7A 25(3) 20(3) 23(3) -2(2) 8(2) 3(2) 
C8A 30(3) 24(3) 20(2) 4(2) 4(2) 8(2) 
C9A 79(5) 30(4) 41(4) -5(3) 12(4) 26(4) 
C10A 44(4) 51(5) 36(4) -8(3) 2(3) 2(3) 
C11A 51(4) 69(5) 24(3) -6(3) 11(3) -2(4) 
Table 3: Anisotropic Displacement Parameters (Å2×103) for 17srv285. The Anisotropic displacement 
factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…] 
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Atom Atom Length/Å Atom Atom Length/Å 
Si1 C8 1.868(6) Si1A C8A 1.870(6) 
Si1 C9 1.858(7) Si1A C9A 1.859(7) 
Si1 C10 1.871(8) Si1A C10A 1.868(7) 
Si1 C11 1.867(7) Si1A C11A 1.876(7) 
O1 C6 1.424(6) O1A C6A 1.412(6) 
O1 C7 1.441(6) O1A C7A 1.443(6) 
N1 N2 1.381(6) N1A N2A 1.378(6) 
N1 C5 1.352(6) N1A C5A 1.353(7) 
N1 C6 1.433(7) N1A C6A 1.435(7) 
N2 C3 1.338(6) N2A C3A 1.316(7) 
N3 C3 1.390(7) N3A C3A 1.378(7) 
C3 C4 1.413(7) C3A C4A 1.424(7) 
C4 C5 1.363(8) C4A C5A 1.356(8) 
C7 C8 1.527(7) C7A C8A 1.523(7) 
Table 4: Bond Lengths for 450  
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Atom Atom Atom Angle/˚ Atom Atom Atom Angle/˚ 
C8 Si1 C10 108.4(3) C8A Si1A C11A 108.6(3) 
C9 Si1 C8 110.6(3) C9A Si1A C8A 109.1(3) 
C9 Si1 C10 109.8(4) C9A Si1A C10A 109.4(4) 
C9 Si1 C11 109.0(4) C9A Si1A C11A 109.9(4) 
C11 Si1 C8 108.7(3) C10A Si1A C8A 110.3(3) 
C11 Si1 C10 110.3(4) C10A Si1A C11A 109.5(3) 
C6 O1 C7 113.5(4) C6A O1A C7A 111.8(4) 
N2 N1 C6 119.9(4) N2A N1A C6A 120.0(4) 
C5 N1 N2 111.4(4) C5A N1A N2A 111.5(4) 
C5 N1 C6 127.5(4) C5A N1A C6A 127.6(4) 
C3 N2 N1 104.1(4) C3A N2A N1A 104.1(4) 
N2 C3 N3 119.6(4) N2A C3A N3A 120.6(5) 
N2 C3 C4 111.5(5) N2A C3A C4A 112.2(4) 
N3 C3 C4 128.8(5) N3A C3A C4A 127.2(5) 
C5 C4 C3 105.0(4) C5A C4A C3A 104.3(5) 
N1 C5 C4 107.9(4) N1A C5A C4A 107.9(4) 
O1 C6 N1 113.8(4) O1A C6A N1A 113.7(4) 
O1 C7 C8 112.4(4) O1A C7A C8A 109.9(4) 
C7 C8 Si1 112.2(4) C7A C8A Si1A 112.8(4) 
Table 5: Bond Angles for 450 
 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
N3 H3A O11 0.89(6) 2.17(6) 3.041(6) 165(5) 
N3 H3B N22 0.87(6) 2.31(6) 3.179(6) 176(5) 
N3A H3AA N2A3 0.86(6) 2.36(7) 3.209(7) 171(5) 
N3A H3AB O1A4 0.77(6) 2.33(6) 3.080(6) 165(6) 
Table 6: Hydrogen Bonds for 450 (11+X,+Y,+Z; 21-X,2-Y,1-Z; 3-X,1-Y,1-Z; 4-1+X,+Y,+Z)  
5 Appendix 
331 
 
 
A B C D Angle/˚   A B C D Angle/˚ 
O1 C7 C8 Si1 172.4(3)   O1A C7A C8A Si1A 174.1(3) 
N2 N1 C6 O1 75.7(5)   N2A N1A C6A O1A -80.5(5) 
C5 N1 C6 O1 -90.7(6)   C5A N1A C6A O1A 88.0(6) 
C7 O1 C6 N1 75.4(5)   C7A O1A C6A N1A -75.3(5) 
C7 C8 Si1 C9 64.5(5)   C7A C8A Si1A C9A -54.0(5) 
C7 C8 Si1 C10 -175.0(5)   C7A C8A Si1A C10A 66.2(5) 
C7 C8 Si1 C11 -55.1(5)   C7A C8A Si1A C11A -173.7(4) 
C8 C7 O1 C6 -99.9(5)   C8A C7A O1A C6A -169.7(4) 
Table 7: Selected Torsion Angles for 450 
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Atom x y z U(eq) 
H4 5657 6603.24 3504.57 24 
H5 2729.08 5671.61 3659.01 24 
H6A 219.21 6695.99 4287.49 23 
H6B 591.09 8215.27 4725.16 23 
H7A -2239.34 7347.3 2655.64 27 
H7B -751.61 6324.45 3046.51 27 
H8A 1367.76 7700 2542.03 28 
H8B -237.08 8546.49 2078.83 28 
H9A -3351.99 5996.56 1225.43 70 
H9B -2713.36 5540.63 434.36 70 
H9C -2846.92 7157.82 680.26 70 
H10A 1148.22 7694.19 653.66 88 
H10B 982.91 6112.82 297.16 88 
H10C 2494.73 6577.14 1053.83 88 
H11A 1447.25 4577.02 2175.32 65 
H11B 179.17 3837.07 1406.63 65 
H11C -596.93 4299.21 2160.54 65 
H3A 7250(70) 9070(60) 4030(30) 12(9) 
H3B 6400(70) 9930(60) 4540(30) 12(9) 
H4A -2266.5 1622.29 3466 25 
H5A 748.06 691.91 3593.85 24 
H6AA 4058.65 3251.31 4664.96 25 
H6AB 3933.38 1707.66 4258.1 25 
H7AA 2504.71 2059.03 2642.92 27 
H7AB 4229.62 1263.33 3038.54 27 
H8AA 5973.66 2885.48 2484.43 29 
H8AB 4188.41 3534.66 2035.7 29 
H9AA 6633.3 -198.41 2074.86 75 
H9AB 5342.22 -1033.89 1346.41 75 
H9AC 4681.84 -656.3 2141.94 75 
H10D 1548.1 653.49 1170.48 68 
H10E 2221.58 452.34 364.44 68 
H10F 1780.93 1973.1 677.02 68 
H11D 5734.22 2957.42 624.27 72 
H11E 5728.07 1412.89 227.61 72 
H11F 7233.65 1915.82 979.17 72 
H3AA -1880(80) 4980(60) 4510(40) 19(15) 
H3AB -3140(80) 4280(60) 3960(30) 11(14) 
Table 8: Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) for 
450 
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tert-butyl 3-nitro-1H-pyrazole-1-carboxylate (495)  
 
 
Empirical formula C8H11N3O4 
Formula weight 213.20 
Temperature/K 120 
Crystal system monoclinic 
Space group P21/n 
a/Å 5.8959(5) 
b/Å 26.572(2) 
c/Å 6.4821(6) 
α/° 90 
β/° 101.672(4) 
γ/° 90 
Volume/Å3 994.53(15) 
Z 4 
ρcalcg/cm3 1.424 
μ/mm-1 0.116 
F(000) 448.0 
Crystal size/mm3 0.337 × 0.266 × 0.102 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 6.132 to 50.082 
Index ranges -7 ≤ h ≤ 6, 0 ≤ k ≤ 31, 0 ≤ l ≤ 7 
Reflections collected 3363 
Independent reflections 3363 [Rint = ?, Rsigma = 0.0473] 
Data/restraints/parameters 3363/0/144 
Goodness-of-fit on F2 1.038 
Final R indexes [I>=2σ (I)] R1 = 0.0423, wR2 = 0.0955 
Final R indexes [all data] R1 = 0.0634, wR2 = 0.1037 
Largest diff. peak/hole / e Å-3 0.17/-0.18 
Table 9: Crystal data and structure refinement for 495 
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Atom x y z U(eq) 
O(1) 6572(2) 1316.0(5) 2761(2) 26.4(4) 
O(2) 10357(2) 1542.1(5) 3118(2) 30.9(4) 
O(3) 10429(2) 3460.6(5) 2560(2) 38.1(4) 
O(4) 7248(2) 3758.0(5) 3263(2) 36.2(4) 
N(1) 7440(3) 2127.1(5) 2933(2) 22.9(4) 
N(2) 8889(3) 2520.0(5) 2871(2) 24.9(4) 
N(3) 8479(3) 3409.8(6) 2925(2) 27.9(4) 
C(1) 8342(3) 1626.3(7) 2953(3) 24.6(4) 
C(2) 6944(3) 759.2(7) 2940(3) 25.9(5) 
C(3) 7524(3) 2907.3(7) 2952(3) 23.5(4) 
C(4) 5257(3) 2787.2(7) 3090(3) 25.8(5) 
C(5) 5248(3) 2276.9(7) 3062(3) 25.6(4) 
C(6) 7870(4) 578.4(7) 1062(3) 33.3(5) 
C(7) 8502(3) 639.6(7) 5032(3) 29.4(5) 
C(8) 4513(3) 569.5(7) 2870(4) 34.3(5) 
Table 10: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for 495. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor. 
 
Atom U11 U22 U33 U23 U13 U12 
O(1) 25.5(7) 17.6(7) 36.5(8) 1.1(6) 7.4(6) -0.4(5) 
O(2) 24.7(8) 22.3(7) 47.2(9) 1.4(7) 10.5(7) 0.1(6) 
O(3) 35.0(9) 24.3(8) 57.7(11) 1.9(7) 15.9(8) -3.7(6) 
O(4) 41.4(9) 21.7(8) 43.3(9) -3.0(7) 3.6(7) 7.3(6) 
N(1) 25.0(9) 18.6(8) 26.2(9) 1.1(7) 7.5(7) -0.8(6) 
N(2) 30.0(9) 20.0(8) 25.1(9) 1.2(7) 6.3(7) -1.9(7) 
N(3) 33.4(10) 21.2(9) 27.9(9) 0.6(7) 3.2(8) 3.4(8) 
C(1) 26.0(11) 23.1(10) 25.5(10) 0.5(8) 7.2(8) -1.4(8) 
C(2) 27.3(11) 15.0(9) 36.2(12) 1.2(8) 8.3(9) 1.1(8) 
C(3) 30.0(11) 20.4(10) 20(1) 0.4(8) 5.0(8) 1.6(8) 
C(4) 29.3(11) 24.1(10) 24.8(10) -0.9(9) 7.4(9) 5.5(8) 
C(5) 23.4(10) 29.3(10) 25.1(10) 1.8(9) 7.1(8) 0.2(8) 
C(6) 38.2(12) 25.3(11) 37.6(12) -3.9(9) 10.5(10) -0.6(9) 
C(7) 31.6(11) 22.3(10) 35.4(12) 1.7(9) 9.4(9) 1.2(8) 
C(8) 29.6(11) 23(1) 50.9(14) 3.4(10) 9.8(10) -2.2(9) 
Table 11: Anisotropic Displacement Parameters (Å2×103) for 495. The Anisotropic displacement factor 
exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…] 
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Atom Atom Length/Å  Atom Atom Length/Å 
O(1) C(1) 1.316(2)  N(2) C(3) 1.314(2) 
O(1) C(2) 1.497(2)  N(3) C(3) 1.451(2) 
O(2) C(1) 1.192(2)  C(2) C(6) 1.510(3) 
O(3) N(3) 1.228(2)  C(2) C(7) 1.510(3) 
O(4) N(3) 1.223(2)  C(2) C(8) 1.512(3) 
N(1) N(2) 1.355(2)  C(3) C(4) 1.395(3) 
N(1) C(1) 1.432(2)  C(4) C(5) 1.356(3) 
N(1) C(5) 1.371(2)     
Table 12: Bond Lengths for 495 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C(1) O(1) C(2) 120.73(14)  O(1) C(2) C(6) 108.88(15) 
N(2) N(1) C(1) 118.78(15)  O(1) C(2) C(7) 109.29(15) 
N(2) N(1) C(5) 112.71(15)  O(1) C(2) C(8) 101.77(14) 
C(5) N(1) C(1) 128.45(16)  C(6) C(2) C(7) 113.81(16) 
C(3) N(2) N(1) 101.96(15)  C(6) C(2) C(8) 111.43(17) 
O(3) N(3) C(3) 118.98(15)  C(7) C(2) C(8) 110.94(17) 
O(4) N(3) O(3) 124.38(16)  N(2) C(3) N(3) 118.55(16) 
O(4) N(3) C(3) 116.64(16)  N(2) C(3) C(4) 115.23(16) 
O(1) C(1) N(1) 107.21(15)  C(4) C(3) N(3) 126.21(16) 
O(2) C(1) O(1) 130.35(17)  C(5) C(4) C(3) 103.25(17) 
O(2) C(1) N(1) 122.44(17)  C(4) C(5) N(1) 106.85(17) 
Table 13: Bond Angles for 495 
 
 
Atom x y z U(eq) 
H(4) 4018.36 3009.17 3182.35 31 
H(5) 3967.92 2063.99 3120.72 31 
H(6A) 6759.14 660.03 -235.5 42(4) 
H(6B) 8102.47 213.28 1156.01 42(4) 
H(6C) 9350.57 744.59 1045.68 42(4) 
H(7A) 10091.23 742.46 5001.38 36(3) 
H(7B) 8464.78 276.91 5297.19 36(3) 
H(7C) 7961.76 821.81 6155.94 36(3) 
H(8A) 3951.4 697.95 4093.21 41(4) 
H(8B) 4517.77 200.79 2898.53 41(4) 
H(8C) 3492.61 686.93 1574.45 41(4) 
Table 14: Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) for 
18srv048. 
 
 
5 Appendix 
336 
 
tert-butyl 5-amino-1H-pyrazole-1-carboxylate (534) 
 
Empirical formula  C8H13N3O2 
Formula weight  183.21 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  9.9588(6) 
b/Å  8.3675(5) 
c/Å  12.2360(7) 
α/°  90 
β/°  108.404(3) 
γ/°  90 
Volume/Å3  967.48(10) 
Z  4 
ρcalcg/cm3  1.258 
μ/mm-1  0.093 
F(000)  392.0 
Crystal size/mm3  0.29 × 0.17 × 0.04 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  6.002 to 55.986 
Index ranges  -13 ≤ h ≤ 12, 0 ≤ k ≤ 11, 0 ≤ l ≤ 16 
Reflections collected  2318 
Independent reflections  2318 [Rint = 0.0660, Rsigma = 0.0395] 
Data/restraints/parameters  2318/0/137 
Goodness-of-fit on F2  1.054 
Final R indexes [I>=2σ (I)]  R1 = 0.0492, wR2 = 0.1142 
Final R indexes [all data]  R1 = 0.0694, wR2 = 0.1249 
Largest diff. peak/hole / e Å-3  0.31/-0.29 
Table 15: Crystal data and structure refinement for 534 
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Table 16: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for 534. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor 
 
 
 
 
 
 
 
 
 
 
 
 
Atom x y z U(eq) 
O1 7603.3(11) 4971.8(13) 6447.4(9) 18.2(3) 
O2 8281.9(13) 4673.0(14) 8386.1(10) 26.6(3) 
N1 6814.7(14) 6693.7(15) 7501.4(11) 16.2(3) 
N2 6083.4(16) 7482.6(15) 6488.0(13) 20.6(3) 
N3 7185(2) 6854(2) 9533.8(14) 32.2(4) 
C1 6578.7(19) 7387.8(19) 8457.9(16) 20.8(4) 
C2 5673.2(18) 8643(2) 8035.8(16) 22.3(4) 
C3 5415.9(17) 8637(2) 6847.3(16) 22.3(4) 
C4 7642.4(16) 5342.0(17) 7503.4(13) 16.7(3) 
C5 8343.6(17) 3516.1(19) 6227.2(15) 19.4(4) 
C6 9905.8(19) 3593(2) 6898.1(17) 33.8(5) 
C7 7609(2) 2057(2) 6505.9(18) 31.3(4) 
C8 8114(2) 3650(2) 4946.2(15) 28.3(4) 
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Atom U11 U22 U33 U23 U13 U12 
O1 25.3(6) 16.4(5) 15.0(6) -1.1(4) 9.2(5) 4.4(4) 
O2 40.8(7) 22.8(6) 16.1(6) 2.7(5) 8.7(5) 6.5(5) 
N1 21.4(7) 16.0(7) 13.2(7) -0.9(5) 8.5(5) -0.7(5) 
N2 24.0(7) 21.2(7) 16.7(8) 1.2(5) 6.7(7) 2.4(5) 
N3 52.4(11) 32.0(9) 16.5(8) -1.7(7) 17.0(8) 10.6(8) 
C1 24.5(8) 20.3(8) 21.6(10) -6.2(6) 13.3(7) -5.7(6) 
C2 22.2(8) 23.0(8) 24.4(9) -9.3(7) 11.2(7) 0.1(7) 
C3 21.0(8) 22.6(8) 23.5(9) -1.9(7) 7.4(7) 2.6(7) 
C4 21.4(7) 12.7(7) 17.9(8) -1.1(6) 9.0(6) -2.6(6) 
C5 23.7(8) 16.8(8) 18.6(8) -3.2(7) 8.1(7) 5.3(6) 
C6 25.1(9) 42.9(11) 32.8(11) -7.1(9) 8.1(8) 8.3(8) 
C7 44.9(11) 17.7(8) 34.0(11) -2.2(8) 16.3(10) -0.4(8) 
C8 39.4(10) 27.6(9) 20.6(9) -3.9(7) 13.4(8) 8.9(8) 
Table 17: Anisotropic Displacement Parameters (Å2×103) for 534. The Anisotropic displacement factor 
exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…] 
 
Atom Atom Length/Å Atom Atom Length/Å 
O1 C4 1.3173(18) N3 C1 1.340(3) 
O1 C5 1.4916(18) C1 C2 1.374(2) 
O2 C4 1.2047(18) C2 C3 1.395(3) 
N1 N2 1.391(2) C5 C6 1.514(2) 
N1 C1 1.392(2) C5 C7 1.517(3) 
N1 C4 1.399(2) C5 C8 1.515(2) 
N2 C3 1.324(2)       
Table 18: Bond Lengths for 534 
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Atom Atom Atom Angle/˚ Atom Atom Atom Angle/˚ 
C4 O1 C5 120.39(12) O1 C4 N1 110.70(13) 
N2 N1 C1 111.83(13) O2 C4 O1 127.86(14) 
N2 N1 C4 121.86(13) O2 C4 N1 121.44(14) 
C1 N1 C4 126.29(14) O1 C5 C6 110.44(13) 
C3 N2 N1 103.11(14) O1 C5 C7 108.42(14) 
N3 C1 N1 122.95(16) O1 C5 C8 101.79(12) 
N3 C1 C2 131.50(17) C6 C5 C7 113.48(15) 
C2 C1 N1 105.54(16) C6 C5 C8 110.59(15) 
C1 C2 C3 105.77(15) C8 C5 C7 111.48(15) 
N2 C3 C2 113.75(16) 
    
Table 19: Bond Angles for 534 
 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
N3 H3A O2 0.87(2) 2.12(2) 2.732(2) 126.9(18) 
N3 H3B N21 0.83(3) 2.17(3) 2.981(2) 165(2) 
Table 20: Hydrogen Bonds for 534 (1+X,3/2-Y,1/2+Z) 
 
A B C D Angle/˚ A B C D Angle/˚ 
N2 N1 C4 O1 -0.25(19) C5 O1 C4 N1 -176.60(12) 
N2 N1 C4 O2 179.39(15) C6 C5 O1 C4 -58.23(19) 
C1 N1 C4 O1 177.88(14) C7 C5 O1 C4 66.67(18) 
C1 N1 C4 O2 -2.5(2) C8 C5 O1 C4 -175.69(14) 
C5 O1 C4 O2 3.8(2) 
     
Table 21: Selected Torsion Angles for 534 
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Atom x y z U(eq) 
H6A 10040.89 3406.9 7716.6 51 
H6B 10275.32 4650.43 6799.77 51 
H6C 10412.42 2772.22 6612.13 51 
H7A 6601.37 2089.84 6058.82 47 
H7B 7715.23 2049.3 7329.86 47 
H7C 8035.83 1087.99 6309 47 
H8A 8501.47 4666.8 4784.03 42 
H8B 7097.7 3607.55 4526.5 42 
H8C 8592.65 2763.56 4699.46 42 
H2 5319(19) 9350(20) 8508(16) 22(5) 
H3 4830(20) 9400(20) 6269(18) 40(6) 
H3A 7720(20) 6010(30) 9648(18) 39(6) 
H3B 6940(30) 7210(30) 10070(20) 37(6) 
Table 22: Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) for 
534 
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5.3 Additional Metal Complexes and Ligands 
5.3.1 Structures of Metal Complexes 
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5.3.2 Strucutures of Ligands 
 
